<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="review-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Pharmacol</journal-id><journal-id journal-id-type="iso-abbrev">Front Pharmacol</journal-id><journal-id journal-id-type="pmc-domain-id">1524</journal-id><journal-id journal-id-type="pmc-domain">frontpharmacol</journal-id><journal-id journal-id-type="publisher-id">Front. Pharmacol.</journal-id><journal-title-group><journal-title>Frontiers in Pharmacology</journal-title></journal-title-group><issn pub-type="epub">1663-9812</issn><publisher><publisher-name>Frontiers Media SA</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11996930</article-id><article-id pub-id-type="pmcid-ver">PMC11996930.1</article-id><article-id pub-id-type="pmcaid">11996930</article-id><article-id pub-id-type="pmcaiid">11996930</article-id><article-id pub-id-type="pmid">40235541</article-id><article-id pub-id-type="doi">10.3389/fphar.2025.1523176</article-id><article-id pub-id-type="publisher-id">1523176</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Pharmacology</subject><subj-group><subject>Review</subject></subj-group></subj-group></article-categories><title-group><article-title>
<italic toggle="yes">Ligusticum chuanxiong</italic>: a chemical, pharmacological and clinical review</article-title><alt-title alt-title-type="left-running-head">Wang et al.</alt-title><alt-title alt-title-type="right-running-head"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.3389/fphar.2025.1523176" ext-link-type="uri">10.3389/fphar.2025.1523176</ext-link></alt-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Wang</surname><given-names initials="Y">Yin</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="fn001" ref-type="author-notes">
<sup>&#8224;</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/Writing - review &amp; editing/"/></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Wu</surname><given-names initials="L">Liuyun</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="fn001" ref-type="author-notes">
<sup>&#8224;</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://loop.frontiersin.org/people/2204682/overview"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/software/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/Writing - review &amp; editing/"/></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Wang</surname><given-names initials="H">Hulin</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="fn001" ref-type="author-notes">
<sup>&#8224;</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Jiang</surname><given-names initials="M">Mingyu</given-names></name><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chen</surname><given-names initials="Y">Yu</given-names></name><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/visualization/"/><role content-type="https://credit.niso.org/contributor-roles/Writing - review &amp; editing/"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zheng</surname><given-names initials="X">Xingyue</given-names></name><xref rid="aff5" ref-type="aff">
<sup>5</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://loop.frontiersin.org/people/2316811/overview"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/project-administration/"/><role content-type="https://credit.niso.org/contributor-roles/Writing - review &amp; editing/"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Li</surname><given-names initials="L">Lian</given-names></name><xref rid="aff6" ref-type="aff">
<sup>6</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://loop.frontiersin.org/people/1467535/overview"/><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/project-administration/"/><role content-type="https://credit.niso.org/contributor-roles/Writing - review &amp; editing/"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yin</surname><given-names initials="Q">Qinan</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/project-administration/"/><role content-type="https://credit.niso.org/contributor-roles/Writing - review &amp; editing/"/></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Han</surname><given-names initials="L">Lizhu</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="c001" ref-type="corresp">*</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://loop.frontiersin.org/people/2316885/overview"/><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/Writing - review &amp; editing/"/></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Bai</surname><given-names initials="L">Lan</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="c001" ref-type="corresp">*</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://loop.frontiersin.org/people/1770941/overview"/><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/validation/"/><role content-type="https://credit.niso.org/contributor-roles/visualization/"/><role content-type="https://credit.niso.org/contributor-roles/Writing - review &amp; editing/"/></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Bian</surname><given-names initials="Y">Yuan</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="c001" ref-type="corresp">*</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://loop.frontiersin.org/people/2205715/overview"/><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/Writing - review &amp; editing/"/></contrib></contrib-group><aff id="aff1">
<sup>1</sup>
<institution>Department of Pharmacy</institution>, <institution>Sichuan Academy of Medical Sciences and Sichuan Provincial People&#8217;s Hospital</institution>, <institution>School of Medicine</institution>, <institution>University of Electronic Science and Technology of China</institution>, <addr-line>Chengdu</addr-line>, <country>China</country>
</aff><aff id="aff2">
<sup>2</sup>
<institution>Personalized Drug Therapy Key Laboratory of Sichuan Province</institution>, <institution>Sichuan Academy of Medical Sciences and Sichuan Provincial People&#8217;s Hospital</institution>, <institution>School of Medicine</institution>, <institution>University of Electronic Science and Technology of China</institution>, <addr-line>Chengdu</addr-line>, <country>China</country>
</aff><aff id="aff3">
<sup>3</sup>
<institution>School of Pharmacy</institution>, <institution>North Sichuan Medical Collage</institution>, <addr-line>Nanchong</addr-line>, <country>China</country>
</aff><aff id="aff4">
<sup>4</sup>
<institution>Power China Chengdu Engineering Corporation Limited</institution>, <addr-line>Chengdu</addr-line>, <country>China</country>
</aff><aff id="aff5">
<sup>5</sup>
<institution>Department of Pharmacy</institution>, <institution>Chengdu Women&#8217;s and Children&#8217;s Central Hospital</institution>, <institution>School of Medicine</institution>, <institution>University of Electronic Science and Technology of China</institution>, <addr-line>Chengdu</addr-line>, <country>China</country>
</aff><aff id="aff6">
<sup>6</sup>
<institution>Department of Pharmacy</institution>, <institution>The Fourth People&#8217;s Hospital of Chengdu</institution>, <addr-line>Chengdu</addr-line>, <country>China</country>
</aff><author-notes><fn fn-type="edited-by"><p>
<bold>Edited by:</bold>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://loop.frontiersin.org/people/15167/overview" ext-link-type="uri">Michael Heinrich</ext-link>, University College London, United Kingdom</p></fn><fn fn-type="edited-by"><p>
<bold>Reviewed by:</bold>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://loop.frontiersin.org/people/462692/overview" ext-link-type="uri">Ruyu Yao</ext-link>, Chinese Academy of Sciences (CAS), China</p><p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://loop.frontiersin.org/people/633715/overview" ext-link-type="uri">Diego Rivera</ext-link>, University of Murcia, Spain</p><p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://loop.frontiersin.org/people/2414116/overview" ext-link-type="uri">Bin Yu</ext-link>, Nanjing University of Chinese Medicine, China</p><p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://loop.frontiersin.org/people/2634816/overview" ext-link-type="uri">Bob Allkin</ext-link>, Royal Botanic Gardens, Kew, United Kingdom</p></fn><corresp id="c001">*Correspondence: Yuan Bian, <email>bianyuan567@126.com</email>; Lan Bai, <email>blci@163.com</email>; Lizhu Han, <email>yummylila@163.com</email></corresp><fn fn-type="equal" id="fn001"><label>
<sup>&#8224;</sup>
</label><p>These authors share first authorship</p></fn></author-notes><pub-date pub-type="epub"><day>01</day><month>4</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>16</volume><issue-id pub-id-type="pmc-issue-id">480654</issue-id><elocation-id>1523176</elocation-id><history><date date-type="received"><day>05</day><month>11</month><year>2024</year></date><date date-type="accepted"><day>21</day><month>3</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>04</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>15</day><month>04</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-04-16 09:25:26.960"><day>16</day><month>04</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2025 Wang, Wu, Wang, Jiang, Chen, Zheng, Li, Yin, Han, Bai and Bian.</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Wang, Wu, Wang, Jiang, Chen, Zheng, Li, Yin, Han, Bai and Bian</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="fphar-16-1523176.pdf"/><abstract><sec><title>Ethnopharmacological Relevance</title><p>The dried rhizome of <italic toggle="yes">Ligusticum chuanxiong</italic> S.H.Qiu, Y.Q.Zeng, K.Y.Pan, Y.C.Tang and J.M.Xu (<italic toggle="yes">Apiaceae</italic>; including the horticultural variety <italic toggle="yes">Ligusticum chuanxiong Hort</italic>.) [synonym: <italic toggle="yes">Conioselinum anthriscoides</italic> (H.Boissieu) Pimenov and Kljuykov (The taxonomic classification has been adopted by the World Checklist of Vascular Plants)] is a traditional Chinese botanical drug renowned for its anti-inflammatory and antioxidant properties. It has been widely used to treatment various diseases, particularly cardio-cerebral vascular diseases (CCVDs).</p></sec><sec><title>Aim of the review</title><p>This review aims to summarize recent advances in <italic toggle="yes">Ligusticum chuanxiong</italic> (CX) research, including its chemical composition and pharmacological effects, and modern clinical applications.</p></sec><sec><title>Materials and methods</title><p>A systematic literature search was conducted using keywords such as &#8220;Chuanxiong,&#8221; &#8220;traditional Chinese medicine,&#8221; &#8220;chemical components,&#8221; &#8220;metabolites,&#8221; &#8220;CCVDs,&#8221; and &#8220;pharmacological effects&#8221; to identify relevant literature published between 2014 and 2025. Databases including PubMed, Web of Science, Google Scholar, and CNKI were utilized. Chemical structures in SMILES format were retrieved from the PubChem, and two-dimensional chemical structures were generated using ChemDraw Ultra 8.0. Classical prescriptions of chuanxiong were obtained from authoritative traditional Chinese medicine databases.</p></sec><sec><title>Results</title><p>Over 100 metabolites have been isolated and identified from CX, classified into nine major classes. Key bioactive compounds include senkyunolide A, ligustilide, tetramethylpyrazine (TMP), and ligusticum CX polysaccharides (LCP). CX demonstrates significant pharmacological effects in treating CCVDs, such as atherosclerosis (AS), myocardial and cerebral ischemia-reperfusion injury, and hypertension. Its therapeutic mechanisms include antiplatelet activity, endothelial cell protection, anti-inflammatory, antioxidant, and anti-apoptotic properties. CX can be administered alone or in combination with other traditional Chinese medicines (TCMs) or chemical drugs, showing efficacy in cardiovascular, nervous system, digestive system disorders, as well as analgesia and anticancer activities.</p></sec><sec><title>Conclusion</title><p>CX holds substantial clinical value for treating multi-system diseases, with extensive evidence supporting its use in CCVDs. Further research and clinical exploration of CX are warranted to fully harness its therapeutic potential.</p></sec></abstract><kwd-group><kwd>ethnopharmacology</kwd><kwd><italic toggle="yes">Ligusticum chuanxiong</italic></kwd><kwd>traditional Chinese medicine</kwd><kwd>metabolite</kwd><kwd>pharmacological effects</kwd><kwd>cardio-cerebral vascular diseases</kwd></kwd-group><funding-group><funding-statement>The author(s) declare that financial support was received for the research and/or publication of this article. This work was supported by Research Project established by Chinese Pharmaceutical Association Hospital Pharmacy department (NO.CPA-Z05-ZC-2023002), China International Medical Foundation (No. Z-2021-46-2101-2023), the Project of Sichuan Provincial Drug Administration (No. 2024012), the Sichuan Pharmaceutical Association New Quality Pharmacy Start-up Plan Project (NO.scyxh20240701), the Sichuan Provincial Administration of Traditional Chinese Medicine (2023MS222), Scientific research project of Sichuan Medical Association (No. S22084), the Open Research Fund of State Key Laboratory of Southwestern Chinese Medicine Resources (No. SKLTCM2022019).</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>section-at-acceptance</meta-name><meta-value>Ethnopharmacology</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1"><title>1 Introduction</title><p>The dried rhizome of <italic toggle="yes">Ligusticum chuanxiong</italic> S.H.Qiu, Y.Q.Zeng, K.Y.Pan, Y.C.Tang and J.M.Xu (Apiaceae; including the horticultural variety <italic toggle="yes">Ligusticum chuanxiong Hort</italic>.) [synonym: <italic toggle="yes">Conioselinum anthriscoides</italic> (H.Boissieu) Pimenov and Kljuykov (The taxonomic classification of this species has been adopted by the World Checklist of Vascular Plants (WCVP))] (CX, <xref rid="F1" ref-type="fig">Figure 1</xref>) is a Chinese herbal medicine first documented in the <italic toggle="yes">Shennong Materia Medica</italic> and further referenced in ancient books such as the <italic toggle="yes">Compendium of Materia Medica</italic> and the <italic toggle="yes">Synopsis of Prescriptions of the Golden Chamber</italic> (<xref rid="B106" ref-type="bibr">Qiu et al., 1979</xref>). <xref rid="T1" ref-type="table">Table 1</xref> summarizes the definitions and descriptions of <italic toggle="yes">Ligusticum chuanxiong</italic> as outlined in various national or regional pharmacopoeias.</p><fig position="float" id="F1" orientation="portrait"><label>FIGURE 1</label><caption><p>Schematic diagram of <italic toggle="yes">Ligusticum chuanxiong</italic> plant and its medicinal rhizome.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fphar-16-1523176-g001.jpg"/></fig><table-wrap position="float" id="T1" orientation="portrait"><label>TABLE 1</label><caption><p>Definition and description of <italic toggle="yes">Ligusticum chuanxiong</italic> in different pharmacopoeias.</p></caption><table frame="hsides" rules="groups"><thead valign="top"><tr><th align="left" rowspan="1" colspan="1">Country/Region</th><th align="left" rowspan="1" colspan="1">Drug name</th><th align="left" rowspan="1" colspan="1">Species name</th><th align="left" rowspan="1" colspan="1">Common name</th><th align="left" rowspan="1" colspan="1">Comment</th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="1" colspan="1">China</td><td align="left" rowspan="1" colspan="1">Chuanxiong Rhizome</td><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">Ligusticum chuanxiong</italic> Hort</td><td align="left" rowspan="1" colspan="1">&#24029;&#33422;</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">America</td><td align="left" rowspan="1" colspan="1">Sichuan Lovage Rhizome</td><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">Ligusticum striatum</italic> DC. (syn. <italic toggle="yes">Ligusticum chuanxiong</italic> S.H.Qiu, Y.Q.Zeng, K.Y.Pan, Y.C.Tang and J.M.Xu)</td><td align="left" rowspan="1" colspan="1">Chuanxiong</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Europe</td><td align="left" rowspan="1" colspan="1">Ligusticum Root and Rhizome</td><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">Ligusticum sinense</italic> Oliv. or <italic toggle="yes">Ligusticum jeholense</italic> (Nakai and Kitag.) Nakai and Kitag</td><td align="left" rowspan="1" colspan="1">Ligusticum Root and Rhizome</td><td align="left" rowspan="1" colspan="1">The species name refers to ligusticum (&#34241;&#26412;) in the Chinese Pharmacopoeia</td></tr><tr><td align="left" rowspan="1" colspan="1">Japan<xref rid="Tfn1" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="left" rowspan="1" colspan="1">Cnidium Rhizome</td><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">Cnidium officinale</italic> Makino</td><td align="left" rowspan="1" colspan="1">&#12475;&#12531;&#12461;&#12517;&#12454;</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Korea<xref rid="Tfn1" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="left" rowspan="1" colspan="1">Cnidium Rhizome</td><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">Cnidium officinale</italic> Makino or <italic toggle="yes">Ligusticum chuanxiong</italic> Hort</td><td align="left" rowspan="1" colspan="1">&#52380;&#44417;(&#24029;&#33422;)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Taiwan</td><td align="left" rowspan="1" colspan="1">Chuanxiong Rhizome</td><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">Ligusticum chuanxiong</italic> Hort</td><td align="left" rowspan="1" colspan="1">&#24029;&#33422;</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">HongKong</td><td align="left" rowspan="1" colspan="1">Rhizoma Chuanxiong</td><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">Ligusticum chuanxiong</italic> Hort</td><td align="left" rowspan="1" colspan="1">&#24029;&#33422;; chuanxiong</td><td align="left" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="Tfn1"><label>
<sup>a</sup>
</label><p>Due to significant controversies surrounding <italic toggle="yes">Cnidium officinale</italic> Makino in the Japanese and Korean Pharmacopeias, we have not included pharmacological literature related to the source plants listed in these pharmacopeias.</p></fn></table-wrap-foot></table-wrap><p>CX is typically harvested during the summer when stem nodes are visibly swollen and exhibit a slight purple hue. After removal of soil and sand, the rhizomes are sun-dried, roasted, and then cleaned of root hairs. The identification of CX involves morphological, microscopic, and physicochemical analyses. Morphologically, CX appears as irregular, nodular masses with a yellow-brown, rough surface marked by parallel raised nodes and small, tumor-like root scars. The rhizome is firm, emitting a fragrant aroma, and possesses a bitter, spicy taste with a mild numbing sensation. Microscopically, CX is characterized by its cellular structure: the cork layer consists of more than ten rows of cells, with a narrow cortex containing scattered vascular bundles and a distinct cambium. The phloem is broad, and the cambium forms wavy rings or irregular polygons. The xylem vessels are polygonal or round, and the pith is notably large. Parenchyma cells contain oil cells, starch grains, and calcium oxalate crystals. The powdered form of CX is light yellow-brown or gray-brown, with oval or elliptical starch grains and round or cluster-like calcium oxalate crystals. Physicochemical identification involves specific chemical reactions, for instance, when CX powder is treated with petroleum ether and methanol, a red-purple color reaction is observed (<xref rid="B18" ref-type="bibr">Commission, 2020</xref>).</p><p>According to TCM theory, CX is characterized by a spicy and warm nature and is associated with the liver, gallbladder, and pericardium meridians. Its therapeutic effects extend upwards to the head and downwards to the <italic toggle="yes">xuehai</italic> point, located in the depression posterior to the ankle joint. CX facilitates blood circulation (&#27963;&#34880;&#36890;&#32476;huo xue tong luo), dispels wind-cold (&#31067;&#39118;&#25955;&#23506;qu feng san han), and exhibits properties such as invigorating blood (&#27963;&#34880;huo xue), promoting qi flow (&#34892;&#27668;xing qi), expelling wind (&#31067;&#39118;qu feng), and alleviating pain (&#27490;&#30171;zhi tong). CX can be used alone or in combination with other Chinese botanical drugs to treat various conditions, including stroke, angina pectoris, bruises, swelling, and menstrual irregularities (<xref rid="F2" ref-type="fig">Figures 2</xref>, <xref rid="F3" ref-type="fig">3</xref>). <xref rid="T2" ref-type="table">Table 2</xref> provides a list of some classic botanical drugs formulas incorporating CX (<xref rid="B13" ref-type="bibr">Chen et al., 2018</xref>; <xref rid="B18" ref-type="bibr">Commission, 2020</xref>; <xref rid="B117" ref-type="bibr">Shao et al., 2021</xref>). Beyond its medicinal applications, CX also holds culinary value, particularly its leaves. The leaves of CX possess a flavor profile reminiscent of celery and yeast, making them suitable for use in soups, stews, or salads. Additionally, the aromatic aerial parts of the plant are often utilized as fragrant botanical drugs (<xref rid="B65" ref-type="bibr">Li Q. et al., 2024</xref>; <xref rid="B191" ref-type="bibr">Zhou et al., 2024</xref>).</p><fig position="float" id="F2" orientation="portrait"><label>FIGURE 2</label><caption><p>Pharmacological Effects of <italic toggle="yes">Ligusticum chuanxiong</italic>. In TCM theory, CX is a kind of Qi medicine that can reach and work in multiple tissues and organs with the blood. This figure is based on the main affecting parts of the body.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fphar-16-1523176-g002.jpg"/></fig><fig position="float" id="F3" orientation="portrait"><label>FIGURE 3</label><caption><p>Pharmacological Targets of <italic toggle="yes">Ligusticum chuanxiong</italic>. The specific pharmacological effects of CX are realized through the above pathways. The arrows represent the promoting effects while the dash lines represent the inhibitory effects.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fphar-16-1523176-g003.jpg"/></fig><table-wrap position="float" id="T2" orientation="portrait"><label>TABLE 2</label><caption><p>Application of <italic toggle="yes">Ligusticum chuanxiong</italic> in Classical Prescriptions of traditional Chinese medicin<bold>e</bold>.</p></caption><table frame="hsides" rules="groups"><thead valign="top"><tr><th align="left" rowspan="1" colspan="1">Prescription name</th><th align="left" rowspan="1" colspan="1">Main ingredients<xref rid="Tfn2" ref-type="table-fn">
<sup>a</sup>
</xref>
</th><th align="left" rowspan="1" colspan="1">Main activities</th><th align="left" rowspan="1" colspan="1">Clinical application</th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="1" colspan="1">Chuangxiong Cha Tiao Powder<break/>&#24029;&#33422;&#33590;&#35843;&#25955;</td><td align="left" rowspan="1" colspan="1">Chuanxiong Rhizome, Notopterygium Root and Rhizome, Dahurian Angelica Root, et al.</td><td align="left" rowspan="1" colspan="1">Remove wind and relieve pain<break/>&#30095;&#39118;&#27490;&#30171; (shu feng zhi tong)</td><td align="left" rowspan="1" colspan="1">headache due to external wind-evil</td></tr><tr><td align="left" rowspan="1" colspan="1">Fangdfeng Tong Shen Powder<break/>&#38450;&#39118;&#36890;&#22307;&#25955;</td><td align="left" rowspan="1" colspan="1">Divaricate Saposhnikovia Root, Chuanxiong Rhizome, Chinese Angelica, et al.</td><td align="left" rowspan="1" colspan="1">Dispersing wind and relieving exterior symptoms, detoxifying heat and relaxing the bowels<break/>&#25955;&#39118;&#35299;&#34920;\&#28165;&#28909;&#35299;&#27602;\&#28070;&#32928;&#36890;&#20415; (san feng jie biao\qing re jie du\run chang tong bian)</td><td align="left" rowspan="1" colspan="1">Treating all cases of wind-heat</td></tr><tr><td align="left" rowspan="1" colspan="1">Dachuanxiong Pill<break/>&#22823;&#24029;&#33422;&#20024;</td><td align="left" rowspan="1" colspan="1">Chuanxiong Rhizome, Tall Gastrodia Tuber</td><td align="left" rowspan="1" colspan="1">Dispelling wind and clearing collaterals, promoting circulation of Qi and relieving pain<break/>&#31067;&#39118;&#36890;&#32476;\&#34892;&#27668;&#27490;&#30171;&#12290; (qu feng tong luo\xing qi zhi tong)</td><td align="left" rowspan="1" colspan="1">head wind and vertigo</td></tr><tr><td align="left" rowspan="1" colspan="1">Channel-Warming Decoction<break/>&#28201;&#32463;&#27748;</td><td align="left" rowspan="1" colspan="1">Medicinal Evodia Fruit, Twig of Chinese Cinnamon Tree, Chuanxiong Rhizome, et al.</td><td align="left" rowspan="1" colspan="1">Warming menstruation and dispersing cold, dispelling blood stasis and nourishing blood<break/>&#28201;&#32463;&#25955;&#23506;\&#31067;&#30208;&#20859;&#34880; (wen jing san han\qu yu yang xue)</td><td align="left" rowspan="1" colspan="1">Evidence of deficiency and coldness of the Chong Ren and stagnation of blood stasis</td></tr><tr><td align="left" rowspan="1" colspan="1">Taohong Siwu Decoction<break/>&#26691;&#32418;&#22235;&#29289;&#27748;</td><td align="left" rowspan="1" colspan="1">Fresh Rehmannia Root, Tail part of Chinese Angelica Root, Chuanxiong Rhizome, et al.</td><td align="left" rowspan="1" colspan="1">Promoting blood circulation and removing blood stasis, regulating menstruation and relieving pain<break/>&#27963;&#34880;&#21270;&#30208;\&#35843;&#32463;&#27490;&#30171; (huo xue hu ayu\tiao jing zhi tong)</td><td align="left" rowspan="1" colspan="1">Blood deficiency with Blood stasis</td></tr><tr><td align="left" rowspan="1" colspan="1">Siwu Decoction<break/>&#22235;&#29289;&#27748;</td><td align="left" rowspan="1" colspan="1">Prepared Rehmannia Root, Chinese Angelica, White Peony Root, Chuanxiong Rhizome</td><td align="left" rowspan="1" colspan="1">Nourishes and regulates blood<break/>&#34917;&#34880;&#35843;&#34880; (bu xue tiao xue)</td><td align="left" rowspan="1" colspan="1">deficiency and stagnation of camp blood</td></tr><tr><td align="left" rowspan="1" colspan="1">Constraint-Resolving Pill<break/>&#36234;&#38816;&#20024;</td><td align="left" rowspan="1" colspan="1">Rhizome of Nutgrass Galingale, Cape Jasmine Fruit, Chuanxiong Rhizome, et al.</td><td align="left" rowspan="1" colspan="1">relieve melancholy and promote qi circulation<break/>&#35299;&#37057;&#34892;&#27668; (jie yu xing qi)</td><td align="left" rowspan="1" colspan="1">six depressive symptoms</td></tr><tr><td align="left" rowspan="1" colspan="1">Pubescent Angelica and Mistletoe Decoction<break/>&#29420;&#27963;&#23492;&#29983;&#27748;</td><td align="left" rowspan="1" colspan="1">Pubescent Angelica Root, Asarum Root and Rhizome, Chuanxiong Rhizome, et al.</td><td align="left" rowspan="1" colspan="1">Dispelling wind-dampness, relieving paralyzing pain, benefiting the liver and kidney, tonifying qi and blood<break/>&#31067;&#39118;&#38500;&#28287;\&#36890;&#30201;&#27490;&#30171;\&#30410;&#32925;&#32958;\&#34917;&#27668;&#34880; (qu feng chu shi\tong bi zhi tong\yi gan shen\bu qi xue)</td><td align="left" rowspan="1" colspan="1">Prolonged paralysis, deficiency of the liver and kidneys, and insufficiency of qi and blood</td></tr><tr><td align="left" rowspan="1" colspan="1">Toxin-Resolving Powder<break/>&#36133;&#27602;&#25955;</td><td align="left" rowspan="1" colspan="1">Notopterygium Root and Rhizome, Pubescent Angelica Root, Chuanxiong Rhizome, et al.</td><td align="left" rowspan="1" colspan="1">Dispersing cold, dispelling dampness, benefiting Qi and relieving symptoms<break/>&#25955;&#23506;&#31067;&#28287;\&#30410;&#27668;&#35299;&#34920; (san han qu shi\yi qi jie biao)</td><td align="left" rowspan="1" colspan="1">Qi deficiency externally affected by wind-cold-dampness superficial evidence</td></tr><tr><td align="left" rowspan="1" colspan="1">Blood Stasis-Expelling Decoction<break/>&#34880;&#24220;&#36880;&#30208;&#27748;</td><td align="left" rowspan="1" colspan="1">Peach Seed, Dried Safflower Flower, Chuanxiong Rhizome, et al.</td><td align="left" rowspan="1" colspan="1">Promoting blood circulation and removing blood stasis, promoting circulation of Qi and relieving pain<break/>&#27963;&#34880;&#21270;&#30208;\&#34892;&#27668;&#27490;&#30171; (huo xue hu ayu\xing qi zhi tong)</td><td align="left" rowspan="1" colspan="1">Evidence of blood stasis in the chest</td></tr><tr><td align="left" rowspan="1" colspan="1">Engendering and Transforming Decoction<break/>&#29983;&#21270;&#27748;</td><td align="left" rowspan="1" colspan="1">Whole Chinese Angelica, Chuanxiong Rhizome, Peach Seed, et al.</td><td align="left" rowspan="1" colspan="1">Nourishing Blood, dispelling blood stasis, warming menstruation and relieving pain<break/>&#20859;&#34880;&#31067;&#30208;\&#28201;&#32463;&#27490;&#30171; (yang xue qu yu\wen jing zhi tong)</td><td align="left" rowspan="1" colspan="1">Blood deficiency and cold condensation, blood stasis and obstruction evidence</td></tr></tbody></table><table-wrap-foot><fn id="Tfn2"><label>
<sup>a</sup>
</label><p>Definitions of prescription ingredients are from the Chinese Pharmacopoeia 2020 edition.</p></fn></table-wrap-foot></table-wrap><p>China faces a high incidence of CCVDs, which rank among the leading causes of mortality in the population (<xref rid="B73" ref-type="bibr">Liberale et al., 2021</xref>; <xref rid="B157" ref-type="bibr">Xu et al., 2022</xref>). In recent years, the onset of CCVDs such as hypertension, stroke, and coronary heart disease has shifted significantly to younger age groups, with a notable rise in incidence and prevalence among young and middle-aged individuals. Pharmacotherapy plays a pivotal role in managing CCVDs, with ongoing research and development of new drugs and therapeutic approaches. Conventional Western medications, including nitrates, statins, &#946;-blockers, and antiplatelet agents, have effectively treated these conditions (<xref rid="B124" ref-type="bibr">Sikora et al., 2022</xref>). However, patients with CCVDs often face significant residual risks, and Western drugs are associated with varying degrees of adverse effects. Consequently, healthcare professionals are increasingly integrating TCM formulations with conventional Western medications to improve therapeutic outcomes (<xref rid="B59" ref-type="bibr">Li H.-q. et al., 2015</xref>; <xref rid="B83" ref-type="bibr">Liu X.-t. et al., 2016</xref>).</p><p>Chinese herbal medicines that promote blood circulation and resolve blood stasis offer unique advantages in enhancing platelet function and hemodynamics, making them valuable in treating CCVDs (<xref rid="B29" ref-type="bibr">Guo et al., 2020</xref>; <xref rid="B56" ref-type="bibr">Li et al., 2022a</xref>). As a prominent Chinese herbal medicine, CX has been used in China for centuries. Through the integration of TCM theory and modern pharmacological research, the diverse pharmacological effects of CX have been elucidated, particularly its anti-inflammatory and antioxidant properties. Recent studies have made significant progress in understanding its chemical metabolites, pharmacological effects, pharmacokinetics, and safety profiles. Over 100 chemical metabolites have been isolated from CX, including phthalides, terpenes and their enol derivatives, alkaloids, polysaccharides, and organic acids and their ester derivatives. These metabolites exhibit multiple pharmacological activities, such as vasodilation, blood circulation enhancement, antiplatelet aggregation, antioxidant, and anti-inflammatory effects. Notably, some metabolites, such as ligustilide, have been clinically applied in the treatment of CCVDs (<xref rid="B31" ref-type="bibr">Han, 2017</xref>; <xref rid="B13" ref-type="bibr">Chen et al., 2018</xref>).</p><p>This study conducted a systematic literature search using keywords such as Chuanxiong, traditional Chinese medicine, chemical components, metabolites, CCVDs, and pharmacological effects. Relevant literature published between 2014 and 2025 was retrieved from databases including PubMed, Web of Science, Google Scholar, and CNKI. The inclusion criteria comprised English articles with an impact factor greater than 3.0 and Chinese articles from &#8220;<italic toggle="yes">China&#8217;s Core Science and Technology Journals</italic>&#8221; or &#8220;<italic toggle="yes">Peking University Library Chinese Core Journals.</italic>&#8221; A total of 8,534 publications were considered to retrospectively review the progress of modern research on CX, summarize its chemical composition and pharmacological effects, and provide a foundation for its contemporary clinical applications.</p></sec><sec id="s2"><title>2 Metabolites of <italic toggle="yes">Ligusticum chuanxiong</italic>
</title><p>To elucidate the pharmacological activities and clinical applications of CX, a comprehensive analysis of its chemical metabolites is essential. Research on the pharmacodynamic basis of CX has progressed since the 1970s, with over 100 metabolites identified to date. Key bioactive metabolites include phthalides, alkaloids, and polysaccharides. Chemical structure in SMILES format were retrieved from PubChem, and two-dimensional chemical structures representations were generated using ChemDraw Ultra 8.0. A detailed summary of the metabolites and their derivatives is presented in <xref rid="T3" ref-type="table">Table 3</xref>, with corresponding chemical structures depicted in <xref rid="F4" ref-type="fig">Figures 4</xref>&#8211;<xref rid="F8" ref-type="fig">8</xref>.</p><table-wrap position="float" id="T3" orientation="portrait"><label>TABLE 3</label><caption><p>Basic information of metabolites in <italic toggle="yes">Ligusticum chuanxion</italic>
<bold>
<italic toggle="yes">g</italic>
</bold>.</p></caption><table frame="hsides" rules="groups"><thead valign="top"><tr><th align="center" rowspan="1" colspan="1">No.</th><th align="center" rowspan="1" colspan="1">Metabolite</th><th align="center" rowspan="1" colspan="1">Chemical formula</th><th align="center" rowspan="1" colspan="1">References</th><th align="center" rowspan="1" colspan="1">No.</th><th align="center" rowspan="1" colspan="1">Metabolite</th><th align="center" rowspan="1" colspan="1">Chemical formula</th><th align="center" rowspan="1" colspan="1">References</th></tr></thead><tbody valign="top"><tr><td colspan="4" align="left" rowspan="1">Pathalides</td><td colspan="4" align="left" rowspan="1">Terpenes and its enols</td></tr><tr><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">cnidilide</td><td align="left" rowspan="1" colspan="1">C<sub>12</sub>H<sub>18</sub>O<sub>2</sub>
</td><td rowspan="4" align="left" colspan="1">
<xref rid="B66" ref-type="bibr">Li et al. (2003)</xref>
</td><td align="left" rowspan="1" colspan="1">30</td><td align="left" rowspan="1" colspan="1">&#945;-terpinene</td><td align="left" rowspan="1" colspan="1">C<sub>10</sub>H<sub>16</sub>
</td><td rowspan="2" align="left" colspan="1">
<xref rid="B122" ref-type="bibr">Shuai et al. (2022)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">neocindilide</td><td align="left" rowspan="1" colspan="1">C<sub>12</sub>H<sub>18</sub>O<sub>2</sub>
</td><td align="left" rowspan="1" colspan="1">31</td><td align="left" rowspan="1" colspan="1">&#946;-terpinene</td><td align="left" rowspan="1" colspan="1">C<sub>10</sub>H<sub>16</sub>
</td></tr><tr><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">senkyunolide a</td><td align="left" rowspan="1" colspan="1">C<sub>12</sub>H<sub>16</sub>O<sub>2</sub>
</td><td align="left" rowspan="1" colspan="1">32</td><td align="left" rowspan="1" colspan="1">&#947;-terpinene</td><td align="left" rowspan="1" colspan="1">C<sub>10</sub>H<sub>16</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B147" ref-type="bibr">Wang et al. (2010)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">3-butylphthalide</td><td align="left" rowspan="1" colspan="1">C<sub>12</sub>H<sub>14</sub>O<sub>2</sub>
</td><td align="left" rowspan="1" colspan="1">33</td><td align="left" rowspan="1" colspan="1">&#945;-terpinolene</td><td align="left" rowspan="1" colspan="1">C<sub>10</sub>H<sub>16</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B172" ref-type="bibr">Yuan et al. (2000)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">butylidene phthalide</td><td align="left" rowspan="1" colspan="1">C<sub>12</sub>H<sub>12</sub>O<sub>2</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B147" ref-type="bibr">Wang et al. (2010)</xref>
</td><td align="left" rowspan="1" colspan="1">34</td><td align="left" rowspan="1" colspan="1">p-cymene</td><td align="left" rowspan="1" colspan="1">C<sub>10</sub>H<sub>14</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B147" ref-type="bibr">Wang et al. (2010)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">z-ligustilide</td><td align="left" rowspan="1" colspan="1">C<sub>12</sub>H<sub>14</sub>O<sub>2</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B66" ref-type="bibr">Li et al. (2003)</xref>
</td><td align="left" rowspan="1" colspan="1">35</td><td align="left" rowspan="1" colspan="1">limonene</td><td align="left" rowspan="1" colspan="1">C<sub>10</sub>H<sub>16</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B38" ref-type="bibr">Huang and Pu (1990)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">7</td><td align="left" rowspan="1" colspan="1">e-ligustilide</td><td align="left" rowspan="1" colspan="1">C<sub>12</sub>H<sub>14</sub>O<sub>2</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B137" ref-type="bibr">Tang et al. (2010)</xref>
</td><td align="left" rowspan="1" colspan="1">36</td><td align="left" rowspan="1" colspan="1">&#945;-phellandrene</td><td align="left" rowspan="1" colspan="1">C<sub>10</sub>H<sub>16</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B125" ref-type="bibr">Siqueira et al. (2016)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">sedanonic acid lactone</td><td align="left" rowspan="1" colspan="1">C<sub>12</sub>H<sub>16</sub>O<sub>2</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B183" ref-type="bibr">Zhang et al. (2020b)</xref>
</td><td align="left" rowspan="1" colspan="1">37</td><td align="left" rowspan="1" colspan="1">&#946;-phellandrene</td><td align="left" rowspan="1" colspan="1">C<sub>10</sub>H<sub>16</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B15" ref-type="bibr">Cheng et al. (2017)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1">senkyunolide b</td><td align="left" rowspan="1" colspan="1">C<sub>12</sub>H<sub>12</sub>O<sub>3</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B133" ref-type="bibr">Tan et al. (2023)</xref>
</td><td align="left" rowspan="1" colspan="1">38</td><td align="left" rowspan="1" colspan="1">&#945;-thujene</td><td align="left" rowspan="1" colspan="1">C<sub>10</sub>H<sub>16</sub>
</td><td rowspan="2" align="left" colspan="1">
<xref rid="B154" ref-type="bibr">Wu and Yang (2008)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1">senkyunolide c</td><td align="left" rowspan="1" colspan="1">C<sub>12</sub>H<sub>12</sub>O<sub>3</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B53" ref-type="bibr">Kobayashi and Mitsuhashi (1987)</xref>
</td><td align="left" rowspan="1" colspan="1">39</td><td align="left" rowspan="1" colspan="1">&#946;-thujene</td><td align="left" rowspan="1" colspan="1">C<sub>10</sub>H<sub>16</sub>
</td></tr><tr><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">senkyunolide d</td><td align="left" rowspan="1" colspan="1">C<sub>12</sub>H<sub>14</sub>O<sub>4</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B196" ref-type="bibr">Zuo et al. (2011)</xref>
</td><td align="left" rowspan="1" colspan="1">40</td><td align="left" rowspan="1" colspan="1">sabinene</td><td align="left" rowspan="1" colspan="1">C<sub>10</sub>H<sub>16</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B39" ref-type="bibr">Huang and Pu (1988)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1">senkyunolide e</td><td align="left" rowspan="1" colspan="1">C<sub>12</sub>H<sub>12</sub>O<sub>3</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B132" ref-type="bibr">Takashi et al. (1992)</xref>
</td><td align="left" rowspan="1" colspan="1">41</td><td align="left" rowspan="1" colspan="1">camphene</td><td align="left" rowspan="1" colspan="1">C<sub>10</sub>H<sub>16</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B182" ref-type="bibr">Zhang et al. (2024a)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">13</td><td align="left" rowspan="1" colspan="1">senkyunolide f</td><td align="left" rowspan="1" colspan="1">C<sub>12</sub>H<sub>14</sub>O<sub>3</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B66" ref-type="bibr">Li et al. (2003)</xref>
</td><td align="left" rowspan="1" colspan="1">42</td><td align="left" rowspan="1" colspan="1">3-carene</td><td align="left" rowspan="1" colspan="1">C<sub>10</sub>H<sub>16</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B1" ref-type="bibr">Asgary et al. (2013)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1">senkyunolide g</td><td align="left" rowspan="1" colspan="1">C<sub>12</sub>H<sub>16</sub>O<sub>3</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B84" ref-type="bibr">Liu et al. (2016b)</xref>
</td><td align="left" rowspan="1" colspan="1">43</td><td align="left" rowspan="1" colspan="1">4-carene</td><td align="left" rowspan="1" colspan="1">C<sub>10</sub>H<sub>16</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B16" ref-type="bibr">Chruszcz-Lipska (2022)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">senkyunolide h</td><td align="left" rowspan="1" colspan="1">C<sub>12</sub>H<sub>16</sub>O<sub>3</sub>
</td><td rowspan="2" align="left" colspan="1">
<xref rid="B66" ref-type="bibr">Li et al. (2003)</xref>
</td><td align="left" rowspan="1" colspan="1">44</td><td align="left" rowspan="1" colspan="1">&#945;-pinene</td><td align="left" rowspan="1" colspan="1">C<sub>10</sub>H<sub>16</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B147" ref-type="bibr">Wang et al. (2010)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">16</td><td align="left" rowspan="1" colspan="1">senkyunolide i</td><td align="left" rowspan="1" colspan="1">C<sub>12</sub>H<sub>16</sub>O<sub>4</sub>
</td><td align="left" rowspan="1" colspan="1">45</td><td align="left" rowspan="1" colspan="1">cis-cyclodecene</td><td align="left" rowspan="1" colspan="1">C<sub>10</sub>H<sub>18</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B154" ref-type="bibr">Wu and Yang (2008)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">17</td><td align="left" rowspan="1" colspan="1">senkyunolide k</td><td align="left" rowspan="1" colspan="1">C<sub>12</sub>H<sub>16</sub>O<sub>3</sub>
</td><td rowspan="2" align="left" colspan="1">
<xref rid="B53" ref-type="bibr">Kobayashi and Mitsuhashi (1987)</xref>
</td><td align="left" rowspan="1" colspan="1">46</td><td align="left" rowspan="1" colspan="1">myrcene</td><td align="left" rowspan="1" colspan="1">C<sub>10</sub>H<sub>16</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B42" ref-type="bibr">Islam et al. (2020)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">18</td><td align="left" rowspan="1" colspan="1">senkyunolide l</td><td align="left" rowspan="1" colspan="1">C<sub>12</sub>H<sub>15</sub>CLO<sub>3</sub>
</td><td align="left" rowspan="1" colspan="1">47</td><td align="left" rowspan="1" colspan="1">&#945;-curcumene</td><td align="left" rowspan="1" colspan="1">C<sub>15</sub>H<sub>22</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B11" ref-type="bibr">Chen et al. (2004)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">19</td><td align="left" rowspan="1" colspan="1">senkyunolide n</td><td align="left" rowspan="1" colspan="1">C<sub>12</sub>H<sub>18</sub>O<sub>4</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B132" ref-type="bibr">Takashi et al. (1992)</xref>
</td><td align="left" rowspan="1" colspan="1">48</td><td align="left" rowspan="1" colspan="1">&#946;-curcumene</td><td align="left" rowspan="1" colspan="1">C<sub>15</sub>H<sub>24</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B82" ref-type="bibr">Liu et al. (2014)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">20</td><td align="left" rowspan="1" colspan="1">senkyunolide s</td><td align="left" rowspan="1" colspan="1">C<sub>12</sub>H<sub>16</sub>O<sub>5</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B101" ref-type="bibr">Naito et al. (1996)</xref>
</td><td align="left" rowspan="1" colspan="1">49</td><td align="left" rowspan="1" colspan="1">thujopsene</td><td align="left" rowspan="1" colspan="1">C<sub>15</sub>H<sub>26</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B44" ref-type="bibr">Jeong et al. (2014)</xref>
</td></tr><tr><td rowspan="2" align="left" colspan="1">21</td><td rowspan="2" align="left" colspan="1">3-butyl-4-hydroxyphthalide</td><td rowspan="2" align="left" colspan="1">C<sub>12</sub>H<sub>14</sub>O<sub>3</sub>
</td><td rowspan="2" align="left" colspan="1">
<xref rid="B40" ref-type="bibr">Industry (1979)</xref>
</td><td align="left" rowspan="1" colspan="1">50</td><td align="left" rowspan="1" colspan="1">&#945;-selinene</td><td align="left" rowspan="1" colspan="1">C<sub>15</sub>H<sub>26</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B8" ref-type="bibr">Chen et al. (2003)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">51</td><td align="left" rowspan="1" colspan="1">&#946;-selinene</td><td align="left" rowspan="1" colspan="1">C<sub>15</sub>H<sub>24</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B154" ref-type="bibr">Wu and Yang (2008)</xref>
</td></tr><tr><td rowspan="2" align="left" colspan="1">22</td><td rowspan="2" align="left" colspan="1">3-butylidene-4-hydroxyphthalide</td><td rowspan="2" align="left" colspan="1">C<sub>12</sub>H<sub>12</sub>O<sub>3</sub>
</td><td rowspan="2" align="left" colspan="1">
<xref rid="B60" ref-type="bibr">Li et al. (2002)</xref>
</td><td align="left" rowspan="1" colspan="1">52</td><td align="left" rowspan="1" colspan="1">delta-selinene</td><td align="left" rowspan="1" colspan="1">C<sub>15</sub>H<sub>24</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B82" ref-type="bibr">Liu et al. (2014)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">53</td><td align="left" rowspan="1" colspan="1">calarene</td><td align="left" rowspan="1" colspan="1">C<sub>15</sub>H<sub>24</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B154" ref-type="bibr">Wu and Yang (2008)</xref>
</td></tr><tr><td rowspan="2" align="left" colspan="1">23</td><td rowspan="2" align="left" colspan="1">3-butylidene-7-hydroxyphthalide</td><td rowspan="2" align="left" colspan="1">C<sub>12</sub>H<sub>12</sub>O<sub>3</sub>
</td><td rowspan="2" align="left" colspan="1">
<xref rid="B80" ref-type="bibr">Liu et al. (2025)</xref>
</td><td align="left" rowspan="1" colspan="1">54</td><td align="left" rowspan="1" colspan="1">muurolene</td><td align="left" rowspan="1" colspan="1">C<sub>15</sub>H<sub>24</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B82" ref-type="bibr">Liu et al. (2014)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">55</td><td align="left" rowspan="1" colspan="1">guaiene</td><td align="left" rowspan="1" colspan="1">C<sub>16</sub>H<sub>26</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B172" ref-type="bibr">Yuan et al. (2000)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">24</td><td align="left" rowspan="1" colspan="1">levistolide a</td><td align="left" rowspan="1" colspan="1">C<sub>25</sub>H<sub>30</sub>O<sub>4</sub>
</td><td rowspan="4" align="left" colspan="1">
<xref rid="B66" ref-type="bibr">Li et al. (2003)</xref>
</td><td align="left" rowspan="1" colspan="1">56</td><td align="left" rowspan="1" colspan="1">&#947;-gurjunene</td><td align="left" rowspan="1" colspan="1">C<sub>15</sub>H<sub>24</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B154" ref-type="bibr">Wu and Yang (2008)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">25</td><td align="left" rowspan="1" colspan="1">senkyunolide p</td><td align="left" rowspan="1" colspan="1">C<sub>25</sub>H<sub>30</sub>O<sub>4</sub>
</td><td align="left" rowspan="1" colspan="1">57</td><td align="left" rowspan="1" colspan="1">(+)-aromadendrene</td><td align="left" rowspan="1" colspan="1">C<sub>15</sub>H<sub>24</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B162" ref-type="bibr">Yan et al. (2024)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">26</td><td align="left" rowspan="1" colspan="1">riligustilide</td><td align="left" rowspan="1" colspan="1">C<sub>24</sub>H<sub>28</sub>O<sub>4</sub>
</td><td align="left" rowspan="1" colspan="1">58</td><td align="left" rowspan="1" colspan="1">&#946;-cubebene</td><td align="left" rowspan="1" colspan="1">C<sub>15</sub>H<sub>24</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B172" ref-type="bibr">Yuan et al. (2000)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">27</td><td align="left" rowspan="1" colspan="1">tokinolide b</td><td align="left" rowspan="1" colspan="1">C<sub>24</sub>H<sub>28</sub>O<sub>4</sub>
</td><td align="left" rowspan="1" colspan="1">59</td><td align="left" rowspan="1" colspan="1">&#946;-elemene</td><td align="left" rowspan="1" colspan="1">C<sub>15</sub>H<sub>24</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B147" ref-type="bibr">Wang et al. (2010)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">28</td><td align="left" rowspan="1" colspan="1">ansaspirolide</td><td align="left" rowspan="1" colspan="1">C<sub>24</sub>H<sub>26</sub>O<sub>4</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B21" ref-type="bibr">Deng et al. (2006)</xref>
</td><td align="left" rowspan="1" colspan="1">60</td><td align="left" rowspan="1" colspan="1">&#947;-elemene</td><td align="left" rowspan="1" colspan="1">C<sub>15</sub>H<sub>24</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B82" ref-type="bibr">Liu et al. (2014)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">29</td><td align="left" rowspan="1" colspan="1">wallichilide</td><td align="left" rowspan="1" colspan="1">C<sub>25</sub>H<sub>32</sub>O<sub>5</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B19" ref-type="bibr">Cui et al. (2024)</xref>
</td><td align="left" rowspan="1" colspan="1">61</td><td align="left" rowspan="1" colspan="1">bicyclogermacrene</td><td align="left" rowspan="1" colspan="1">C<sub>15</sub>H<sub>24</sub>
</td><td align="left" rowspan="1" colspan="1">(<xref rid="B147" ref-type="bibr">Wang et al., 2010</xref>)</td></tr><tr><td colspan="3" align="left" rowspan="1">Alkaloids</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">62</td><td align="left" rowspan="1" colspan="1">humulene</td><td align="left" rowspan="1" colspan="1">C<sub>15</sub>H<sub>24</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B168" ref-type="bibr">Yeo et al. (2021)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">73</td><td align="left" rowspan="1" colspan="1">trimethylamine</td><td align="left" rowspan="1" colspan="1">C<sub>3</sub>H<sub>9</sub>NO</td><td align="left" rowspan="1" colspan="1">
<xref rid="B178" ref-type="bibr">Zhang et al. (2021)</xref>
</td><td align="left" rowspan="1" colspan="1">63</td><td align="left" rowspan="1" colspan="1">copaene</td><td align="left" rowspan="1" colspan="1">C<sub>15</sub>H<sub>24</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B139" ref-type="bibr">T&#252;rkez et al. (2014)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">74</td><td align="left" rowspan="1" colspan="1">choline</td><td align="left" rowspan="1" colspan="1">C<sub>5</sub>H<sub>14</sub>NO<sup>+</sup>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B156" ref-type="bibr">Xie et al. (2019)</xref>
</td><td align="left" rowspan="1" colspan="1">64</td><td align="left" rowspan="1" colspan="1">xiongterpene</td><td align="left" rowspan="1" colspan="1">C<sub>39</sub>H<sub>54</sub>O<sub>5</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B6" ref-type="bibr">Chang et al. (2007)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">75</td><td align="left" rowspan="1" colspan="1">tetramethylpyrazine</td><td align="left" rowspan="1" colspan="1">C<sub>9</sub>H<sub>13</sub>N</td><td align="left" rowspan="1" colspan="1">
<xref rid="B76" ref-type="bibr">Lin et al. (2022)</xref>
</td><td align="left" rowspan="1" colspan="1">65</td><td align="left" rowspan="1" colspan="1">terpineol</td><td align="left" rowspan="1" colspan="1">C<sub>10</sub>H<sub>18</sub>O</td><td align="left" rowspan="1" colspan="1">
<xref rid="B154" ref-type="bibr">Wu and Yang (2008)</xref>
</td></tr><tr><td rowspan="2" align="left" colspan="1">76</td><td rowspan="2" align="left" colspan="1">l-valine-l-valine anhydride</td><td rowspan="2" align="left" colspan="1">C<sub>10</sub>H<sub>20</sub>N<sub>2</sub>O<sub>3</sub>
</td><td rowspan="2" align="left" colspan="1">
<xref rid="B32" ref-type="bibr">He et al. (2020)</xref>
</td><td align="left" rowspan="1" colspan="1">66</td><td align="left" rowspan="1" colspan="1">carotol</td><td align="left" rowspan="1" colspan="1">C<sub>15</sub>H<sub>26</sub>O</td><td align="left" rowspan="1" colspan="1">
<xref rid="B147" ref-type="bibr">Wang et al. (2010)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">67</td><td align="left" rowspan="1" colspan="1">cedar camphor</td><td align="left" rowspan="1" colspan="1">C<sub>15</sub>H<sub>26</sub>O</td><td rowspan="2" align="left" colspan="1">
<xref rid="B82" ref-type="bibr">Liu et al. (2014)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">77</td><td align="left" rowspan="1" colspan="1">liguzinediol</td><td align="left" rowspan="1" colspan="1">C<sub>8</sub>H<sub>12</sub>N<sub>2</sub>O<sub>2</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B71" ref-type="bibr">Li et al. (2014b)</xref>
</td><td align="left" rowspan="1" colspan="1">68</td><td align="left" rowspan="1" colspan="1">(&#8722;)-globulol</td><td align="left" rowspan="1" colspan="1">C<sub>15</sub>H<sub>26</sub>O</td></tr><tr><td align="left" rowspan="1" colspan="1">78</td><td align="left" rowspan="1" colspan="1">uracil</td><td align="left" rowspan="1" colspan="1">C<sub>4</sub>H<sub>4</sub>N<sub>2</sub>O<sub>2</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B4" ref-type="bibr">Cao et al. (1983)</xref>
</td><td align="left" rowspan="1" colspan="1">69</td><td align="left" rowspan="1" colspan="1">spathulenol</td><td align="left" rowspan="1" colspan="1">C<sub>15</sub>H<sub>24</sub>O</td><td align="left" rowspan="1" colspan="1">
<xref rid="B130" ref-type="bibr">Suru&#269;i&#263; et al. (2017)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">79</td><td align="left" rowspan="1" colspan="1">adenine</td><td align="left" rowspan="1" colspan="1">C<sub>5</sub>H<sub>5</sub>N<sub>5</sub>
</td><td rowspan="2" align="left" colspan="1">
<xref rid="B148" ref-type="bibr">Wang et al. (1985)</xref>
</td><td align="left" rowspan="1" colspan="1">70</td><td align="left" rowspan="1" colspan="1">p-menth-1-en-4-ol</td><td align="left" rowspan="1" colspan="1">C<sub>10</sub>H<sub>18</sub>O</td><td align="left" rowspan="1" colspan="1">
<xref rid="B114" ref-type="bibr">Ruan et al. (2003)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">80</td><td align="left" rowspan="1" colspan="1">adenosine</td><td align="left" rowspan="1" colspan="1">C<sub>10</sub>H<sub>15</sub>N<sub>5</sub>O<sub>4</sub>
</td><td align="left" rowspan="1" colspan="1">71</td><td align="left" rowspan="1" colspan="1">p-cymen-8-ol</td><td align="left" rowspan="1" colspan="1">C<sub>10</sub>H<sub>14</sub>O</td><td align="left" rowspan="1" colspan="1">
<xref rid="B154" ref-type="bibr">Wu and Yang (2008)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">81</td><td align="left" rowspan="1" colspan="1">2-hydrazinopyridine</td><td align="left" rowspan="1" colspan="1">C<sub>5</sub>H<sub>7</sub>N<sub>3</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B192" ref-type="bibr">Zhu and Sheng (2013)</xref>
</td><td align="left" rowspan="1" colspan="1">72</td><td align="left" rowspan="1" colspan="1">cis-sabinenehydrate</td><td align="left" rowspan="1" colspan="1">C<sub>10</sub>H<sub>18</sub>O</td><td align="left" rowspan="1" colspan="1">
<xref rid="B114" ref-type="bibr">Ruan et al. (2003)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">82</td><td align="left" rowspan="1" colspan="1">perlolyrine</td><td align="left" rowspan="1" colspan="1">C<sub>16</sub>H<sub>12</sub>N<sub>2</sub>O<sub>2</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B135" ref-type="bibr">Tang et al. (2000)</xref>
</td><td colspan="3" align="left" rowspan="1">Aldehyde</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">83</td><td align="left" rowspan="1" colspan="1">scopoletin</td><td align="left" rowspan="1" colspan="1">C<sub>10</sub>H<sub>8</sub>O<sub>4</sub>
</td><td align="left" rowspan="1" colspan="1">(Ren et al., 2007)</td><td align="left" rowspan="1" colspan="1">103</td><td align="left" rowspan="1" colspan="1">benzeneacetaldehyde</td><td align="left" rowspan="1" colspan="1">C<sub>8</sub>H<sub>8</sub>O</td><td align="left" rowspan="1" colspan="1">
<xref rid="B147" ref-type="bibr">Wang et al. (2010)</xref>
</td></tr><tr><td colspan="4" align="left" rowspan="1">Organic Acids and Its Esters</td><td colspan="4" align="left" rowspan="1">Phenols</td></tr><tr><td align="left" rowspan="1" colspan="1">84</td><td align="left" rowspan="1" colspan="1">ferulic acid</td><td align="left" rowspan="1" colspan="1">C<sub>10</sub>H<sub>10</sub>O<sub>4</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B66" ref-type="bibr">Li et al. (2003)</xref>
</td><td align="left" rowspan="1" colspan="1">104</td><td align="left" rowspan="1" colspan="1">vanillin</td><td align="left" rowspan="1" colspan="1">C<sub>8</sub>H<sub>8</sub>O<sub>3</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B66" ref-type="bibr">Li et al. (2003)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">85</td><td align="left" rowspan="1" colspan="1">caffeic acid</td><td align="left" rowspan="1" colspan="1">C<sub>9</sub>H<sub>8</sub>O<sub>4</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B27" ref-type="bibr">Gang (2018)</xref>
</td><td align="left" rowspan="1" colspan="1">105</td><td align="left" rowspan="1" colspan="1">p-vinylguaiacol</td><td align="left" rowspan="1" colspan="1">C<sub>9</sub>H<sub>10</sub>O<sub>2</sub>
</td><td rowspan="2" align="left" colspan="1">
<xref rid="B82" ref-type="bibr">Liu et al. (2014)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">86</td><td align="left" rowspan="1" colspan="1">sinapic acid</td><td align="left" rowspan="1" colspan="1">C<sub>11</sub>H<sub>12</sub>O<sub>5</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B170" ref-type="bibr">Yoon et al. (2007)</xref>
</td><td align="left" rowspan="1" colspan="1">106</td><td align="left" rowspan="1" colspan="1">eugenin</td><td align="left" rowspan="1" colspan="1">C<sub>11</sub>H<sub>10</sub>O<sub>4</sub>
</td></tr><tr><td align="left" rowspan="1" colspan="1">87</td><td align="left" rowspan="1" colspan="1">vanillic acid</td><td align="left" rowspan="1" colspan="1">C<sub>8</sub>H<sub>8</sub>O<sub>4</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B167" ref-type="bibr">Yao et al. (2020)</xref>
</td><td align="left" rowspan="1" colspan="1">107</td><td align="left" rowspan="1" colspan="1">cosmosiin</td><td align="left" rowspan="1" colspan="1">C<sub>22</sub>H<sub>22</sub>O<sub>9</sub>
</td><td rowspan="2" align="left" colspan="1">
<xref rid="B111" ref-type="bibr">Ren et al. (2007)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">88</td><td align="left" rowspan="1" colspan="1">protocatechuic acid</td><td align="left" rowspan="1" colspan="1">C<sub>7</sub>H<sub>6</sub>O<sub>4</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B2" ref-type="bibr">Bai et al. (2021)</xref>
</td><td align="left" rowspan="1" colspan="1">108</td><td align="left" rowspan="1" colspan="1">apigenin</td><td align="left" rowspan="1" colspan="1">C<sub>15</sub>H<sub>10</sub>O<sub>5</sub>
</td></tr><tr><td align="left" rowspan="1" colspan="1">89</td><td align="left" rowspan="1" colspan="1">chlorogenic acid</td><td align="left" rowspan="1" colspan="1">C<sub>16</sub>H<sub>18</sub>O<sub>9</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B121" ref-type="bibr">Shi et al. (2024b)</xref>
</td><td align="left" rowspan="1" colspan="1">109</td><td align="left" rowspan="1" colspan="1">antioxidant 2,246</td><td align="left" rowspan="1" colspan="1">C<sub>23</sub>H<sub>34</sub>O<sub>2</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B82" ref-type="bibr">Liu et al. (2014)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">90</td><td align="left" rowspan="1" colspan="1">gallic acid</td><td align="left" rowspan="1" colspan="1">C<sub>7</sub>H<sub>6</sub>O<sub>5</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B49" ref-type="bibr">Jin et al. (2018)</xref>
</td><td colspan="4" align="left" rowspan="1">Ketones</td></tr><tr><td align="left" rowspan="1" colspan="1">91</td><td align="left" rowspan="1" colspan="1">palmitic acid</td><td align="left" rowspan="1" colspan="1">C<sub>16</sub>H<sub>32</sub>O<sub>2</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B41" ref-type="bibr">International (2024)</xref>
</td><td align="left" rowspan="1" colspan="1">110</td><td align="left" rowspan="1" colspan="1">daidzein</td><td align="left" rowspan="1" colspan="1">C<sub>15</sub>H<sub>10</sub>O<sub>4</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B177" ref-type="bibr">Zhai et al. (2020)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">92</td><td align="left" rowspan="1" colspan="1">oleic acid</td><td align="left" rowspan="1" colspan="1">C<sub>18</sub>H<sub>34</sub>O<sub>2</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B5" ref-type="bibr">Cao et al. (2024)</xref>
</td><td align="left" rowspan="1" colspan="1">111</td><td align="left" rowspan="1" colspan="1">meletin</td><td align="left" rowspan="1" colspan="1">C<sub>15</sub>H<sub>10</sub>O<sub>6</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B110" ref-type="bibr">Ren et al. (2008)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">93</td><td align="left" rowspan="1" colspan="1">linoleic acid</td><td align="left" rowspan="1" colspan="1">C<sub>18</sub>H<sub>32</sub>O<sub>2</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B151" ref-type="bibr">Whelan (2008)</xref>
</td><td align="left" rowspan="1" colspan="1">112</td><td align="left" rowspan="1" colspan="1">pregnenolone</td><td align="left" rowspan="1" colspan="1">C<sub>21</sub>H<sub>32</sub>O<sub>2</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B6" ref-type="bibr">Chang et al. (2007)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">94</td><td align="left" rowspan="1" colspan="1">coniferyl ferulate</td><td align="left" rowspan="1" colspan="1">C<sub>19</sub>H<sub>18</sub>O<sub>6</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B66" ref-type="bibr">Li et al. (2003)</xref>
</td><td align="left" rowspan="1" colspan="1">113</td><td align="left" rowspan="1" colspan="1">isopropyl phenyl ketone</td><td align="left" rowspan="1" colspan="1">C<sub>10</sub>H<sub>12</sub>O</td><td align="left" rowspan="1" colspan="1">
<xref rid="B114" ref-type="bibr">Ruan et al. (2003)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">95</td><td align="left" rowspan="1" colspan="1">methyl palmitate</td><td align="left" rowspan="1" colspan="1">C<sub>17</sub>H<sub>34</sub>O<sub>2</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B119" ref-type="bibr">Sharawy et al. (2013)</xref>
</td><td rowspan="2" align="left" colspan="1">114</td><td rowspan="2" align="left" colspan="1">1-bicyclo [ 4.1.0] hept-7-yl-1-pentanone</td><td rowspan="2" align="left" colspan="1">C<sub>12</sub>H<sub>20</sub>O</td><td align="left" rowspan="1" colspan="1">
<xref rid="B154" ref-type="bibr">Wu and Yang (2008)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">96</td><td align="left" rowspan="1" colspan="1">ethyl palmitate</td><td align="left" rowspan="1" colspan="1">C<sub>18</sub>H<sub>36</sub>O<sub>2</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B114" ref-type="bibr">Ruan et al. (2003)</xref>
</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">97</td><td align="left" rowspan="1" colspan="1">bornyl acetate</td><td align="left" rowspan="1" colspan="1">C<sub>12</sub>H<sub>20</sub>O<sub>2</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B164" ref-type="bibr">Yang et al. (2018)</xref>
</td><td colspan="4" align="left" rowspan="1">Anhydride</td></tr><tr><td align="left" rowspan="1" colspan="1">98</td><td align="left" rowspan="1" colspan="1">dibutyl phthalate</td><td align="left" rowspan="1" colspan="1">C<sub>16</sub>H<sub>22</sub>O<sub>4</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B43" ref-type="bibr">Jang et al. (2025)</xref>
</td><td rowspan="2" align="left" colspan="1">115</td><td rowspan="2" align="left" colspan="1">1,4-cyclohexadiene-1,2-dicarboxylic anhydride</td><td rowspan="2" align="left" colspan="1">C<sub>8</sub>H<sub>6</sub>O<sub>3</sub>
</td><td rowspan="2" align="left" colspan="1">
<xref rid="B114" ref-type="bibr">Ruan et al. (2003)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">99</td><td align="left" rowspan="1" colspan="1">diisooctyl phthalate</td><td align="left" rowspan="1" colspan="1">C<sub>24</sub>H<sub>38</sub>O<sub>4</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B91" ref-type="bibr">Luo et al. (2025)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">100</td><td align="left" rowspan="1" colspan="1">ethyl oleate</td><td align="left" rowspan="1" colspan="1">C<sub>20</sub>H<sub>38</sub>O<sub>2</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B127" ref-type="bibr">Srimagal et al. (2017)</xref>
</td><td colspan="4" align="left" rowspan="1">Aromatic Hydrocarbon</td></tr><tr><td align="left" rowspan="1" colspan="1">101</td><td align="left" rowspan="1" colspan="1">ethyl linoleate</td><td align="left" rowspan="1" colspan="1">C<sub>20</sub>H<sub>36</sub>O<sub>2</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B7" ref-type="bibr">Charakida et al. (2007)</xref>
</td><td align="left" rowspan="1" colspan="1">116</td><td align="left" rowspan="1" colspan="1">1-methyl-2-isopropylbenzene</td><td align="left" rowspan="1" colspan="1">C<sub>10</sub>H<sub>14</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B82" ref-type="bibr">Liu et al. (2014)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">102</td><td align="left" rowspan="1" colspan="1">ethyl palmitate</td><td align="left" rowspan="1" colspan="1">C<sub>18</sub>H<sub>36</sub>O<sub>2</sub>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B154" ref-type="bibr">Wu and Yang (2008)</xref>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr></tbody></table></table-wrap><fig position="float" id="F4" orientation="portrait"><label>FIGURE 4</label><caption><p>Pathalides from <italic toggle="yes">Ligusticum chuanxiong</italic>.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fphar-16-1523176-g004.jpg"/></fig><fig position="float" id="F5" orientation="portrait"><label>FIGURE 5</label><caption><p>Terpenes and its enols from <italic toggle="yes">Ligusticum chuanxiong</italic>.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fphar-16-1523176-g005.jpg"/></fig><fig position="float" id="F6" orientation="portrait"><label>FIGURE 6</label><caption><p>Alkaloids from <italic toggle="yes">Ligusticum chuanxiong</italic>.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fphar-16-1523176-g006.jpg"/></fig><fig position="float" id="F7" orientation="portrait"><label>FIGURE 7</label><caption><p>Organic acids and its ester derives from <italic toggle="yes">Ligusticum chuanxiong</italic>.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fphar-16-1523176-g007.jpg"/></fig><fig position="float" id="F8" orientation="portrait"><label>FIGURE 8</label><caption><p>Other metabolites from <italic toggle="yes">Ligusticum chuanxiong</italic>.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fphar-16-1523176-g008.jpg"/></fig><sec id="s2-1"><title>2.1 Volatile oils</title><p>Volatile oils are characteristic metabolites of plants in the <italic toggle="yes">Apiaceae</italic> family, contributing significantly to the aroma of CX. Low-polarity metabolites, such as pathalides, terpenes, and their enol derivatives are typically volatile and are often present in volatile oils (<xref rid="B136" ref-type="bibr">Tang et al., 2022</xref>). Currently, several phthalide metabolites have been identified and isolated, which can be categorized into three main types based on their core structures: monomeric phthalides (1&#8211;8), hydroxylated phthalides (9&#8211;23), and dimeric phthalides (24&#8211;29). Representative metabolites include cnidilide, senkyunolide A, and ligustilide. Previous studies have demonstrated the efficacy of phthalides in improving blood circulation, reducing blood stasis, and providing progressive stimulation, particularly for cardiovascular and cerebrovascular diseases, as well as dysmenorrhea (<xref rid="B10" ref-type="bibr">Chen et al., 2011</xref>; <xref rid="B63" ref-type="bibr">Li J.-h. et al., 2015</xref>; <xref rid="B62" ref-type="bibr">Li et al., 2017</xref>). Research on terpenes remains limited; however, terpenes can be classified into monoterpenes (30&#8211;46), sesquiterpenes (47&#8211;63), triterpenes (64), and terpene derivatives (65&#8211;72).</p></sec><sec id="s2-2"><title>2.2 Organic acids</title><p>Organic acids are primarily found in the volatile oil of CX and to a lesser extent in CX extracts, with 19 types identified. These are categorized into phenolic acids (84&#8211;90), fatty acids (91&#8211;93), and organic esters (94&#8211;102), among which ferulic acid and caffeic acid have been extensively studied. Ferulic acid, one of the most active metabolites in CX, has clinical applications, demonstrating anti-inflammatory properties, enhancement of blood flow, inhibition of platelet aggregation, prevention of thrombosis, and neuroprotective effects (<xref rid="B96" ref-type="bibr">Mathew and Abraham, 2004</xref>; <xref rid="B78" ref-type="bibr">Lin et al., 2009</xref>; <xref rid="B90" ref-type="bibr">Luo et al., 2019</xref>). Ferulic acid has shown antioxidant properties through its interaction with 1,1-diphenyl-2-picryl-hydrazyl radical, acting as a key antioxidant metabolite in CX (<xref rid="B144" ref-type="bibr">Wang et al., 2015</xref>). Meanwhile, due to its abundance, ferulic acid is frequently used as a quality control marker for CX. According to the 2020 edition of the Chinese Pharmacopoeia, the ferulic acid content in dried CX should not be less than 0.01% (<xref rid="B18" ref-type="bibr">Commission, 2020</xref>).</p></sec><sec id="s2-3"><title>2.3 Alkaloids</title><p>Alkaloids are among the most important metabolites of CX; yet only a limited number of alkaloids have been isolated from CX, including organic amines (73,74), pyrazines (75&#8211;77), pyrimidines (78), purines (79,80), pyridines (81), carbolines (82), and scopolamine types (83) (<xref rid="B103" ref-type="bibr">Pu et al., 2019a</xref>). Contemporary research has confirmed the various pharmacological activities of alkaloids (<xref rid="B57" ref-type="bibr">Li et al., 2022b</xref>). In 1977, Chinese researchers identified ligustilide, also known as TMP, a pyrazine metabolite widely present in <italic toggle="yes">Ligusticum</italic> species. TMP is a representative alkaloid in CX (<xref rid="B13" ref-type="bibr">Chen et al., 2018</xref>; <xref rid="B173" ref-type="bibr">Yue et al., 2024</xref>).</p></sec><sec id="s2-4"><title>2.4 Others</title><p>LCPs are another active metabolite of CX with multiple bioactivities, including antioxidant, immunomodulatory, antitumor, and antibacterial effects. In addition to these metabolites, CX also contains aldehydes (103), phenols (104&#8211;109), ketones (110&#8211;114), anhydrides (115), and aromatic hydrocarbons (116). This study collects and summarizes pharmacological studies of CX extracts from the past 5&#160;years in <xref rid="T4" ref-type="table">Table 4</xref>.</p><table-wrap position="float" id="T4" orientation="portrait"><label>TABLE 4</label><caption><p>Pharmacological studies of <italic toggle="yes">Ligusticum chuanxiong</italic> extracts in the last five years.</p></caption><table frame="hsides" rules="groups"><thead valign="top"><tr><th align="left" rowspan="1" colspan="1">Extracts</th><th align="left" rowspan="1" colspan="1">Metabolite</th><th align="left" rowspan="1" colspan="1">Type of study</th><th align="left" rowspan="1" colspan="1">Model</th><th align="left" rowspan="1" colspan="1">Dose range administered</th><th align="left" rowspan="1" colspan="1">Duration</th><th align="left" rowspan="1" colspan="1">Positive control</th><th align="left" rowspan="1" colspan="1">Negative control</th><th align="left" rowspan="1" colspan="1">Targets/singal pathway</th><th align="left" rowspan="1" colspan="1">Action/Disease</th><th align="left" rowspan="1" colspan="1">References</th></tr></thead><tbody valign="top"><tr><td colspan="11" align="left" rowspan="1">Volatile oil</td></tr><tr><td align="left" rowspan="1" colspan="1">Methanol, water</td><td align="left" rowspan="1" colspan="1">Various metabolites</td><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">In</italic>
<italic toggle="yes">vivo</italic>
</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">0.02&#8211;0.1&#160;mg/mL<break/>25, 50, 100&#160;mg/mL</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">Nifedipine, ferulic acid, vitamin C</td><td align="left" rowspan="1" colspan="1">Blank control group</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">Antioxidant, vasodilator, anticoagulant</td><td align="left" rowspan="1" colspan="1">
<xref rid="B161" ref-type="bibr">Yan et al. (2022)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Ether</td><td align="left" rowspan="1" colspan="1">CX Essential Oils</td><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">In vivo</italic>
</td><td align="left" rowspan="1" colspan="1">Cerebral Ischemia Reperfusion Injury Mouse Model</td><td align="left" rowspan="1" colspan="1">50, 60, 100&#160;mg/kg</td><td align="left" rowspan="1" colspan="1">7 days, 15 days, 25&#160;days</td><td align="left" rowspan="1" colspan="1">1% Sodium deoxycholate</td><td align="left" rowspan="1" colspan="1">Sham operation group, model group</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">Antioxidant, cerebral ischemia-reperfusion injury</td><td align="left" rowspan="1" colspan="1">
<xref rid="B86" ref-type="bibr">Long et al. (2023)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Ethanol</td><td align="left" rowspan="1" colspan="1">Phthalides</td><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">In vivo</italic> and <italic toggle="yes">in vitro</italic>
</td><td align="left" rowspan="1" colspan="1">Diabetic nephropathy model in mice</td><td align="left" rowspan="1" colspan="1">10, 20, 100&#160;mg/kg</td><td align="left" rowspan="1" colspan="1">14 weeks</td><td align="left" rowspan="1" colspan="1">Captopril</td><td align="left" rowspan="1" colspan="1">Blank control group</td><td align="left" rowspan="1" colspan="1">Nrf2 &#8593;</td><td align="left" rowspan="1" colspan="1">Diabetic nephropathy</td><td align="left" rowspan="1" colspan="1">
<xref rid="B105" ref-type="bibr">Qi et al. (2024)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Ethanol, water, etc</td><td align="left" rowspan="1" colspan="1">Chuanxiongdiolide R4&#12289;Chuanxiongdiolide R5, Chuanxiongdiolide R6, etc</td><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">In vivo</italic>
</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">3.3, 16.8, 7.5, 12&#160;&#181;M</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">Nifedipine</td><td align="left" rowspan="1" colspan="1">Blank control group</td><td align="left" rowspan="1" colspan="1">Cav1.2 &#8595;</td><td align="left" rowspan="1" colspan="1">Vasodilation</td><td align="left" rowspan="1" colspan="1">
<xref rid="B134" ref-type="bibr">Tang et al. (2021)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Ethanoland water</td><td align="left" rowspan="1" colspan="1">Various metabolites</td><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">In vivo</italic>
</td><td align="left" rowspan="1" colspan="1">Mouse model of liver fibrosis</td><td align="left" rowspan="1" colspan="1">10, 17, 18, 50&#160;mg/kg</td><td align="left" rowspan="1" colspan="1">7&#160;days</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">Sham operation group</td><td align="left" rowspan="1" colspan="1">CTCF - c - MYC - H19 &#8595;</td><td align="left" rowspan="1" colspan="1">Liver fibrosis</td><td align="left" rowspan="1" colspan="1">
<xref rid="B67" ref-type="bibr">Li et al. (2024b)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Water</td><td align="left" rowspan="1" colspan="1">CX volatile oil</td><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">In vivo</italic>
</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">0.5%, 1%, 2%, 3%, 4%</td><td align="left" rowspan="1" colspan="1">1 h, 2&#160;h, 4&#160;h, 6&#160;h, 8&#160;h, 10&#160;h</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">Blank control group</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">Good transdermal permeability</td><td align="left" rowspan="1" colspan="1">
<xref rid="B34" ref-type="bibr">Hongmei et al. (2024)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Water</td><td align="left" rowspan="1" colspan="1">Various metabolites</td><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">In vivo</italic>
</td><td align="left" rowspan="1" colspan="1">Myocardial ischemic injury model in rats</td><td align="left" rowspan="1" colspan="1">74, 149, 297&#160;mg/kg</td><td align="left" rowspan="1" colspan="1">2 weeks</td><td align="left" rowspan="1" colspan="1">Nitroglycerin</td><td align="left" rowspan="1" colspan="1">Blank control group</td><td align="left" rowspan="1" colspan="1">ADRA1A, CHRM5 protein &#8593;</td><td align="left" rowspan="1" colspan="1">angina pectoris</td><td align="left" rowspan="1" colspan="1">
<xref rid="B99" ref-type="bibr">Ming et al. (2024)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">Essential oil of CX</td><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">In vitro</italic> and <italic toggle="yes">in vivo</italic>
</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">1.155, 5.75, 11.55, 115.5, 1,150&#160;&#956;g/mL</td><td align="left" rowspan="1" colspan="1">24&#160;h</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">Blank control group</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">Promote the transdermal absorption and reduce the toxicity of triptolide</td><td align="left" rowspan="1" colspan="1">
<xref rid="B14" ref-type="bibr">Cheng et al. (2024)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">Essential oil of CX</td><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">In vitro</italic>
</td><td align="left" rowspan="1" colspan="1">Common carotid artery thrombosis rats, tail thrombosis rats, platelet aggregation rat model</td><td align="left" rowspan="1" colspan="1">0.5, 1.5, 4.5&#160;g/kg<break/>0.4, 1.6, 6.4&#160;g/kg<break/>0.6, 1.8, 5.6&#160;g/kg</td><td align="left" rowspan="1" colspan="1">3.5&#160;days</td><td align="left" rowspan="1" colspan="1">Aspirin</td><td align="left" rowspan="1" colspan="1">Blank control group</td><td align="left" rowspan="1" colspan="1">COX-1 &#8595;</td><td align="left" rowspan="1" colspan="1">Prevent arterial thrombosis</td><td align="left" rowspan="1" colspan="1">
<xref rid="B77" ref-type="bibr">Lin et al. (2024)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Water vapor</td><td align="left" rowspan="1" colspan="1">Essential oil of CX</td><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">In vitro</italic>
</td><td align="left" rowspan="1" colspan="1">Amigraine rats</td><td align="left" rowspan="1" colspan="1">45, 90, 135&#160;mg/kg</td><td align="left" rowspan="1" colspan="1">7&#160;days</td><td align="left" rowspan="1" colspan="1">Zolmitriptemp</td><td align="left" rowspan="1" colspan="1">Blank control group</td><td align="left" rowspan="1" colspan="1">5-HT, 5-HT1 Bprotein &#8593;</td><td align="left" rowspan="1" colspan="1">Relieve and treat migraines</td><td align="left" rowspan="1" colspan="1">
<xref rid="B138" ref-type="bibr">Tianhao et al. (2022)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">Dl-3-n-butylphthalide (NBP)</td><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">In vivo</italic>
</td><td align="left" rowspan="1" colspan="1">traumatic brain injury rats</td><td align="left" rowspan="1" colspan="1">10, 20, 40&#160;mg/kg</td><td align="left" rowspan="1" colspan="1">7&#160;days</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">Blank control group</td><td align="left" rowspan="1" colspan="1">lRE1/XBP1 &#8595;</td><td align="left" rowspan="1" colspan="1">Improvement neurologieal function</td><td align="left" rowspan="1" colspan="1">
<xref rid="B175" ref-type="bibr">Yun et al. (2021)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">Essential oil of CX</td><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">In vitro</italic>
</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">20, 40, 80&#160;&#956;mol/L</td><td align="left" rowspan="1" colspan="1">24&#160;h</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">Blank control group</td><td align="left" rowspan="1" colspan="1">EGFR/VEGF-A &#8595;</td><td align="left" rowspan="1" colspan="1">glioma angiogenesis</td><td align="left" rowspan="1" colspan="1">
<xref rid="B159" ref-type="bibr">Xuhui et al. (2023)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Water vapor</td><td align="left" rowspan="1" colspan="1">Essential oil of CX</td><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">In vitro</italic>
</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">1.56 &#215; 10^<sup>&#8722;3</sup>, 6.25 &#215; 10^<sup>&#8722;3</sup>&#160;&#956;L/mL</td><td align="left" rowspan="1" colspan="1">48&#160;h</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">Blank control group</td><td align="left" rowspan="1" colspan="1">LRIG2, EGFR, VEGF-A &#8595;</td><td align="left" rowspan="1" colspan="1">Inhibit glioma and angiogenesis</td><td align="left" rowspan="1" colspan="1">
<xref rid="B174" ref-type="bibr">Yumei et al. (2022)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Water vapor</td><td align="left" rowspan="1" colspan="1">Essential oil of CX</td><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">In vitro</italic>
</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">1.25, 2.5, 5, 10, 20, 40, 60, 80&#160;&#956;g/mL</td><td align="left" rowspan="1" colspan="1">12&#160;h</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">Blank control group</td><td align="left" rowspan="1" colspan="1">IL-6 &#8595;</td><td align="left" rowspan="1" colspan="1">Anti-inflammatory</td><td align="left" rowspan="1" colspan="1">
<xref rid="B169" ref-type="bibr">Yiyu et al. (2023)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">Ligustilide&#12289;Senkyunolide A&#12289;Senkyunolide I</td><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">In</italic>
<italic toggle="yes">vitro</italic>
</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">20, 40, 80&#160;&#956;g/mL</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">Blank control group</td><td align="left" rowspan="1" colspan="1">P-glycoprotein, claudin-5, ZO-1 &#8595;</td><td align="left" rowspan="1" colspan="1">Inhibit damage cells and promote the transmembrane transport</td><td align="left" rowspan="1" colspan="1">
<xref rid="B116" ref-type="bibr">Shanshan et al. (2021)</xref>
</td></tr><tr><td colspan="11" align="left" rowspan="1">Organic acids</td></tr><tr><td align="left" rowspan="1" colspan="1">95%ethanol</td><td align="left" rowspan="1" colspan="1">Ferulic acid</td><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">In vivo</italic> and <italic toggle="yes">in vitro</italic>
</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">5.8&#160;g/kg<break/>1, 10, 100&#160;&#956;mol/L</td><td align="left" rowspan="1" colspan="1">0.5&#160;h, 1&#160;h, 2&#160;h, 4&#160;h, 6&#160;h, 8&#160;h</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">Blank control group</td><td align="left" rowspan="1" colspan="1">NF-Kb/MAPK/c-Jun/TLR4 &#8595;</td><td align="left" rowspan="1" colspan="1">Diseases of the central nervous system</td><td align="left" rowspan="1" colspan="1">
<xref rid="B100" ref-type="bibr">Mingyan et al. (2024)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">water</td><td align="left" rowspan="1" colspan="1">Ferulic acid</td><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">In vivo</italic> and <italic toggle="yes">in vitro</italic>
</td><td align="left" rowspan="1" colspan="1">Cholestatic liver injury mice</td><td align="left" rowspan="1" colspan="1">50&#160;mg/kg<break/>80&#160;&#956;g/mL</td><td align="left" rowspan="1" colspan="1">4 days; 24&#160;h</td><td align="left" rowspan="1" colspan="1">Nimodipine group</td><td align="left" rowspan="1" colspan="1">Blank control group, model group</td><td align="left" rowspan="1" colspan="1">HSCs activation &#8595;</td><td align="left" rowspan="1" colspan="1">Cholestatic liver injury, anti-inflammatory, antioxidant</td><td align="left" rowspan="1" colspan="1">
<xref rid="B160" ref-type="bibr">Yajing et al. (2023)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">75% ethanol</td><td align="left" rowspan="1" colspan="1">Isogreen source acid A</td><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">In vitro</italic>
</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">1.5&#160;mg/L</td><td align="left" rowspan="1" colspan="1">60&#160;s</td><td align="left" rowspan="1" colspan="1">Agaqu team</td><td align="left" rowspan="1" colspan="1">Blank control group</td><td align="left" rowspan="1" colspan="1">factor Xa &#8595;</td><td align="left" rowspan="1" colspan="1">Thromboembolic disease</td><td align="left" rowspan="1" colspan="1">
<xref rid="B166" ref-type="bibr">Yang et al. (2020)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">ethyl acetate</td><td align="left" rowspan="1" colspan="1">Phthalate derivatives</td><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">In</italic>
<italic toggle="yes">vitro</italic>
</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">500.00&#160;&#956;M</td><td align="left" rowspan="1" colspan="1">3&#160;min</td><td align="left" rowspan="1" colspan="1">Allopurinol group</td><td align="left" rowspan="1" colspan="1">Blank control group</td><td align="left" rowspan="1" colspan="1">Xanthine oxidase &#8595;</td><td align="left" rowspan="1" colspan="1">Anti-gout</td><td align="left" rowspan="1" colspan="1">
<xref rid="B94" ref-type="bibr">ManLi et al. (2023)</xref>
</td></tr><tr><td colspan="11" align="left" rowspan="1">Alkaloids</td></tr><tr><td align="left" rowspan="1" colspan="1">80% ethanol</td><td align="left" rowspan="1" colspan="1">Ligustrazine</td><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">In vivo</italic>
</td><td align="left" rowspan="1" colspan="1">Mouse model of hepatic fibrosis</td><td align="left" rowspan="1" colspan="1">10&#160;mg/kg</td><td align="left" rowspan="1" colspan="1">2 days, 4&#160;days</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">Blank control group</td><td align="left" rowspan="1" colspan="1">CF-c -MYC-H19, cholangiocyte &#8595;</td><td align="left" rowspan="1" colspan="1">Liver fibrosis</td><td align="left" rowspan="1" colspan="1">
<xref rid="B67" ref-type="bibr">Li et al. (2024b),</xref>
<xref rid="B68" ref-type="bibr">Li et al. (2024c)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Water</td><td align="left" rowspan="1" colspan="1">Adenines</td><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">In vitro</italic>
</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">12.5, 25, 50&#160;&#956;M</td><td align="left" rowspan="1" colspan="1">24&#160;h</td><td align="left" rowspan="1" colspan="1">Curcumin group</td><td align="left" rowspan="1" colspan="1">Blank control group</td><td align="left" rowspan="1" colspan="1">TNF-&#945;, IL-6 &#8595;</td><td align="left" rowspan="1" colspan="1">Anti-inflammatory</td><td align="left" rowspan="1" colspan="1">
<xref rid="B25" ref-type="bibr">Feng et al. (2023a)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Water</td><td align="left" rowspan="1" colspan="1">Isoindoline alkaloids</td><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">In vitro</italic>
</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">1, 10, 50&#160;&#956;M</td><td align="left" rowspan="1" colspan="1">10&#160;min</td><td align="left" rowspan="1" colspan="1">Verapamil hydrochloride group</td><td align="left" rowspan="1" colspan="1">Blank control group</td><td align="left" rowspan="1" colspan="1">inward flow of extracellular calcium ions&#8595;</td><td align="left" rowspan="1" colspan="1">Relaxation of uterine smooth muscle</td><td align="left" rowspan="1" colspan="1">
<xref rid="B51" ref-type="bibr">Juan et al. (2022)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">80% ethanol</td><td align="left" rowspan="1" colspan="1">Total alkaloids</td><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">In vivo</italic>
</td><td align="left" rowspan="1" colspan="1">Migraine Rat Model/Migraine Mouse Model</td><td align="left" rowspan="1" colspan="1">12.5, 25, 50&#160;mg/kg</td><td align="left" rowspan="1" colspan="1">1 week; 3&#160;days</td><td align="left" rowspan="1" colspan="1">Zolmitriptan group</td><td align="left" rowspan="1" colspan="1">Blank control group, model group</td><td align="left" rowspan="1" colspan="1">5-HT &#8593;; c-Jun &#8595;</td><td align="left" rowspan="1" colspan="1">migraine</td><td align="left" rowspan="1" colspan="1">
<xref rid="B190" ref-type="bibr">Zhong-Hui et al. (2019)</xref>
</td></tr><tr><td colspan="11" align="left" rowspan="1">Other</td></tr><tr><td align="left" rowspan="1" colspan="1">Water</td><td align="left" rowspan="1" colspan="1">Polysaccharide (LCP70-2&#160;A)</td><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">In vivo</italic> and <italic toggle="yes">in vitro</italic>
</td><td align="left" rowspan="1" colspan="1">Zebrafish embryo model</td><td align="left" rowspan="1" colspan="1">50, 100, 200&#160;&#956;g/mL</td><td align="left" rowspan="1" colspan="1">24 h, 3&#160;days</td><td align="left" rowspan="1" colspan="1">LPS group</td><td align="left" rowspan="1" colspan="1">Blank control group</td><td align="left" rowspan="1" colspan="1">immune cells, NO, TNF-&#945;, IL-6, IL-1&#946; &#8593;</td><td align="left" rowspan="1" colspan="1">Anti-inflammatory</td><td align="left" rowspan="1" colspan="1">
<xref rid="B118" ref-type="bibr">Shaojie et al. (2021)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">80% ethanol</td><td align="left" rowspan="1" colspan="1">Polysaccharide (LCX0&#12289;LCX1&#12289;LCX2)</td><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">In vitro</italic>
</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">0.57, 2.57.2.95, 8&#160;&#956;g/mL<break/>25&#8211;1,000&#160;&#956;g/mL</td><td align="left" rowspan="1" colspan="1">48&#160;h</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">Blank control group</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">Antioxidant/anti-cancer</td><td align="left" rowspan="1" colspan="1">
<xref rid="B36" ref-type="bibr">Hu et al. (2016b)</xref>
</td></tr></tbody></table><table-wrap-foot><fn><p>-, unavailable data; &#8593;, Upward adjustment, promotion or increase; &#8595;, Downward, inhibit or decrease c-Jun, c-Jun N-terminal kinase; IL, interleukin; MAPK, mitogen-activated protein kinase; Nrf2, Nuclear factor erythroid 2-related factor 2; NF-&#954;B, nuclear factor kappa-B; TLR4, Toll-like receptor 4; 5-HT, 5-hydroxytryptamine; TNF, tumor necrosis factor; NO, nitric oxide; ZO-1, Zonula occludens-1; LRIG2, Leucine Rich Repeats And Immunoglobulin Like Domains 2; EGFR, epidermal growth factor receptor; VEGF-A, Vascular endothelial growth factor-A; HSC, hepatic stellate cell and XBP1, X-Box Binding Protein 1.</p></fn></table-wrap-foot></table-wrap></sec></sec><sec id="s3"><title>3 Pharmacological properties of <italic toggle="yes">Ligusticum chuanxiong</italic>
</title><sec id="s3-1"><title>3.1 Central nervous system</title><sec id="s3-1-1"><title>3.1.1 Cerebral ischemia</title><p>Cerebral ischemia/reperfusion (I/R) injury is commonly associated with high rates of disability and mortality due to its complex pathological mechanisms. CX, a traditional medicine, is widely used in the treatment of ischemic stroke. Several metabolites of CX have demonstrated efficacy in managing cerebral ischemia by modulating oxidative stress, protecting blood vessels, and regulating inflammation. For instance, the National Medical Products Administration (NMPA) recognized butylphthalide as a therapeutic agent for ischemic stroke in 2005 (<xref rid="B195" ref-type="bibr">Zou et al., 2018</xref>). TMP inhibits platelet adhesion and the release of inflammatory factors by suppressing the P38 mitogen-activated protein kinase (MAPK) and nuclear factor kappa-B (NF-&#954;B) signaling pathways, thereby protecting microvascular endothelial cells in the brain (<xref rid="B180" ref-type="bibr">Zhang H. et al., 2020</xref>). Ligustilide activates adenosine 5&#8216;-monophosphate (AMP)-activated protein kinase (AMPK) signaling and PTEN induced putative kinase 1 (PINK1)/Parkin expression, which helps alleviate ischemic stroke damage (<xref rid="B95" ref-type="bibr">Mao et al., 2022</xref>; <xref rid="B153" ref-type="bibr">Wu et al., 2022</xref>). In a mouse model of induced intracerebral hemorrhage, ligustilide and senkyunolide H were shown to exert potent neuroprotective effects against hemorrhagic stroke by inhibiting the Paired Related Homeobox 1 (Prx1)/Toll-like receptor 4 (TLR4)/NF-&#954;B pathway, and subsequent immune and neuroinflammatory damage (<xref rid="B30" ref-type="bibr">Han et al., 2018</xref>). In a subacute ischemic rat model, TMP was found to inhibit the overexpression of aquaporin 4 (AQP4) and connexin 43 (Cx43) in astrocytes by altering A1-A2 reactivity. TMP also activates the fibroblast growth factor (FGF) 2/phosphoinositide 3-kinase (PI3K)/Akt pathway, which may contribute to its promotion of neurovascular repair following ischemic stroke (<xref rid="B26" ref-type="bibr">Feng X. F. et al., 2023</xref>). Additional studies have reported that CX and Binpian <italic toggle="yes">[Cinnamomum camphora(L.)Presl]</italic> exhibit significant synergistic effects in promoting neurogenesis and reducing astrocyte generation, with CX playing a central role and Binpian enhancing its effects. Binpian is frequently combined with CX to improve the treatment of ischemic stroke (<xref rid="B126" ref-type="bibr">Song et al., 2023</xref>; <xref rid="B182" ref-type="bibr">Zhang X. et al., 2024</xref>).</p></sec><sec id="s3-1-2"><title>3.1.2 Inflammation inhibition</title><p>Senkyunolide A and Z-ligustilide, two isolated metabolites, demonstrate inhibitory effects on neuroinflammation (<xref rid="B102" ref-type="bibr">Or et al., 2011</xref>). In microsphere-embolized (ME) rats, CX promotes neurogenesis and reduces inflammatory factors, thereby protecting neurons from cerebral ischemia (<xref rid="B146" ref-type="bibr">Wang et al., 2020</xref>). TMP has been shown to decrease the levels of inflammatory factors, such as tumor necrosis factor (TNF)-&#945;, interleukin (IL)-1&#946;, IL-6, and matrix metalloproteinase (MMP)-9, in ischemic brain tissue, exerting neuroprotective effects in mice subjected to I/R injury. This neuroprotective effect may be mediated by the upregulation of monocyte chemoattractant protein-induced protein 1 (MCPIP1), as the neuroprotection and anti-inflammatory effect were inhibited upon knockdown of MCPIP1 using specific small interfering RNA (siRNA) (<xref rid="B50" ref-type="bibr">Jin et al., 2021</xref>). TMP also protects retinal ganglion cells by inhibiting apoptosis and autophagy via the PI3K/Akt/mammalian target of rapamycin (mTOR) pathway. Additionally, Senkyunolide I has been found to protect mouse neuroblastoma cells from glutamate-induced injury by downregulating the c-Jun N-terminal kinase (c-JUN)/cysteinyl aspartate specific proteinase 3 (caspase-3) pathway and attenuating apoptosis (<xref rid="B145" ref-type="bibr">Wang M. et al., 2021</xref>). Furthermore, ligustilide exerts protective effects against oxygen-glucose deprivation/reperfusion (OGD/R) injury in PC12 cells by inhibiting apoptosis through the mitochondrial pathway and promoting autophagy via the Liver kinase B1 (LKB1)-AMPK-mTOR signaling pathway (<xref rid="B187" ref-type="bibr">Zhao et al., 2020</xref>). <xref rid="B93" ref-type="bibr">Ma et al. (2024)</xref> found that QBT, a novel phthalein metabolite, significantly reduced cognitive dysfunction and neuronal damage in rats with vascular dementia (VaD). It also inhibited VaD-induced hyperactivation of microglia and astrocytes, along with associated inflammatory responses. Moreover, QBT exerts anti-inflammatory effects by inhibiting the chemokine C-X-C motif ligand 12 (CXCL12)/chemokine C-X-C motif receptor 4 (CXCR4) axis and its downstream Janus kinase 2 (JAK2)/signal transducer and activator of transcription 3 (STAT3) and PI3K/Akt/NF-&#954;B pathways, thereby attenuating neuroinflammatory responses both <italic toggle="yes">in vivo</italic> and <italic toggle="yes">in vitro</italic>.</p></sec><sec id="s3-1-3"><title>3.1.3 Alzheimer&#8217;s disease</title><p>Alzheimer&#8217;s disease (AD) is the most common neurodegenerative disorder, leading to various functional impairments, including memory loss, dementia, and aphasia. It is the third leading cause of disability and death in the elderly, following cardiovascular diseases and malignant tumors, and is considered a major societal burden (<xref rid="B45" ref-type="bibr">Jeremic et al., 2021</xref>). Several hypotheses have been proposed regarding the pathogenesis of AD, with the most widely accepted mechanisms involving the excessive accumulation of beta-amyloid (A&#946;) outside neurons and the aggregation of hyperphosphorylated tau protein within neurons, resulting in the formation of neurofibrillary tangles (NFTs) (<xref rid="B22" ref-type="bibr">Du et al., 2018</xref>; <xref rid="B115" ref-type="bibr">Scheltens et al., 2021</xref>). Despite extensive efforts to develop therapeutic strategies for AD, only a few drugs have been approved for treatment, all of which merely provide symptomatic relief and are associated with significant side effects. Effective cures or preventive treatments remain scarce.</p><p>In the context of tau pathology, CX has been reported to target 70 key pathways associated with tau-related pathological mechanisms, including interactions with astrocytes, endothelial cells, and microglia. This action effectively reverses tau hyperphosphorylation and promotes its degradation through the lysosomal pathway, thereby mitigating tau-mediated intracellular transport impairment, axonal and synaptic damage, and neuronal death. The primary active metabolites identified in this process include neocnidilide, ferulic acid, Z-ligustilide, and butylidene phthalide, which have demonstrated neuroprotective effects against AD. In contrast, TMP, a widely used therapeutic agent for I/R-induced brain injury, has been associated with only two tau-related targets, suggesting limited therapeutic relevance in tau pathology-based AD (<xref rid="B176" ref-type="bibr">Zeng et al., 2022</xref>). However, compared to the control group, the TMP-related group exhibited significant improvements in learning and memory abilities in transgenic AD mice, along with reduced levels of A&#946; and tau phosphorylation in the brain (<xref rid="B37" ref-type="bibr">Huang et al., 2021</xref>). These effects may be attributed to TMP&#8217;s ability to regulate mitochondrial function, maintain synaptic integrity and cytoskeletal stability, and modulate proteins associated with adenosine triphosphate (ATP) and guanosine triphosphate (GTP) binding. Another potential mechanism underlying TMP&#8217;s anti-AD&#8217;s effects involves the downregulation of Cullin 4B (CUL4B) in the brain tissue of AD mice, which inhibits the ubiquitination of somatostatin receptor 4 (SSRT4) and upregulates SSRT4 protein levels. This mechanism has been confirmed in mice with CUL4B overexpression or SSRT4 silencing (<xref rid="B150" ref-type="bibr">Weng et al., 2021</xref>). Additionally, TMP may partially restore cholinergic neuronal function in streptozotocin (STZ)-induced AD rats by inhibiting glycogen synthase kinase (GSK)-3&#946; activity, thereby improving learning and memory deficits (<xref rid="B88" ref-type="bibr">Lu F. et al., 2017</xref>).</p><p>One study demonstrated that QBT exhibits strong biological activity against cerebrovascular diseases. In VaD rats, QBT reversed aberrant changes associated with ferroptosis and pyroptosis by upregulating the nuclear factor erythroid 2-related factor 2 (Nrf2)/cystine-glutamate antiporter (xCT)/glutathione peroxidase 4 (GPX4) pathway, downregulating the nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing 3 (NLRP3)/cysteine-requiring aspartate protease-1 (Caspase-1)/gasdermin D (GSDMD) pathway, and inhibiting both ferroptosis and pyroptosis in neuronal cells. These actions exerted neuroprotective effects, significantly reducing neuronal damage and cognitive dysfunction in VaD rats (<xref rid="B24" ref-type="bibr">Feng et al., 2024</xref>). Furthermore, the methanol extract of CX effectively mitigated cognitive impairment caused by bilateral common carotid artery stenosis, primarily through the inhibition of astrocytes and microglia (<xref rid="B75" ref-type="bibr">Lim et al., 2024</xref>).</p></sec><sec id="s3-1-4"><title>3.1.4 Others</title><p>Parkinson&#8217;s disease (PD) is a progressive neurodegenerative disorder characterized by a gradual loss of motor function, with the primary pathological hallmarks being the sustained degeneration of dopaminergic neurons in the substantia nigra and the intracellular accumulation of &#945;-synuclein in the form of Lewy bodies and Lewy neurites (<xref rid="B54" ref-type="bibr">Kouli et al., 2018</xref>). CX may play a role in PD biology, as 53 metabolites in CX have been found to affect the biological compartments of human neuronal oxidative stress (hNOS) cells derived from PD patients. These metabolites may interfere with the biological functions of cellular organelles, including early endosomes, lysosomes, and autophagosomes. Additionally, TMP downregulates neuroinflammation markers such as NF-&#954;B, inducible nitric oxide synthase (iNOS), and cyclooxygenase-2 (COX2) (<xref rid="B97" ref-type="bibr">Michel et al., 2017</xref>). <xref rid="B3" ref-type="bibr">Canhui and Mengchan (2023)</xref> found that ligustilide improved the survival rate of PD cell models, reduced cell cycle arrest in the G0/G1 phase, and inhibited apoptosis, primarily by suppressing the activation of the p38 MAPK/c-JUN signaling pathway.</p><p>The antimigraine effects of total alkaloids in CX have been confirmed to be mediated by the upregulation of 5-hydroxytryptamine (5-HT) and its metabolite 5-hydroxyindole acetic acid (5-HIAA), achieved through increased expression of the 5-Hydroxytryptamine Receptor 1B (5-HT1B) and suppression of c-Jun (<xref rid="B104" ref-type="bibr">Pu et al., 2019b</xref>). Furthermore, TMP selectively inhibits c-Jun phosphorylation and reduces the expression of MMP-2/9 and pro-inflammatory cytokines secreted by astrocytes, thereby alleviating neuropathic pain caused by chronic compression injury (CCI). TMP also inhibits the activation of the NF-&#954;B pathway in microglia by upregulating the expression of silent information regulator 1 (SIRT-1), thereby reducing neuroinflammatory responses and alleviating migraine (<xref rid="B12" ref-type="bibr">Chen et al., 2024</xref>).</p><p>Huntington&#8217;s disease (HD) is a neurodegenerative disorder with an autosomal dominant inheritance pattern, primarily characterized by motor dysfunction, ataxia, and cognitive decline. 3-Nitropropionic acid (3-NP) is commonly used to induce HD-like symptoms in animal models. Treatment with TMP significantly improves behavioral outcomes in 3-NP-induced HD rats, with biochemical analyses indicating a marked reduction in oxidative stress parameters (<xref rid="B20" ref-type="bibr">Danduga et al., 2018</xref>).</p></sec></sec><sec id="s3-2"><title>3.2 Cadio-vascular system</title><sec id="s3-2-1"><title>3.2.1 Myocardial ischemia</title><p>Myocardial ischemia improvement is one of the most significant pharmacological actions of CX and its most widely applied use in clinical practice. Research indicates that CX exerts anti-inflammatory, antioxidative, and anti-apoptotic effects on cardiomyocytes subjected to I/R injury, while also promoting coronary blood flow and myocardial metabolism, thereby limiting the extent of myocardial infarction (<xref rid="B188" ref-type="bibr">Zheng et al., 2018</xref>). Additionally, studies have shown that CX protects against acute myocardial ischemia induced by isoproterenol through activation of the PI3K/Akt/GSK-3 signaling pathway (<xref rid="B165" ref-type="bibr">Yang et al., 2019</xref>).</p><p>
<xref rid="B143" ref-type="bibr">Wang et al. (2024)</xref> demonstrated that TMP intervention reduced cardiomyocyte apoptosis induced by OGD/R and I/R, enhanced cellular viability and autophagy, and improved myocardial tissue necrosis in I/R mice in a dose-dependent manner. Ligustilide has been shown to attenuate myocardial injury caused by inflammation, reduce fibrosis and hypertrophy of myocardial cells, and inhibit ventricular dilation following myocardial infarction. Furthermore, ligustilide provides protective effects in familial dilated cardiomyopathy. When combined with other Chinese herbal medicines, ligustilide can enhance therapeutic efficacy synergistically; for example, its combination with berberine has demonstrated more effective antiplatelet and anti-inflammatory effects in rats with acute myocardial infarction (<xref rid="B185" ref-type="bibr">Zhang et al., 2016</xref>).</p><p>In addition to inflammation and oxidative stress, autophagic dysfunction plays a significant role in various cardiovascular diseases. Studies have demonstrated that the lactone metabolite of ligustilide can activate the PI3K/Akt/mTOR signaling pathway, restore autophagic flux, and exert cardioprotective effects (<xref rid="B140" ref-type="bibr">Wang et al., 2018</xref>). Moreover, CX protects the myocardium from I/R injury by inhibiting Beclin-1-related autophagic dysfunction and enhancing the translocation of B-cell lymphoma-2 (Bcl-2) through increased expression of 14-3-3&#947;(<xref rid="B197" ref-type="bibr">Zuo et al., 2019</xref>).</p></sec><sec id="s3-2-2"><title>3.2.2 Atherosclerosis</title><p>AS is characterized by the accumulation of lipids, complex carbohydrates, and/or thrombus formation, accompanied by a progressive fibrotic response and calcium deposition, ultimately leading to arterial thickening, hardening, and luminal narrowing (<xref rid="B72" ref-type="bibr">Libby, 2021</xref>). <xref rid="B184" ref-type="bibr">Zhang et al. (2024b)</xref> explored the mechanisms through which Zhizi <italic toggle="yes">(Gardenia jasminoides Ellis)</italic> and CX botanical drugs attenuate the progression of AS via Deoxyribonucleic Acid (DNA) methylation. The results indicate that both Zhizi and CX effectively slow AS progression by inhibiting MAPK/extracellular signal-regulated kinase (ERK)-mediated apoptosis through hypermethylation of the fibroblast growth factor receptor 3 (FGFR3) promoter region. Additionally, they alleviate AS by inhibiting the TNF/NF-&#954;B axis and M1 macrophage polarization (<xref rid="B186" ref-type="bibr">Zhang et al., 2024c</xref>). <xref rid="B81" ref-type="bibr">Liu et al. (2024)</xref> demonstrated for the first time the potential of oral Z-ligustilide treatment to alleviate AS by reducing inflammation and enhancing intestinal barrier function. TMP exerts therapeutic effects on AS primarily through its anti-inflammatory, antioxidant, and lipid-lowering actions, effectively inhibiting lipid accumulation and enhancing intracellular cholesterol efflux. Key targets implicated in these mechanisms include peroxisome proliferator-activated receptors (PPAR), sterol regulatory element-binding proteins (SREBPs)/cleavage activating protein (SCAP), progesterone and adiponectin receptors 3, scavenger receptors (SR-A, CD36), ATP-binding cassette transporters (ABCA1 and ABCG1), and the PI3K/Akt and p38/MAPK signaling pathways (<xref rid="B9" ref-type="bibr">Chen et al., 2017</xref>; <xref rid="B23" ref-type="bibr">Duan et al., 2017</xref>).</p></sec><sec id="s3-2-3"><title>3.2.3 Qthers</title><p>In the management of hypertension, TMP has been reported to exert dual actions: it blocks the entry of extracellular Ca<sup>2+</sup> through calcium channels and inhibits the release of Ca<sup>2+</sup> stored within vascular smooth muscle cells (SMCs) (<xref rid="B113" ref-type="bibr">Ren et al., 2012</xref>). The Kcnma1 gene encodes the large conductance calcium-activated potassium channels (BKCa), which are critical for treating various cardiovascular, muscular, and nervous system disorders. Research has shown that TMP helps maintain BKCa &#946;1 protein expression by inhibiting endoplasmic reticulum stress, restoring BKCa currents in porcine coronary artery SMCs, and improving BKCa-mediated vasodilation in coronary arteries (<xref rid="B129" ref-type="bibr">Sun et al., 2019</xref>; <xref rid="B131" ref-type="bibr">Szteyn and Singh, 2020</xref>).</p><p>Liguzinediol exhibits a dose-dependent positive inotropic effect in doxorubicin-induced heart failure mice, indicating its potential as a treatment for heart failure without causing adverse reactions such as arrhythmias or hypotension. This beneficial effect is primarily mediated by an increase in the bcl-2/Bcl-2 associated X protein (Bax) ratio and the suppression of caspase-3 expression and NK-&#954;B activation (<xref rid="B70" ref-type="bibr">Li et al., 2014a</xref>). Sodium ferulate has been shown to mitigate myocardial hypertrophy induced by abdominal aorta coarctation by inhibiting protein kinase C beta (PKC-&#946;) and activating the MAPK signaling pathways (<xref rid="B90" ref-type="bibr">Luo et al., 2019</xref>).</p><p>TMP also demonstrates inhibitory effects on thrombosis. It exerts its antithrombotic effects by reducing inflammatory cytokines and adhesion molecules, modulating MAPK signaling, attenuating oxidative stress, preventing apoptosis, inhibiting platelet aggregation, and suppressing the expression of fibrinogen and von Willebrand factor (<xref rid="B163" ref-type="bibr">Yang et al., 2023</xref>). In addition to TMP and ferulic acid, four other effective metabolites have been identified: neochlorogenic acid, 1-H-benzimidazole-2-amine, 3,8-dihydroxyacyl lactone, and CX triterpenes. These metabolites interact with the core amino acids of target proteins, effectively inhibiting blood clot formation.</p></sec></sec><sec id="s3-3"><title>3.3 Effects of <italic toggle="yes">Ligusticum chuanxiong</italic> on other systems or organs</title><sec id="s3-3-1"><title>3.3.1 Respiratory system</title><p>Studies have found that CX adjunctive therapy can significantly improve the clinical symptoms of patients with chronic idiopathic pulmonary fibrosis (<xref rid="B123" ref-type="bibr">Shupei, 2010</xref>). The use of microemulsion formulations encapsulating the volatile oils of Danggui [<italic toggle="yes">Angelica sinensis (Oliv.) Diels</italic>] and CX has been shown to enhance their ability to alleviate acute lung injury (ALI) (<xref rid="B181" ref-type="bibr">Zhang et al., 2022</xref>). TMP is primarily regarded as an active medicinal metabolite of CX that targets the respiratory system. <italic toggle="yes">In vivo</italic> studies have demonstrated that TMP inhibits the proliferation of airway SMCs by reducing p-ERK 1/2 levels, a process associated with the MAPK signaling pathway (<xref rid="B58" ref-type="bibr">Li et al., 2018</xref>). Jiang et al. confirmed that TMP exhibits both anti-inflammatory and anti-apoptotic activities in macrophages, which have been validated <italic toggle="yes">in vivo</italic> and <italic toggle="yes">in vitro</italic>. These effects involve the TLR4/Tumor necrosis factor receptor-associated factor 6 (TRAF6)/NF-&#954;B/NLRP3/caspase-1 and TLR4/cysteine-requiring aspartate protease-8 (caspase-8)/caspase-3 signaling pathways (<xref rid="B48" ref-type="bibr">Jiang R. et al., 2021</xref>). Furthermore, TMP has been shown to alleviate lung inflammation in an ovalbumin-induced asthma mouse model by downregulating C-C Motif Chemokine Receptor 1 (CCR1), STAT3, and p38 MAPK proteins, thereby inhibiting airway hyperresponsiveness and the release of inflammatory and chemotactic factors (<xref rid="B149" ref-type="bibr">Wei et al., 2016</xref>). These findings suggest that TMP may have potential in treating ALI and acute respiratory distress syndrome (ARDS) primarily through reducing inflammatory cell infiltration and lowering pro-inflammatory factor secretion in the alveoli. Furthermore, TMP has shown efficacy in alleviating ALI caused by sepsis, reducing inflammatory cell infiltration, and mitigating lipopolysaccharide-induced lung tissue damage. TMP significantly inhibits the Rac Family Small GTPase 1 (Rac1)/LIM Domain Kinase 1 (LIMK1)/Zonula occludens-1 (ZO-1)/occludin signaling pathway (<xref rid="B98" ref-type="bibr">Min et al., 2022</xref>).</p></sec><sec id="s3-3-2"><title>3.3.2 Hepatic protection</title><p>Ferulic acid demonstrates anti-hepatic stellate cell (HSC) activity by inhibiting focal adhesion kinase (FAK) and blocking the Smad and ERK1/2 signaling pathways, highlighting its potential in treating liver fibrosis (<xref rid="B158" ref-type="bibr">Xu et al., 2015</xref>). In a rat model of thioacetamide-induced liver fibrosis, butylidene phthalide exhibited significant anti-fibrotic effects by inhibiting epithelial-mesenchymal transition, reducing inflammatory responses, and promoting hepatocyte proliferation (<xref rid="B17" ref-type="bibr">Chuang et al., 2016</xref>). Additionally, CX combined with Danggui has been shown to prevent liver fibrosis (<xref rid="B152" ref-type="bibr">Wu et al., 2021</xref>). TMP has been reported to effectively attenuate hepatic I/R injury by inhibiting neutrophil extracellular trap formation and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (<xref rid="B85" ref-type="bibr">Liu et al., 2021</xref>). In the study by Lu et al., TMP was also found to confer hepatoprotective effects and improve hepatic steatosis via Nrf2 activation (<xref rid="B87" ref-type="bibr">Lu C. et al., 2017</xref>). Furthermore, <xref rid="B89" ref-type="bibr">Lu et al. (2023)</xref> reported that the organic acids in CX can alleviate liver injury through multiple signaling pathways, primarily involving the positive regulation of nitric oxide (NO) biosynthesis, Toll-like receptor signaling, NOD-like receptor signaling, and TNF signaling pathways. Additionally, the phthalate ester extract from CX exhibits stronger anti-cholestatic activity, both <italic toggle="yes">in vivo</italic> and <italic toggle="yes">in vitro</italic>, compared to other CX extracts. Its protective effect on bile duct cells and HSCs is mediated by reducing the transcription and release of plasminogen activator inhibitor-1 (PAI-1) and fibronectin through lysine acetyltransferase 2A (KAT2A)/histone 3 lysine 9 acetylation (H3K9ac) (<xref rid="B69" ref-type="bibr">Li Y. et al., 2023</xref>).</p></sec><sec id="s3-3-3"><title>3.3.3 Nephric protection</title><p>Studies have shown that CX and Dahuang<italic toggle="yes">(Rheum officinale Baill.)</italic> may inhibit renal tubular epithelial cell apoptosis and improve acute kidney injury (AKI) and renal fibrosis by suppressing the p38 MAPK/p53 signaling pathway (<xref rid="B61" ref-type="bibr">Li J. et al., 2023</xref>). <xref rid="B155" ref-type="bibr">Xia et al. (2024)</xref> found that ligustilide alleviates oxidative stress during renal I/R injury by maintaining Sirt3-dependent mitochondrial homeostasis. <xref rid="B105" ref-type="bibr">Qi et al. (2024)</xref> identified potential effective metabolites of CX in renal protection, revealing that phthalides improve hyperglycemia-induced renal dysfunction by enhancing Nrf2 activation, reducing collagen deposition, and alleviating inflammation and oxidative stress. Levistolide A mitigates AKI through its antioxidant properties and modulation of the TLR4/NF-&#954;B signaling pathway (<xref rid="B120" ref-type="bibr">Shi J. et al., 2024</xref>). TMP exhibits anti-apoptotic and therapeutic effects in diabetic nephropathy (DN) rats by activating the Akt signaling pathway and reducing oxidative stress (<xref rid="B108" ref-type="bibr">Rai et al., 2019</xref>). Its renal protective effects include attenuation of renal pathological changes, reduction in blood urea nitrogen, serum creatinine, 24-h urinary albumin, and glycated hemoglobin (HbA1c) levels, as well as an improvement in creatinine clearance (<xref rid="B194" ref-type="bibr">Zhuang et al., 2020</xref>). Additionally, TMP plays a significant protective role in AKI, primarily by downregulating the expression of nucleotide-binding oligomerization domain 2 (NOD2), which reduces renal cell apoptosis in a rat ischemia-reperfusion injury model (<xref rid="B47" ref-type="bibr">Jiang G. et al., 2021</xref>). TMP has been applied clinically to mitigate AKI. Senkyunolide I alleviates renal I/R injury by inhibiting oxidative stress, endoplasmic reticulum stress, and apoptosis (<xref rid="B193" ref-type="bibr">Zhu et al., 2022</xref>).</p></sec><sec id="s3-3-4"><title>3.3.4 Cytotoxic effects</title><p>Tumor metastasis plays a critical role in the progression of malignant tumors, inhibiting autophagy and apoptosis in cancer cells, thereby promoting uncontrolled cell division and proliferation. CX, a natural plant extract, contains various metabolites with multi-targeted antitumor activities, including the promotion of tumor cell apoptosis and the inhibition of metastasis (<xref rid="B142" ref-type="bibr">Wang K. et al., 2021</xref>). Perlolyrine has been identified as a metabolite with antiproliferative effects on human gastric cancer cell lines (<xref rid="B55" ref-type="bibr">Lee et al., 2016</xref>); metabolites CX0, CX1, and CX2 exhibit inhibitory effects on the growth of HepG2, SMMC7721, A549, and HCT-116 cells (<xref rid="B35" ref-type="bibr">Hu et al., 2016a</xref>); metabolites CXP-1a and CXP-3a stimulate macrophages to produce NO, TNF-&#945;, IL-6, and IL-12, while inhibiting the growth of HepG2 and Hep3B cells through immune modulation by blocking the cell cycle in the G0/G1 phase, thus promoting cancer cell apoptosis (<xref rid="B189" ref-type="bibr">Zhong et al., 2021</xref>). <xref rid="B52" ref-type="bibr">Jung et al. (2025)</xref> elucidated the molecular mechanisms underlying TMP&#8217;s anticancer effects: TMP induces apoptosis in HCCLM3 and Hep3B cells by activating key apoptosis factors and inhibiting proteins associated with cell survival and angiogenesis. It enhances autophagy by promoting the formation of autophagosomes and stimulating autophagy-related proteins, while upregulating SHP-1 to inhibit the activation of the STAT3 signaling pathway, thereby suppressing tumorigenesis and activating cell death pathways. TMP significantly inhibits tumor growth and triggers apoptosis and autophagy in tumor tissues.</p></sec></sec></sec><sec id="s4"><title>4 Clinical practice of <italic toggle="yes">Ligusticum chuanxiong</italic>
</title><p>Seventeen Chinese patent medicines containing CX as the main ingredient were retrieved from the NMPA, including CX Cha Tiao Power, CX Cha Tiao Granules, CX Cha Tiao Pills, Compound CX Capsules, DaCX Tablets, CX Cha Tiao Tablets, CX Qingnao Granules, CX Cha Tiao Dai Pao Ji, CX Cha Tiao Dripping Pills, CX Cha Tiao Oral Liquid, CX Cha Tiao Chong Ji, Shiquan Dabu Pills, Compound CX Tablets, DaCX Oral Liquid, CX Cha Tiao Dai Pao Cha, and DaCX Granules.</p><p>
<xref rid="B107" ref-type="bibr">Qunfang (2024)</xref> found that the combining of CX Cha Tiao Power and acupuncture significantly improved clinical efficacy, alleviated headache symptoms, and positively influenced prognosis. <xref rid="B74" ref-type="bibr">Lihua et al. (2023)</xref> study on 224 patients with chronic cerebral ischemia and headache using CX Qingnao Granules showed a significantly higher total clinical efficacy rate than the control group (P &lt; 0.05), with reductions in headache frequency and protection of cognitive function. <xref rid="B109" ref-type="bibr">Ran and Qingfang (2024)</xref> used DaCX Oral Liquid to treat 192 stroke sequela patients, finding a clinical efficacy rate of 94.79% in the treatment group (DaCX Oral Liquid + conventional therapy), significantly higher than the 84.38% in the control group. <xref rid="B46" ref-type="bibr">Jianfang and Wenlong (2022)</xref> investigated the clinical effect of Compound CX Capsules combined with Arorol hydrochloride tablets in treating angina pectoris, reporting a significantly higher total effective rate in the treatment group (98.31% vs. 86.44%, P &lt; 0.05). This combination therapy not only improved symptoms but also promoted cytokine level improvements and enhanced quality of life. CX-based formulations have been widely used in clinical practice for related diseases, but most research is still focused on Chinese literature, with limited studies published in English. Additionally, these studies often combine CX with other clinical treatments (e.g., acupuncture and Western medicines). The effectiveness of CX-based formulations in clinical applications still requires further validation through multicenter, large-sample studies.</p></sec><sec id="s5"><title>5 Safety</title><p>As a traditional Chinese botanical drug, CX is not classified as highly toxic, moderately toxic, or low-toxicity in the 2020 edition of the Chinese Pharmacopoeia. To date, no significant organ toxicity has been reported in relation to its use, distinguishing it from other botanical drugs known to have toxic effects. For example, Baihuasheshecao (<italic toggle="yes">Hedyotis diffusa Willd.)</italic> has been linked to toxicity in the cardiac, digestive, neurological, urinary, and respiratory systems; Maqianzi <italic toggle="yes">(Strychnos nux-vomica Linn.)</italic> is toxic to the digestive, hepatic, renal, and nervous systems; and Feiyangcao<italic toggle="yes">(Euphorbia hirta Linn.)</italic> exhibits corrosive toxicity to the digestive system (<xref rid="B64" ref-type="bibr">Li N. et al., 2022</xref>).</p><p>In a study by Zhang et al., the acute toxicity and dermal sensitivity of essential oil (EO) extracted from CX were evaluated. The results showed that the EO caused mild irritation to rabbit skin, but no significant signs of pigmentation, bleeding, roughness, or skin thinning were observed in guinea pigs after 7&#160;days of treatment. The median lethal doses (LD50) were determined to be 7.23&#160;g/kg and 2.25&#160;g/kg for oral and intraperitoneal administration, respectively, equivalent to approximately 14,606 and 5,091 times the clinical dosage (<xref rid="B179" ref-type="bibr">Zhang et al., 2012</xref>). Furthermore, CX demonstrated low embryotoxicity, as indicated by the median inhibitory proliferation values of mouse embryonic stem cells (9.39&#160;mg/mL) and mouse embryonic fibroblasts (18.78&#160;mg/mL), suggesting a weak potential for embryonic developmental toxicity based on the embryonic stem cell test linear discriminant formula (<xref rid="B141" ref-type="bibr">Wang et al., 2019</xref>).</p></sec><sec id="s6"><title>6 Critical discussion on the taxonomic status of <italic toggle="yes">Ligusticum chuanxiong</italic>
</title><p>Based upon more recent botanical literature, WCVP recognises the plant employed as CX as <italic toggle="yes">C. anthriscoides</italic> &#8216;Chuanxiong&#8217; a variety of the species <italic toggle="yes">C. anthriscoides</italic> (H.Boissieu) Pimenov and Kljuykov. It cites a single scientific synonym for this variety: <italic toggle="yes">Ligusticum chuanxiong</italic> S.H.Qiu, Y.Q.Zeng, K.Y.Pan, Y.C.Tang and J.M.Xu. Medicinal Plant Names Services records 18 non-scientific names in use in the medical literature for drugs derived from this plant drawn from 24 different medical references (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://mpns.science.kew.org/mpns-portal/plantDetail?plantId=2934837&amp;query=conioselinum+anthriscoides&amp;filter=&amp;fuzzy=false&amp;nameType=all&amp;dbs=wcsCmp" ext-link-type="uri">https://mpns.science.kew.org/mpns-portal/plantDetail?plantId=2934837&amp;query=conioselinum+anthriscoides&amp;filter=&amp;fuzzy=false&amp;nameType=all&amp;dbs=wcsCmp</ext-link>).</p><p>According to WCVP, the species <italic toggle="yes">C. anthriscoides</italic> belongs to the Genus <italic toggle="yes">Conioselinum</italic> which is in the <italic toggle="yes">Apiaceae</italic> family (APG IV classification). WCVP lists 11 scientific synonyms for this species (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:77146159-1#synonyms" ext-link-type="uri">https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:77146159-1#synonyms</ext-link>). Globally WCVP lists 18 species belonging to the Genus <italic toggle="yes">Conioselinum</italic> Fisch. ex Hoffm. and a further 37 species belonging to the Genus <italic toggle="yes">Ligusticum L</italic> (in the same family). Regardless of the name used for this species, the 18 species placed by WCVP into the same Genus indicate where the closer evolutionary relationships exist and therefore where there is a greater likelihood of shared chemical pathways. The understanding of taxonomic relationships evolves as more evidence (chemical or molecular) becomes available and will reflect regional access and disciplinary tradition. As a consequence the names employed in different disciplines or at different times will also vary.</p><p>Currently, there remain certain discrepancies among researchers regarding the classification of CX whole plant. <xref rid="B171" ref-type="bibr">Yuan et al. (2021)</xref> were the first to reveal that the phylogenetic relationship between <italic toggle="yes">Ligusticum chuanxiong</italic> and <italic toggle="yes">Ligusticum jeholense</italic> is closer than that with <italic toggle="yes">Ligusticum sinense</italic>. Consequently, they endorsed the original nomenclature proposed by Qiu for <italic toggle="yes">Ligusticum chuanxiong</italic>, rather than the revision suggested by Pu. Similarly, a 2009 Master&#8217;s thesis noted that a comparative study of <italic toggle="yes">Ligusticum chuanxiong</italic> from Sichuan, Gansu, and Yunnan, and its closely related species <italic toggle="yes">Ligusticum sinense</italic> Oliv., revealed morphological, chemical, and chromosomal differences. The study suggested that the <italic toggle="yes">Ligusticum chuanxiong</italic> from Gansu and Yunnan closely resembles the medicinal CX, and the differences in plant morphology and medicinal properties might be attributed to regional, ecological, and anthropogenic factors. In contrast, <italic toggle="yes">Ligusticum sinense</italic> Oliv. showed substantial differences and should be classified as a separate species (<xref rid="B92" ref-type="bibr">Ma, 2009</xref>). Furthermore, Ren et al.'s chloroplast phylogenomic analysis emphasized the need to narrow the classification scope of Chinese <italic toggle="yes">Ligusticum chuanxiong</italic>, calling for urgent revisions to its taxonomy (<xref rid="B112" ref-type="bibr">Ren et al., 2022</xref>).</p><p>In this study, the scientific name used is classified as &#8220;unplaced&#8221; in authoritative plant taxonomy literature (<xref rid="B28" ref-type="bibr">Govaerts et al., 2021</xref>). However, the authors still consider its application in this research to be reasonable. Firstly, the authors focus on the clinical application of CX in China, particularly based on its plant source from the Chinese Pharmacopoeia. The pharmacological effects and clinical applications of CX in CCVDs are summarized and analyzed in detail. CX is a medicinal botanical drug native to Sichuan, China, which is considered a &#8220;authentic&#8221; medicinal material (authentic medicinal materials refer to those that have been long selected and optimized through clinical application in TCM, grown in specific regions, and distinguished from other materials of the same species by superior quality, efficacy, and stability, and are well-recognized) (<xref rid="B79" ref-type="bibr">Linying et al., 2021</xref>). The scientific name <italic toggle="yes">Ligusticum chuanxiong</italic> S.H.Qiu, Y.Q.Zeng, K.Y.Pan, Y.C.Tang and J.M.Xu also appears in the <italic toggle="yes">United States Pharmacopeia</italic>, with a specific reference to its origin from &#8220;Sichuan,&#8221; confirming it as the plant referred to in this study. Moreover, in March 2024, the International Organization for Standardization (ISO) established a standard for Chinese CX (ISO 8071:2024) (<xref rid="B128" ref-type="bibr">Standardization, 2024</xref>), which defines the scope as Ligusticum chuanxiong rhizome (rhizome of <italic toggle="yes">Ligusticum chuanxiong</italic> Hort.), further validating the legitimacy of this scientific name.</p><p>However, it is important to note that the taxonomic status of CX whole plant remains an area worthy of further investigation, particularly regarding its relationship with wild populations in terms of morphological, chemical, and genetic characteristics, which has yet to be fully elucidated. Although this study has drawn significant conclusions based on existing literature and experimental data, the complexity of taxonomic classification suggests that the term <italic toggle="yes">Ligusticum chuanxiong</italic> used in different studies may refer to distinct species, varieties, or even different Genus. This potential heterogeneity may influence the comparability and reproducibility of the research results. Additionally, some of the referenced studies did not provide voucher specimen [13 pharmacological studies did provide such data (<xref rid="B161" ref-type="bibr">Yan et al., 2022</xref>; <xref rid="B105" ref-type="bibr">Qi et al., 2024</xref>; <xref rid="B134" ref-type="bibr">Tang et al., 2021</xref>; <xref rid="B166" ref-type="bibr">Yang et al., 2020</xref>; <xref rid="B94" ref-type="bibr">ManLi et al., 2023</xref>; <xref rid="B25" ref-type="bibr">Feng R. et al., 2023</xref>; <xref rid="B51" ref-type="bibr">Juan et al., 2022</xref>; <xref rid="B190" ref-type="bibr">Zhong-Hui et al., 2019</xref>; <xref rid="B118" ref-type="bibr">Shaojie et al., 2021</xref>; <xref rid="B146" ref-type="bibr">Wang et al., 2020</xref>; <xref rid="B75" ref-type="bibr">Lim et al., 2024</xref>; <xref rid="B104" ref-type="bibr">Pu et al., 2019b</xref>; <xref rid="B152" ref-type="bibr">Wu et al., 2021</xref>)], highlighting the need for greater emphasis on the standardization and traceability of materials in future research. The conclusions of this study are based on available data, but due to the ongoing taxonomic controversy, future investigations could further validate and refine these findings through more rigorous taxonomic identification and material standardization. Overall, this study provides an important foundation for understanding the pharmacological effects of CX and points the way for future improvements in research.</p></sec><sec id="s7"><title>7 Conclusion and prospects</title><p>CX, a traditional Chinese medicinal botanical drug, exhibits multiple pharmacological effects, including promoting blood circulation (&#27963;&#34880; huoxue), anti-inflammatory, antioxidant, and analgesic activities, and its active components and modern formulations have made it an important agent for the prevention and treatment of cardiovascular diseases and tumors. However, CX also presents the following research limitations: (1) Unclear Taxonomic Status: The distinction between <italic toggle="yes">Ligusticum chuanxiong</italic> and its wild populations (which may be considered different species or subspecies) has not been fully explored. We advocate for multidisciplinary collaboration, involving botanists, chemists, and pharmacologists, to conduct a comprehensive morphological, chemical, and genetic comparative study of <italic toggle="yes">Ligusticum chuanxiong</italic> and its closely related species. This also highlights the need to full describe from where the material was sourced, who authenticated it and where voucher specimens have been consulted. Aubtors should consult <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://ga-online.org/best-practice/" ext-link-type="uri">https://ga-online.org/best-practice/</ext-link>. Additionally, we recommend that future studies adhere to the standards outlined in the ConPhyMP guidelines to further enhance the scientific rigor and reliability of the research (<xref rid="B33" ref-type="bibr">Heinrich et al., 2022</xref>). Only by clarifying its taxonomic status can the scientific validity and reproducibility of future studies be ensured, thereby providing a more reliable theoretical foundation for the clinical application of this medicinal botanical drug. (2) Limitations of Animal Models: The therapeutic effects of CX in disease treatment have primarily been investigated in animal or cell models. These models do not accurately reflect the pathophysiological impact of multiple comorbidities in humans, and translating laboratory findings into clinical practice remains a critical unresolved issue. Consequently, advancing large-scale clinical trials is an essential step to further research and validate the effects of CX. (3) Lack of Bioinformatics Research: Although studies on the metabolites and pharmacological effects of CX have progressively increased, bioinformatics research remains relatively underdeveloped. Bioinformatics, an emerging research methodology, can integrate diverse biological data through computational analysis to elucidate the mechanisms, targets, and relationships between drugs and diseases. When confronted with the limitations of clinical or animal research, network pharmacology studies of CX may provide valuable insights. By constructing the interaction network between drugs and diseases, network pharmacology helps identify potential targets of CX metabolites, explore their pathways in complex biological systems, and further enrich and broaden the scope of traditional pharmacological research. (4) Unresolved Mechanisms of Action: Although several studies have explored the mechanisms of action of CX, a unified consensus has yet to emerge within the academic community. Elucidating the mechanisms of CX will enable a more accurate assessment of its safety and efficacy. (5) Delayed Product Development: Currently, CX products remain limited. The CX-related drugs marketed in China primarily consist of CX tea powder, with limited products developed through the compatibility of CX and its active metabolites with other drugs, such as Danggui and Huangqi <italic toggle="yes">[Astragalus membranaceus (Fisch.) Bge. var.mongholicus (Bge.) Hsiao]</italic>. The national government has yet to prioritize the development of relevant innovative products. (6) Neuropharmacological Potential Yet to Be Explored: Although some literature suggests limited pharmacological properties of CX in the nervous system, the research is still in its preliminary stages. Nevertheless, CX holds significant research potential in neuroprotection and antidepressant effects. In conclusion, CX is a multifunctional compound with vast research potential. Future research will facilitate the advancement of its development in broader applications, particularly in the treatment of neurological diseases.</p></sec></body><back><sec sec-type="author-contributions" id="s8"><title>Author contributions</title><p>YW: Investigation, Methodology, Writing &#8211; review and editing. LW: Investigation, Methodology, Software, Supervision, Writing &#8211; original draft, Writing &#8211; review and editing. HW: Data curation, Writing &#8211; original draft. MJ: Data curation, Writing &#8211; original draft. YC: Conceptualization, Resources, Visualization, Writing &#8211; review and editing. XZ: Methodology, Project administration, Writing &#8211; review and editing. LL: Formal Analysis, Project administration, Writing &#8211; review and editing. QY: Formal Analysis, Investigation, Project administration, Writing &#8211; review and editing. LH: Formal Analysis, Investigation, Supervision, Writing &#8211; review and editing. LB: Formal Analysis, Validation, Visualization, Writing &#8211; review and editing. YB: Conceptualization, Funding acquisition, Investigation, Methodology, Resources, Writing &#8211; review and editing.</p></sec><sec sec-type="COI-statement" id="s10"><title>Conflict of interest</title><p>Author YC was employed by Power China Chengdu Engineering Corporation Limited.</p><p>The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec><sec sec-type="ai-statement" id="s11"><title>Generative AI statement</title><p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p></sec><sec sec-type="disclaimer" id="s12"><title>Publisher&#8217;s note</title><p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Asgary</surname><given-names>S.</given-names></name><name name-style="western"><surname>Naderi</surname><given-names>G. A.</given-names></name><name name-style="western"><surname>Shams Ardekani</surname><given-names>M. R.</given-names></name><name name-style="western"><surname>Sahebkar</surname><given-names>A.</given-names></name><name name-style="western"><surname>Airin</surname><given-names>A.</given-names></name><name name-style="western"><surname>Aslani</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Chemical analysis and biological activities of Cupressus sempervirens var. horizontalis essential oils</article-title>. <source>Pharm. Biol.</source><volume>51</volume> (<issue>2</issue>), <fpage>137</fpage>&#8211;<lpage>144</lpage>. <pub-id pub-id-type="doi">10.3109/13880209.2012.715168</pub-id><pub-id pub-id-type="pmid">23167275</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bai</surname><given-names>L.</given-names></name><name name-style="western"><surname>Kee</surname><given-names>H. J.</given-names></name><name name-style="western"><surname>Han</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>T.</given-names></name><name name-style="western"><surname>Kee</surname><given-names>S. J.</given-names></name><name name-style="western"><surname>Jeong</surname><given-names>M. H.</given-names></name></person-group> (<year>2021</year>). <article-title>Protocatechuic acid attenuates isoproterenol-induced cardiac hypertrophy via downregulation of ROCK1-Sp1-PKC&#947; axis</article-title>. <source>Sci. Rep.</source><volume>11</volume> (<issue>1</issue>), <fpage>17343</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-021-96761-2</pub-id><pub-id pub-id-type="pmid">34462460</pub-id><pub-id pub-id-type="pmcid">PMC8405624</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Canhui</surname><given-names>T.</given-names></name><name name-style="western"><surname>Mengchan</surname><given-names>W.</given-names></name></person-group> (<year>2023</year>). <article-title>Protective effect of ligustilide on a cellular model of Parkinson's disease and its mechanism study</article-title>. <source>Chin. J. Clin. Pharmacol.</source><volume>39</volume> (<issue>06</issue>), <fpage>795</fpage>&#8211;<lpage>799</lpage>. <pub-id pub-id-type="doi">10.13699/j.cnki.1001-6821.2023.06.008</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cao</surname><given-names>F.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>W.</given-names></name><name name-style="western"><surname>Wen</surname><given-names>Y.</given-names></name><name name-style="western"><surname>He</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Qin</surname><given-names>W.</given-names></name></person-group> (<year>1983</year>). <article-title>Studies on the chemical constituents of Ligusticum chuanxiong Hort</article-title>. <source>Chin. Tradit. Herb. Drugs</source><volume>14</volume>, <fpage>1</fpage>&#8211;<lpage>2</lpage>.</mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cao</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Yao</surname><given-names>W.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>T.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>M.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Luo</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>Elucidating the mechanisms of Buyang Huanwu Decoction in treating chronic cerebral ischemia: a combined approach using network pharmacology, molecular docking, and <italic toggle="yes">in vivo</italic> validation</article-title>. <source>Phytomedicine</source><volume>132</volume>, <fpage>155820</fpage>. <pub-id pub-id-type="doi">10.1016/j.phymed.2024.155820</pub-id><pub-id pub-id-type="pmid">39004032</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chang</surname><given-names>X. L.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>Y. B.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X. M.</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>Z. Y.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J. J.</given-names></name></person-group> (<year>2007</year>). <article-title>Studies on chemical constituents of rhizomes of Ligusticum chuanxiong</article-title>. <source>Zhongguo Zhong Yao Za Zhi</source><volume>32</volume> (<issue>15</issue>), <fpage>1533</fpage>&#8211;<lpage>1536</lpage>.<pub-id pub-id-type="pmid">17972581</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Charakida</surname><given-names>A.</given-names></name><name name-style="western"><surname>Charakida</surname><given-names>M.</given-names></name><name name-style="western"><surname>Chu</surname><given-names>A. C.</given-names></name></person-group> (<year>2007</year>). <article-title>Double-blind, randomized, placebo-controlled study of a lotion containing triethyl citrate and ethyl linoleate in the treatment of acne vulgaris</article-title>. <source>Br. J. Dermatol</source><volume>157</volume> (<issue>3</issue>), <fpage>569</fpage>&#8211;<lpage>574</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2133.2007.08083.x</pub-id><pub-id pub-id-type="pmid">17635508</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>C.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>D.</given-names></name><name name-style="western"><surname>Bo</surname><given-names>C.</given-names></name><name name-style="western"><surname>Du</surname><given-names>L.</given-names></name></person-group> (<year>2003</year>). <article-title>Studies on the chemical constituents of ligusticum chuanxiong hort in yanbian</article-title>. <source>Chin. Tradit. Herb. Drugs</source> (<issue>24-25</issue>).</mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>J.</given-names></name><name name-style="western"><surname>Tian</surname><given-names>J.</given-names></name><name name-style="western"><surname>Ge</surname><given-names>H.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>R.</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>J.</given-names></name></person-group> (<year>2017</year>). <article-title>Effects of tetramethylpyrazine from Chinese black vinegar on antioxidant and hypolipidemia activities in HepG2 cells</article-title>. <source>Food Chem. Toxicol.</source><volume>109</volume>, <fpage>930</fpage>&#8211;<lpage>940</lpage>. <pub-id pub-id-type="doi">10.1016/j.fct.2016.12.017</pub-id><pub-id pub-id-type="pmid">28034800</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>L.</given-names></name><name name-style="western"><surname>Peng</surname><given-names>C.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>H.</given-names></name><name name-style="western"><surname>Xiang</surname><given-names>C.</given-names></name></person-group> (<year>2011</year>). <article-title>Discussion on forming pattern of dao-di herbs Ligusticum chuanxiong</article-title>. <source>China J. Chin. Mater Med.</source><volume>36</volume> (<issue>16</issue>), <fpage>2303</fpage>&#8211;<lpage>2305</lpage>.<pub-id pub-id-type="pmid">22097350</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Mo</surname><given-names>S.</given-names></name><name name-style="western"><surname>Li</surname><given-names>J.</given-names></name><name name-style="western"><surname>Ge</surname><given-names>F.</given-names></name></person-group> (<year>2004</year>). <article-title>Study on constituents of volatile oil of Ligusticum chuanxiong Hort</article-title>. <source>J. Chin. Med.</source>, <fpage>580</fpage>&#8211;<lpage>582</lpage>. <pub-id pub-id-type="doi">10.13863/j.issn1001-4454.2004.08.017</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Xing</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>C.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Peng</surname><given-names>C.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>SIRT1 activation by Ligustrazine ameliorates migraine via the paracrine interaction of microglia and neurons</article-title>. <source>Phytomedicine</source><volume>135</volume>, <fpage>156069</fpage>. <pub-id pub-id-type="doi">10.1016/j.phymed.2024.156069</pub-id><pub-id pub-id-type="pmid">39341123</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>C.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>F.</given-names></name><name name-style="western"><surname>Fu</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Fu</surname><given-names>C.</given-names></name><name name-style="western"><surname>He</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>A systematic review on the rhizome of Ligusticum chuanxiong Hort. (Chuanxiong)</article-title>. <source>Food Chem. Toxicol.</source><volume>119</volume>, <fpage>309</fpage>&#8211;<lpage>325</lpage>. <pub-id pub-id-type="doi">10.1016/j.fct.2018.02.050</pub-id><pub-id pub-id-type="pmid">29486278</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cheng</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zhengzhong</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Lihua</surname><given-names>C.</given-names></name><name name-style="western"><surname>Haiting</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Shihua</surname><given-names>F.</given-names></name><name name-style="western"><surname>Weifeng</surname><given-names>Z.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>Effect of volatile oil of Ligusticum chuanxiong on transdermal properties and cytotoxicity of triptolide <italic toggle="yes">in vitro</italic>
</article-title>. <source>Chin. Pharm.</source><volume>35</volume> (<issue>4</issue>), <fpage>413</fpage>&#8211;<lpage>418</lpage>. <pub-id pub-id-type="doi">10.6039/j.issn.1001-0408.2024.04.06</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cheng</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Chu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Jin</surname><given-names>M.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>The research of genetic toxicity of &#946;-phellandrene</article-title>. <source>Environ. Toxicol. Pharmacol.</source><volume>54</volume>, <fpage>28</fpage>&#8211;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1016/j.etap.2017.06.011</pub-id><pub-id pub-id-type="pmid">28668705</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chruszcz-Lipska</surname><given-names>K.</given-names></name></person-group> (<year>2022</year>). <article-title>Probing the stereochemical structure of carenes using Raman and Raman optical activity spectroscopy</article-title>. <source>Spectrochim. Acta A Mol. Biomol. Spectrosc.</source><volume>276</volume>, <fpage>121176</fpage>. <pub-id pub-id-type="doi">10.1016/j.saa.2022.121176</pub-id><pub-id pub-id-type="pmid">35439653</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chuang</surname><given-names>H.-M.</given-names></name><name name-style="western"><surname>Su</surname><given-names>H.-L.</given-names></name><name name-style="western"><surname>Li</surname><given-names>C.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>S.-Z.</given-names></name><name name-style="western"><surname>Yen</surname><given-names>S.-Y.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>M.-H.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>The role of butylidenephthalide in targeting the microenvironment which contributes to liver fibrosis amelioration</article-title>. <source>Front. Pharmacol.</source><volume>7</volume>, <fpage>112</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2016.00112</pub-id><pub-id pub-id-type="pmid">27199755</pub-id><pub-id pub-id-type="pmcid">PMC4847481</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Commission</surname><given-names>N. P.</given-names></name></person-group> (<year>2020</year>). <source>Chinese pharmacopoeia (2020 edition I)</source>. <publisher-loc>Bei Jing</publisher-loc>: <publisher-name>China Medical Science and Technology Press</publisher-name>.</mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cui</surname><given-names>S.</given-names></name><name name-style="western"><surname>Feng</surname><given-names>X.</given-names></name><name name-style="western"><surname>Xia</surname><given-names>Z.</given-names></name></person-group> (<year>2024</year>). <article-title>Ligusticum chuanxiong hort. Ameliorates neuropathic pain by regulating microglial M1 polarization: a study based on network pharmacology</article-title>. <source>J. Pain Res.</source><volume>17</volume>, <fpage>1881</fpage>&#8211;<lpage>1901</lpage>. <pub-id pub-id-type="doi">10.2147/jpr.S446137</pub-id><pub-id pub-id-type="pmid">38803692</pub-id><pub-id pub-id-type="pmcid">PMC11129751</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Danduga</surname><given-names>R. C. S. R.</given-names></name><name name-style="western"><surname>Dondapati</surname><given-names>S. R.</given-names></name><name name-style="western"><surname>Kola</surname><given-names>P. K.</given-names></name><name name-style="western"><surname>Grace</surname><given-names>L.</given-names></name><name name-style="western"><surname>Tadigiri</surname><given-names>R. V. B.</given-names></name><name name-style="western"><surname>Kanakaraju</surname><given-names>V. K.</given-names></name></person-group> (<year>2018</year>). <article-title>Neuroprotective activity of tetramethylpyrazine against 3-nitropropionic acid induced Huntington's disease-like symptoms in rats</article-title>. <source>Biomed. Pharmacother.</source><volume>105</volume>, <fpage>1254</fpage>&#8211;<lpage>1268</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopha.2018.06.079</pub-id><pub-id pub-id-type="pmid">30021362</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Deng</surname><given-names>S.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>S. N.</given-names></name><name name-style="western"><surname>Yao</surname><given-names>P.</given-names></name><name name-style="western"><surname>Nikolic</surname><given-names>D.</given-names></name><name name-style="western"><surname>van Breemen</surname><given-names>R. B.</given-names></name><name name-style="western"><surname>Bolton</surname><given-names>J. L.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>Serotonergic activity-guided phytochemical investigation of the roots of Angelica sinensis</article-title>. <source>J. Nat. Prod.</source><volume>69</volume> (<issue>4</issue>), <fpage>536</fpage>&#8211;<lpage>541</lpage>. <pub-id pub-id-type="doi">10.1021/np050301s</pub-id><pub-id pub-id-type="pmid">16643021</pub-id><pub-id pub-id-type="pmcid">PMC1866289</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Du</surname><given-names>X.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Geng</surname><given-names>M.</given-names></name></person-group> (<year>2018</year>). <article-title>Alzheimer's disease hypothesis and related therapies</article-title>. <source>Transl. Neurodegener.</source><volume>7</volume>, <fpage>2</fpage>. <pub-id pub-id-type="doi">10.1186/s40035-018-0107-y</pub-id><pub-id pub-id-type="pmid">29423193</pub-id><pub-id pub-id-type="pmcid">PMC5789526</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Duan</surname><given-names>J.</given-names></name><name name-style="western"><surname>Xiang</surname><given-names>D.</given-names></name><name name-style="western"><surname>Luo</surname><given-names>H.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>G.</given-names></name><name name-style="western"><surname>Ye</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>C.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Tetramethylpyrazine suppresses lipid accumulation in macrophages via upregulation of the ATP-binding cassette transporters and downregulation of scavenger receptors</article-title>. <source>Oncol. Rep.</source><volume>38</volume> (<issue>4</issue>), <fpage>2267</fpage>&#8211;<lpage>2276</lpage>. <pub-id pub-id-type="doi">10.3892/or.2017.5881</pub-id><pub-id pub-id-type="pmid">28791414</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Feng</surname><given-names>L.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Y. J.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y. R.</given-names></name><name name-style="western"><surname>Yue</surname><given-names>B. J.</given-names></name><name name-style="western"><surname>Peng</surname><given-names>C.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>C.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>QBT improved cognitive dysfunction in rats with vascular dementia by regulating the Nrf2/xCT/GPX4 and NLRP3/Caspase-1/GSDMD pathways to inhibit ferroptosis and pyroptosis of neurons</article-title>. <source>Int. Immunopharmacol.</source><volume>142</volume> (<issue>Pt A</issue>), <fpage>113070</fpage>. <pub-id pub-id-type="doi">10.1016/j.intimp.2024.113070</pub-id><pub-id pub-id-type="pmid">39265351</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Feng</surname><given-names>R.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>L.</given-names></name><name name-style="western"><surname>Shu</surname><given-names>H.-Z.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Q.-M.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2023a</year>). <article-title>A pair of new enantiomeric hybrid phthalide&#8211;adenines with a rare 5-oxa-1-azaspiro[3,4]octane moiety and two pairs of new enantiomeric hybrid paraethyl phenol&#8211;adenines from Ligusticum chuanxiong</article-title>. <source>Arabian J. Chem.</source><volume>16</volume> (<issue>5</issue>), <fpage>104696</fpage>. <pub-id pub-id-type="doi">10.1016/j.arabjc.2023.104696</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Feng</surname><given-names>X. F.</given-names></name><name name-style="western"><surname>Li</surname><given-names>M. C.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>Z. Y.</given-names></name><name name-style="western"><surname>Li</surname><given-names>M. Z.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhuang</surname><given-names>Y. M.</given-names></name><etal/></person-group> (<year>2023b</year>). <article-title>Tetramethylpyrazine promotes stroke recovery by inducing the restoration of neurovascular unit and transformation of A1/A2 reactive astrocytes</article-title>. <source>Front. Cell Neurosci.</source><volume>17</volume>, <fpage>1125412</fpage>. <pub-id pub-id-type="doi">10.3389/fncel.2023.1125412</pub-id><pub-id pub-id-type="pmid">37051111</pub-id><pub-id pub-id-type="pmcid">PMC10083399</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Gang</surname><given-names>W.</given-names></name></person-group> (<year>2018</year>). &#8220;<article-title>StudyonStructural characteristics of ligusticum CHUANXIONG in the prevention and treatment of myocardial ischemia injury and biopharmaceutical properries of CHUANXIONG lactone components</article-title>,&#8221; in <source>master</source> (<publisher-loc>Chengdu</publisher-loc>: <publisher-name>Anhui University of traditional Chinese Medicine</publisher-name>).</mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Govaerts</surname><given-names>R.</given-names></name><name name-style="western"><surname>Nic Lughadha</surname><given-names>E.</given-names></name><name name-style="western"><surname>Black</surname><given-names>N.</given-names></name><name name-style="western"><surname>Turner</surname><given-names>R.</given-names></name><name name-style="western"><surname>Paton</surname><given-names>A.</given-names></name></person-group> (<year>2021</year>). <article-title>The World Checklist of Vascular Plants, a continuously updated resource for exploring global plant diversity</article-title>. <source>Sci. Data</source><volume>8</volume>, <fpage>215</fpage>. <pub-id pub-id-type="doi">10.1038/s41597-021-00997-6</pub-id><pub-id pub-id-type="pmid">34389730</pub-id><pub-id pub-id-type="pmcid">PMC8363670</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guo</surname><given-names>R.</given-names></name><name name-style="western"><surname>Li</surname><given-names>L.</given-names></name><name name-style="western"><surname>Su</surname><given-names>J.</given-names></name><name name-style="western"><surname>Li</surname><given-names>S.</given-names></name><name name-style="western"><surname>Duncan</surname><given-names>S. E.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Z.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Pharmacological activity and mechanism of tanshinone IIA in related diseases</article-title>. <source>Drug Des. Devel Ther.</source><volume>14</volume>, <fpage>4735</fpage>&#8211;<lpage>4748</lpage>. <pub-id pub-id-type="doi">10.2147/dddt.S266911</pub-id><pub-id pub-id-type="pmcid">PMC7653026</pub-id><pub-id pub-id-type="pmid">33192051</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Han</surname><given-names>L.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>D.-L.</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>Q.-K.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>M.-Q.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>L.-X.</given-names></name><name name-style="western"><surname>He</surname><given-names>Q.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>The neuroprotective effects and probable mechanisms of Ligustilide and its degradative products on intracerebral hemorrhage in mice</article-title>. <source>Int. Immunopharmacol.</source><volume>63</volume>, <fpage>43</fpage>&#8211;<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1016/j.intimp.2018.06.045</pub-id><pub-id pub-id-type="pmid">30075428</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Han</surname><given-names>W.</given-names></name></person-group> (<year>2017</year>). <article-title>Research progress on chemical composition and pharmacological effects of chuanxiong</article-title>. <source>China J. Chin. Mater Med.</source><volume>19</volume> (<issue>09</issue>), <fpage>1341</fpage>&#8211;<lpage>1349</lpage>. <pub-id pub-id-type="doi">10.13313/j.issn.1673-4890.2017.9.027</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>He</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>L.</given-names></name><name name-style="western"><surname>Zhong</surname><given-names>W.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>H. Y.</given-names></name><name name-style="western"><surname>Shan</surname><given-names>X.</given-names></name><name name-style="western"><surname>Tang</surname><given-names>N.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Insight into potent leads for alzheimer's disease by using several artificial intelligence algorithms</article-title>. <source>Biomed. Pharmacother.</source><volume>129</volume>, <fpage>110360</fpage>. <pub-id pub-id-type="doi">10.1016/j.biopha.2020.110360</pub-id><pub-id pub-id-type="pmid">32559623</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Heinrich</surname><given-names>M.</given-names></name><name name-style="western"><surname>Jalil</surname><given-names>B.</given-names></name><name name-style="western"><surname>Abdel-Tawab</surname><given-names>M.</given-names></name><name name-style="western"><surname>Echeverria</surname><given-names>J.</given-names></name><name name-style="western"><surname>Kuli&#263;</surname><given-names>&#381;.</given-names></name><name name-style="western"><surname>McGaw</surname><given-names>L. J.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Best Practice in the chemical characterisation of extracts used in pharmacological and toxicological research-The ConPhyMP-Guidelines</article-title>. <source>Front. Pharmacol.</source><volume>13</volume>, <fpage>953205</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2022.953205</pub-id><pub-id pub-id-type="pmid">36176427</pub-id><pub-id pub-id-type="pmcid">PMC9514875</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hongmei</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Aijun</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Shuai</surname><given-names>L.</given-names></name></person-group> (<year>2024</year>). <article-title>Chuanxiong rhizoma and angelicase sinensis radix volatile oil study and transdermal effect based on the concept of unification of drugs and excipients</article-title>. <source>Chin. J. Pharm.</source><volume>59</volume> (<issue>23</issue>), <fpage>2249</fpage>&#8211;<lpage>2257</lpage>.</mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Jia</surname><given-names>X.</given-names></name><name name-style="western"><surname>Fang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Li</surname><given-names>P.</given-names></name><name name-style="western"><surname>He</surname><given-names>C.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>M.</given-names></name></person-group> (<year>2016a</year>). <article-title>Ultrasonic extraction, antioxidant and anticancer activities of novel polysaccharides from Chuanxiong rhizome</article-title>. <source>Int. J. Biol. Macromol.</source><volume>85</volume>, <fpage>277</fpage>&#8211;<lpage>284</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2015.12.046</pub-id><pub-id pub-id-type="pmid">26712703</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Jia</surname><given-names>X.</given-names></name><name name-style="western"><surname>Fang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Li</surname><given-names>P.</given-names></name><name name-style="western"><surname>He</surname><given-names>C.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>M.</given-names></name></person-group> (<year>2016b</year>). <article-title>Ultrasonic extraction, antioxidant and anticancer activities of novel polysaccharides from Chuanxiong rhizome</article-title>. <source>Int. J. Biol. Macromol.</source><volume>85</volume>, <fpage>277</fpage>&#8211;<lpage>284</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2015.12.046</pub-id><pub-id pub-id-type="pmid">26712703</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zou</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Tetramethylpyrazine improves cognitive impairment and modifies the hippocampal proteome in two mouse models of alzheimer's disease</article-title>. <source>Front. Cell Dev. Biol.</source><volume>9</volume>, <fpage>632843</fpage>. <pub-id pub-id-type="doi">10.3389/fcell.2021.632843</pub-id><pub-id pub-id-type="pmid">33791294</pub-id><pub-id pub-id-type="pmcid">PMC8005584</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Pu</surname><given-names>F.</given-names></name></person-group> (<year>1990</year>). <article-title>Chemical components of the essential oil from Ligusticum brachylobum Franch</article-title>. <source>Zhongguo Zhong Yao Za Zhi</source><volume>15</volume> (<issue>7</issue>), <fpage>422</fpage>&#8211;<lpage>423</lpage>.<pub-id pub-id-type="pmid">2261075</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>Y. Z.</given-names></name><name name-style="western"><surname>Pu</surname><given-names>F. D.</given-names></name></person-group> (<year>1988</year>). <article-title>Studies on the chemical components of the essential oil from the rhizome of Ligusticum sinense Oliv. cv. Chuanxiong hort</article-title>. <source>Yao Xue Xue Bao</source><volume>23</volume> (<issue>6</issue>), <fpage>426</fpage>&#8211;<lpage>429</lpage>.<pub-id pub-id-type="pmid">3213528</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Industry</surname><given-names>B. I. o.t.P.</given-names></name></person-group> (<year>1979</year>). <article-title>Studyies on the structuer of a phthalide compound</article-title>. <source>Acta Pharm. Sin.</source><volume>14</volume>, <fpage>670</fpage>&#8211;<lpage>675</lpage>.<pub-id pub-id-type="pmid">552206</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>International</surname><given-names>B. R.</given-names></name></person-group> (<year>2024</year>). <article-title>Retracted: molecular mechanism of palmitic acid on myocardial contractility in hypertensive rats and its relationship with neural nitric oxide synthase protein in cardiomyocytes</article-title>. <source>Biomed. Res. Int.</source><volume>2024</volume>, <fpage>9809026</fpage>. <pub-id pub-id-type="doi">10.1155/2024/9809026</pub-id><pub-id pub-id-type="pmid">38230031</pub-id><pub-id pub-id-type="pmcid">PMC10791398</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Islam</surname><given-names>A. U. S.</given-names></name><name name-style="western"><surname>Hellman</surname><given-names>B.</given-names></name><name name-style="western"><surname>Nyberg</surname><given-names>F.</given-names></name><name name-style="western"><surname>Amir</surname><given-names>N.</given-names></name><name name-style="western"><surname>Jayaraj</surname><given-names>R. L.</given-names></name><name name-style="western"><surname>Petroianu</surname><given-names>G.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Myrcene attenuates renal inflammation and oxidative stress in the adrenalectomized rat model</article-title>. <source>Molecules</source><volume>25</volume> (<issue>19</issue>), <fpage>4492</fpage>. <pub-id pub-id-type="doi">10.3390/molecules25194492</pub-id><pub-id pub-id-type="pmid">33007969</pub-id><pub-id pub-id-type="pmcid">PMC7582976</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Song</surname><given-names>G.</given-names></name><name name-style="western"><surname>Lim</surname><given-names>W.</given-names></name><name name-style="western"><surname>Park</surname><given-names>S.</given-names></name></person-group> (<year>2025</year>). <article-title>Toxic effects of dibutyl phthalate on trophoblast through mitochondria mediated cellular dysfunction</article-title>. <source>Toxicol. Appl. Pharmacol.</source><volume>495</volume>, <fpage>117186</fpage>. <pub-id pub-id-type="doi">10.1016/j.taap.2024.117186</pub-id><pub-id pub-id-type="pmid">39647510</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jeong</surname><given-names>H. U.</given-names></name><name name-style="western"><surname>Kwon</surname><given-names>S. S.</given-names></name><name name-style="western"><surname>Kong</surname><given-names>T. Y.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>J. H.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>H. S.</given-names></name></person-group> (<year>2014</year>). <article-title>Inhibitory effects of cedrol, &#946;-cedrene, and thujopsene on cytochrome P450 enzyme activities in human liver microsomes</article-title>. <source>J. Toxicol. Environ. Health A</source><volume>77</volume> (<issue>22-24</issue>), <fpage>1522</fpage>&#8211;<lpage>1532</lpage>. <pub-id pub-id-type="doi">10.1080/15287394.2014.955906</pub-id><pub-id pub-id-type="pmid">25343299</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jeremic</surname><given-names>D.</given-names></name><name name-style="western"><surname>Jimenez-Diaz</surname><given-names>L.</given-names></name><name name-style="western"><surname>Navarro-Lopez</surname><given-names>J. D.</given-names></name></person-group> (<year>2021</year>). <article-title>Past, present and future of therapeutic strategies against amyloid-beta peptides in Alzheimer's disease: a systematic review</article-title>. <source>Ageing Res. Rev.</source><volume>72</volume>, <fpage>101496</fpage>. <pub-id pub-id-type="doi">10.1016/j.arr.2021.101496</pub-id><pub-id pub-id-type="pmid">34687956</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jianfang</surname><given-names>W.</given-names></name><name name-style="western"><surname>Wenlong</surname><given-names>L.</given-names></name></person-group> (<year>2022</year>). <article-title>Clinical study on the treatment of angina pectoris with compound Chuanxiong capsule combined with Arolol</article-title>. <source>Mod. Drugs Clin.</source><volume>37</volume> (<issue>03</issue>), <fpage>531</fpage>&#8211;<lpage>534</lpage>.</mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jiang</surname><given-names>G.</given-names></name><name name-style="western"><surname>Xin</surname><given-names>R.</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>W.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Meng</surname><given-names>X.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>W.</given-names></name><etal/></person-group> (<year>2021a</year>). <article-title>Ligustrazine ameliorates acute kidney injury through downregulation of NOD2-mediated inflammation</article-title>. <source>Int. J. Mol. Med.</source><volume>45</volume> (<issue>3</issue>), <fpage>731</fpage>&#8211;<lpage>742</lpage>. <pub-id pub-id-type="doi">10.3892/ijmm.2020.4464</pub-id><pub-id pub-id-type="pmcid">PMC7015130</pub-id><pub-id pub-id-type="pmid">31985025</pub-id></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jiang</surname><given-names>R.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Tan</surname><given-names>Y.</given-names></name></person-group> (<year>2021b</year>). <article-title>Ligustrazine alleviate acute lung injury through suppressing pyroptosis and apoptosis of alveolar macrophages</article-title>. <source>Front. Pharmacol.</source><volume>12</volume>, <fpage>680512</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2021.680512</pub-id><pub-id pub-id-type="pmid">34122107</pub-id><pub-id pub-id-type="pmcid">PMC8193053</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jin</surname><given-names>L.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ryu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Piao</surname><given-names>Z. H.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>B.</given-names></name><name name-style="western"><surname>Choi</surname><given-names>S. Y.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Gallic acid improves cardiac dysfunction and fibrosis in pressure overload-induced heart failure</article-title>. <source>Sci. Rep.</source><volume>8</volume> (<issue>1</issue>), <fpage>9302</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-018-27599-4</pub-id><pub-id pub-id-type="pmid">29915390</pub-id><pub-id pub-id-type="pmcid">PMC6006337</pub-id></mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jin</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Liang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Kolattukudy</surname><given-names>P. E.</given-names></name></person-group> (<year>2021</year>). <article-title>Tetramethylpyrazine preserves the integrity of blood-brain barrier associated with upregulation of MCPIP1 in a murine model of focal ischemic stroke</article-title>. <source>Front. Pharmacol.</source><volume>12</volume>, <fpage>710358</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2021.710358</pub-id><pub-id pub-id-type="pmid">34393790</pub-id><pub-id pub-id-type="pmcid">PMC8355423</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Juan</surname><given-names>L.</given-names></name><name name-style="western"><surname>Rui</surname><given-names>F.</given-names></name><name name-style="western"><surname>Ou</surname><given-names>D.</given-names></name><name name-style="western"><surname>Hong</surname><given-names>N.</given-names></name><name name-style="western"><surname>Si</surname><given-names>L. L.</given-names></name><name name-style="western"><surname>Zhen</surname><given-names>S. H.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Isoindolines and phthalides from the rhizomes of Ligusticum chuanxiong and their relaxant effects on the uterine smooth muscle</article-title>. <source>Phytochem. (prepublish)</source><volume>198</volume>, <fpage>113159</fpage>. <pub-id pub-id-type="doi">10.1016/j.phytochem.2022.113159</pub-id><pub-id pub-id-type="pmid">35283167</pub-id></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jung</surname><given-names>Y. Y.</given-names></name><name name-style="western"><surname>Hong</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Nam</surname><given-names>D.</given-names></name><name name-style="western"><surname>Deivasigamani</surname><given-names>A.</given-names></name><name name-style="western"><surname>Narula</surname><given-names>A. S.</given-names></name><name name-style="western"><surname>Chinnathambi</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2025</year>). <article-title>TMP: a dual modulator of apoptosis and autophagy via SHP-1 regulation in hepatocellular carcinoma</article-title>. <source>Life Sci.</source><volume>361</volume>, <fpage>123316</fpage>. <pub-id pub-id-type="doi">10.1016/j.lfs.2024.123316</pub-id><pub-id pub-id-type="pmid">39675549</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kobayashi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Mitsuhashi</surname><given-names>H.</given-names></name></person-group> (<year>1987</year>). <article-title>Studies on the constituents of umbelliferae plantx. XVII. Structures of three new ligustilide derivatives from Ligusticum wallichii</article-title>. <source>Chem. and Pharm. Bull.</source><volume>35</volume> (<issue>12</issue>), <fpage>4789</fpage>&#8211;<lpage>4792</lpage>. <pub-id pub-id-type="doi">10.1248/cpb.35.4789</pub-id></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Kouli</surname><given-names>A.</given-names></name><name name-style="western"><surname>Torsney</surname><given-names>K. M.</given-names></name><name name-style="western"><surname>Kuan</surname><given-names>W. L.</given-names></name></person-group> (<year>2018</year>). &#8220;<article-title>Parkinson's disease: etiology, neuropathology, and pathogenesis</article-title>,&#8221; in <source>Parkinson's disease: pathogenesis and clinical aspects</source>. Editors <person-group person-group-type="editor"><name name-style="western"><surname>Stoker,</surname><given-names>T. B.</given-names></name><name name-style="western"><surname>Greenland</surname><given-names>J. C.</given-names></name></person-group> (<publisher-loc>Brisbane (AU)</publisher-loc>: <publisher-name>Codon Publications</publisher-name>).<pub-id pub-id-type="pmid">30702842</pub-id></mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>S. H.</given-names></name><name name-style="western"><surname>Jeong</surname><given-names>S. J.</given-names></name><name name-style="western"><surname>Jang</surname><given-names>G. Y.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>M. Y.</given-names></name><name name-style="western"><surname>Hwang</surname><given-names>I. G.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>H. Y.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Isolation and identification of an antiproliferative compound from fructose-tryptophan maillard reaction products</article-title>. <source>J. Agric. Food Chem.</source><volume>64</volume> (<issue>15</issue>), <fpage>3041</fpage>&#8211;<lpage>3047</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jafc.6b00157</pub-id><pub-id pub-id-type="pmid">27041128</pub-id></mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>D.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>S.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Xing</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>M.</given-names></name></person-group> (<year>2022a</year>). <article-title>Mechanism and potential target of blood-activating Chinese botanical drugs combined with anti-platelet drugs: prevention and treatment of atherosclerotic cardiovascular diseases</article-title>. <source>Front. Pharmacol.</source><volume>13</volume>, <fpage>811422</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2022.811422</pub-id><pub-id pub-id-type="pmid">35721128</pub-id><pub-id pub-id-type="pmcid">PMC9204194</pub-id></mixed-citation></ref><ref id="B57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>D.</given-names></name><name name-style="western"><surname>Long</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>S.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Wan</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wen</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2022b</year>). <article-title>Research advances in cardio-cerebrovascular diseases of ligusticum chuanxiong hort</article-title>. <source>Front. Pharmacol.</source><volume>12</volume>, <fpage>832673</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2021.832673</pub-id><pub-id pub-id-type="pmid">35173614</pub-id><pub-id pub-id-type="pmcid">PMC8841966</pub-id></mixed-citation></ref><ref id="B58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>H.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>S.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>D.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>Y.</given-names></name></person-group> (<year>2018</year>). <article-title>Research progress on the pharmacology of the main pharmacologically active ingredients of Chuanxiong</article-title>. <source>Clin. Pharmacol. Ther.</source><volume>23</volume>, <fpage>1302</fpage>&#8211;<lpage>1308</lpage>. <pub-id pub-id-type="doi">10.12092/j.issn.1009-2501.2018.11.018</pub-id></mixed-citation></ref><ref id="B59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>H.-q.</given-names></name><name name-style="western"><surname>Wei</surname><given-names>J.-j.</given-names></name><name name-style="western"><surname>Xia</surname><given-names>W.</given-names></name><name name-style="western"><surname>Li</surname><given-names>J.-h.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>A.-j.</given-names></name><name name-style="western"><surname>Yin</surname><given-names>S.-b.</given-names></name><etal/></person-group> (<year>2015a</year>). <article-title>Promoting blood circulation for removing blood stasis therapy for acute intracerebral hemorrhage: a systematic review and meta-analysis</article-title>. <source>Acta Pharmacol. Sin.</source><volume>36</volume> (<issue>6</issue>), <fpage>659</fpage>&#8211;<lpage>675</lpage>. <pub-id pub-id-type="doi">10.1038/aps.2014.139</pub-id><pub-id pub-id-type="pmid">25960132</pub-id><pub-id pub-id-type="pmcid">PMC4594185</pub-id></mixed-citation></ref><ref id="B60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>H. X.</given-names></name><name name-style="western"><surname>Ding</surname><given-names>M. Y.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>J. Y.</given-names></name></person-group> (<year>2002</year>). <article-title>Separation and identification of the phthalic anhydride derivatives of Liqusticum Chuanxiong Hort by GC-MS, TLC, HPLC-DAD, and HPLC-MS</article-title>. <source>J. Chromatogr. Sci.</source><volume>40</volume> (<issue>3</issue>), <fpage>156</fpage>&#8211;<lpage>161</lpage>. <pub-id pub-id-type="doi">10.1093/chromsci/40.3.156</pub-id><pub-id pub-id-type="pmid">11954653</pub-id></mixed-citation></ref><ref id="B61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>J.</given-names></name><name name-style="western"><surname>Li</surname><given-names>T.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Song</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Gong</surname><given-names>X.</given-names></name></person-group> (<year>2023a</year>). <article-title>Nephroprotective mechanisms of Rhizoma Chuanxiong and Radix et Rhizoma Rhei against acute renal injury and renal fibrosis based on network pharmacology and experimental validation</article-title>. <source>Front. Pharmacol.</source><volume>14</volume>, <fpage>1154743</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2023.1154743</pub-id><pub-id pub-id-type="pmid">37229255</pub-id><pub-id pub-id-type="pmcid">PMC10203597</pub-id></mixed-citation></ref><ref id="B62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>J.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>H.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>N.</given-names></name><name name-style="western"><surname>Li</surname><given-names>L.</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>D.-d.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Intranasal pretreatment with Z-ligustilide, the main volatile component of rhizoma chuanxiong, confers prophylaxis against cerebral ischemia via Nrf2 and HSP70 signaling pathways</article-title>. <source>J. Agric. Food Chem.</source><volume>65</volume> (<issue>8</issue>), <fpage>1533</fpage>&#8211;<lpage>1542</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jafc.6b04979</pub-id><pub-id pub-id-type="pmid">28169530</pub-id></mixed-citation></ref><ref id="B63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>J.-h.</given-names></name><name name-style="western"><surname>Cao</surname><given-names>X.-p.</given-names></name><name name-style="western"><surname>Wei</surname><given-names>J.-j.</given-names></name><name name-style="western"><surname>Song</surname><given-names>L.</given-names></name><name name-style="western"><surname>Liao</surname><given-names>F.-j.</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>G.-q.</given-names></name><etal/></person-group> (<year>2015b</year>). <article-title>Chuanxiong chadiao powder, a famous Chinese herbal prescription, for headache: a systematic review and meta-analysis</article-title>. <source>Complement. Ther. Med.</source><volume>23</volume> (<issue>4</issue>), <fpage>577</fpage>&#8211;<lpage>590</lpage>. <pub-id pub-id-type="doi">10.1016/j.ctim.2015.06.012</pub-id><pub-id pub-id-type="pmid">26275651</pub-id></mixed-citation></ref><ref id="B64"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>N.</given-names></name><name name-style="western"><surname>Miao</surname><given-names>M.</given-names></name><name name-style="western"><surname>Bai</surname><given-names>L.</given-names></name></person-group> (<year>2022c</year>). <article-title>Clinical toxicity mechanism and rescue measures of large poisonous traditional Chinese medicine</article-title>. <source>J. Tradit. Chin. Med.</source><volume>37</volume>, <fpage>659</fpage>&#8211;<lpage>664</lpage>.</mixed-citation></ref><ref id="B65"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Q.</given-names></name><name name-style="western"><surname>He</surname><given-names>P.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>D.</given-names></name><name name-style="western"><surname>Pei</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Z.</given-names></name><etal/></person-group> (<year>2024a</year>). <article-title>Current situation and development strategy of Chuanxiong Rhizoma industry</article-title>. <source>Chin. Herb. Med.</source><volume>55</volume>, <fpage>2771</fpage>&#8211;<lpage>2783</lpage>.</mixed-citation></ref><ref id="B66"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>S. L.</given-names></name><name name-style="western"><surname>Chan</surname><given-names>S. S.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>G.</given-names></name><name name-style="western"><surname>Ling</surname><given-names>L.</given-names></name><name name-style="western"><surname>Yan</surname><given-names>R.</given-names></name><name name-style="western"><surname>Chung</surname><given-names>H. S.</given-names></name><etal/></person-group> (<year>2003</year>). <article-title>Simultaneous analysis of seventeen chemical ingredients of Ligusticum chuanxiong by on-line high performance liquid chromatography-diode array detector-mass spectrometry</article-title>. <source>Planta Med.</source><volume>69</volume> (<issue>5</issue>), <fpage>445</fpage>&#8211;<lpage>451</lpage>. <pub-id pub-id-type="doi">10.1055/s-2003-39709</pub-id><pub-id pub-id-type="pmid">12802727</pub-id></mixed-citation></ref><ref id="B67"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Li</surname><given-names>F.</given-names></name><name name-style="western"><surname>Ding</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Li</surname><given-names>S.</given-names></name><name name-style="western"><surname>Qu</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2024b</year>). <article-title>Chuanxiong Rhizoma extracts prevent liver fibrosis via targeting CTCF-c-MYC-H19 pathway</article-title>. <source>Chin. Herb. Med.</source><volume>16</volume> (<issue>1</issue>), <fpage>82</fpage>&#8211;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1016/j.chmed.2023.07.003</pub-id><pub-id pub-id-type="pmid">38375042</pub-id><pub-id pub-id-type="pmcid">PMC10874761</pub-id></mixed-citation></ref><ref id="B68"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Li</surname><given-names>F.</given-names></name><name name-style="western"><surname>Ding</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Li</surname><given-names>S.</given-names></name><name name-style="western"><surname>Qu</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2024c</year>). <article-title>Chuanxiong Rhizoma extracts prevent liver fibrosis via targeting CTCF-c-MYC-H19 pathway</article-title>. <source>Chin. Herb. Med.</source><volume>16</volume> (<issue>01</issue>), <fpage>82</fpage>&#8211;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1016/j.chmed.2023.07.003</pub-id><pub-id pub-id-type="pmid">38375042</pub-id><pub-id pub-id-type="pmcid">PMC10874761</pub-id></mixed-citation></ref><ref id="B69"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Ding</surname><given-names>M.</given-names></name><name name-style="western"><surname>Jia</surname><given-names>K.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>B.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>F.</given-names></name><etal/></person-group> (<year>2023b</year>). <article-title>Chuanxiong Rhizoma extracts prevent cholestatic liver injury by targeting H3K9ac-mediated and cholangiocyte-derived secretory protein PAI-1 and FN</article-title>. <source>Chin. J. Nat. Med.</source><volume>21</volume> (<issue>9</issue>), <fpage>694</fpage>&#8211;<lpage>709</lpage>. <pub-id pub-id-type="doi">10.1016/s1875-5364(23)60416-9</pub-id><pub-id pub-id-type="pmid">37777319</pub-id></mixed-citation></ref><ref id="B70"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Song</surname><given-names>P.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Yin</surname><given-names>Q.-y.</given-names></name><name name-style="western"><surname>Ji</surname><given-names>J.-w.</given-names></name><name name-style="western"><surname>Li</surname><given-names>W.</given-names></name><etal/></person-group> (<year>2014a</year>). <article-title>Liguzinediol improved the heart function and inhibited myocardial cell apoptosis in rats with heart failure</article-title>. <source>Acta Pharmacol. Sin.</source><volume>35</volume> (<issue>10</issue>), <fpage>1257</fpage>&#8211;<lpage>1264</lpage>. <pub-id pub-id-type="doi">10.1038/aps.2014.75</pub-id><pub-id pub-id-type="pmid">25220638</pub-id><pub-id pub-id-type="pmcid">PMC4186991</pub-id></mixed-citation></ref><ref id="B71"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Song</surname><given-names>P.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Yin</surname><given-names>Q. Y.</given-names></name><name name-style="western"><surname>Ji</surname><given-names>J. W.</given-names></name><name name-style="western"><surname>Li</surname><given-names>W.</given-names></name><etal/></person-group> (<year>2014b</year>). <article-title>Liguzinediol improved the heart function and inhibited myocardial cell apoptosis in rats with heart failure</article-title>. <source>Acta Pharmacol. Sin.</source><volume>35</volume> (<issue>10</issue>), <fpage>1257</fpage>&#8211;<lpage>1264</lpage>. <pub-id pub-id-type="doi">10.1038/aps.2014.75</pub-id><pub-id pub-id-type="pmid">25220638</pub-id><pub-id pub-id-type="pmcid">PMC4186991</pub-id></mixed-citation></ref><ref id="B72"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Libby</surname><given-names>P.</given-names></name></person-group> (<year>2021</year>). <article-title>The changing landscape of atherosclerosis</article-title>. <source>Nature</source><volume>592</volume> (<issue>7855</issue>), <fpage>524</fpage>&#8211;<lpage>533</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-021-03392-8</pub-id><pub-id pub-id-type="pmid">33883728</pub-id></mixed-citation></ref><ref id="B73"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liberale</surname><given-names>L.</given-names></name><name name-style="western"><surname>Ministrini</surname><given-names>S.</given-names></name><name name-style="western"><surname>Carbone</surname><given-names>F.</given-names></name><name name-style="western"><surname>Camici</surname><given-names>G. G.</given-names></name><name name-style="western"><surname>Montecucco</surname><given-names>F.</given-names></name></person-group> (<year>2021</year>). <article-title>Cytokines as therapeutic targets for cardio- and cerebrovascular diseases</article-title>. <source>Basic Res. Cardiol.</source><volume>116</volume> (<issue>1</issue>), <fpage>23</fpage>. <pub-id pub-id-type="doi">10.1007/s00395-021-00863-x</pub-id><pub-id pub-id-type="pmid">33770265</pub-id><pub-id pub-id-type="pmcid">PMC7997823</pub-id></mixed-citation></ref><ref id="B74"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lihua</surname><given-names>W.</given-names></name><name name-style="western"><surname>Yi</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Desheng</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Yamei</surname><given-names>T.</given-names></name><name name-style="western"><surname>Huimin</surname><given-names>L.</given-names></name></person-group> (<year>2023</year>). <article-title>Study on the efficacy of Chuanxiong Qingbao Granules in the treatment of chronic cerebral ischemia with headache</article-title>. <source>Chin. J. Pract. Intern. Med.</source><volume>43</volume> (<issue>01</issue>), <fpage>74</fpage>&#8211;<lpage>77</lpage>. <pub-id pub-id-type="doi">10.19538/j.nk2023010115</pub-id></mixed-citation></ref><ref id="B75"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lim</surname><given-names>S.</given-names></name><name name-style="western"><surname>Lim</surname><given-names>C.</given-names></name><name name-style="western"><surname>Cho</surname><given-names>S.</given-names></name></person-group> (<year>2024</year>). <article-title>Methanol extract of Ligusticum chuanxiong Hort. Rhizome ameliorates bilateral common carotid artery stenosis-induced cognitive deficit in mice by altering microglia and astrocyte activation</article-title>. <source>Front. Pharmacol.</source><volume>15</volume>, <fpage>1329895</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2024.1329895</pub-id><pub-id pub-id-type="pmid">38549667</pub-id><pub-id pub-id-type="pmcid">PMC10973115</pub-id></mixed-citation></ref><ref id="B76"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>S.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>S.</given-names></name><name name-style="western"><surname>Yao</surname><given-names>K.</given-names></name></person-group> (<year>2022</year>). <article-title>Tetramethylpyrazine: a review on its mechanisms and functions</article-title>. <source>Biomed. Pharmacother.</source><volume>150</volume>, <fpage>113005</fpage>. <pub-id pub-id-type="doi">10.1016/j.biopha.2022.113005</pub-id><pub-id pub-id-type="pmid">35483189</pub-id></mixed-citation></ref><ref id="B77"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>L.</given-names></name><name name-style="western"><surname>Jingyue</surname><given-names>X.</given-names></name><name name-style="western"><surname>Sisi</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Shijing</surname><given-names>D.</given-names></name><name name-style="western"><surname>Fengjuan</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Qinshan</surname><given-names>Z.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>Study on the mechanism of prevention of arterial thrombosis by volatile oil of Rhizoma Ligusticum chuanxiong</article-title>. <source>Chin. Med. Pharmacol. Clin.</source><volume>40</volume> (<issue>6</issue>), <fpage>67</fpage>&#8211;<lpage>71</lpage>.</mixed-citation></ref><ref id="B78"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>D.</given-names></name><name name-style="western"><surname>Yan</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>B.</given-names></name></person-group> (<year>2009</year>). <article-title>Neuroprotection by herbal formula FBD and its active compounds</article-title>. <source>Pharm. Biol.</source><volume>47</volume> (<issue>7</issue>), <fpage>608</fpage>&#8211;<lpage>614</lpage>. <pub-id pub-id-type="doi">10.1080/13880200902913403</pub-id></mixed-citation></ref><ref id="B79"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Linying</surname><given-names>N.</given-names></name><name name-style="western"><surname>Tiezhu</surname><given-names>C.</given-names></name><name name-style="western"><surname>Qingmao</surname><given-names>F.</given-names></name></person-group> (<year>2021</year>). <article-title>Evolution of the distribution of genuine medicinal materials in sichuan province in Materia Medica works in different historical periods</article-title>. <source>China J. Chin. Materia Medica</source><volume>46</volume>, <fpage>1564</fpage>&#8211;<lpage>1573</lpage>. <pub-id pub-id-type="doi">10.19540/j.cnki.cjcmm.20201214.602</pub-id></mixed-citation></ref><ref id="B80"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>X. M.</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>T.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>M. Z.</given-names></name><name name-style="western"><surname>Feng</surname><given-names>S.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2025</year>). <article-title>Chemical constituents of butyl-phthalides from Ligusticum sinense</article-title>. <source>Zhongguo Zhong Yao Za Zhi</source><volume>50</volume> (<issue>2</issue>), <fpage>439</fpage>&#8211;<lpage>443</lpage>. <pub-id pub-id-type="doi">10.19540/j.cnki.cjcmm.20241101.202</pub-id><pub-id pub-id-type="pmid">39929625</pub-id></mixed-citation></ref><ref id="B81"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>S. J.</given-names></name><name name-style="western"><surname>Fu</surname><given-names>J. J.</given-names></name><name name-style="western"><surname>Liao</surname><given-names>Z. Y.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y. X.</given-names></name><name name-style="western"><surname>He</surname><given-names>J.</given-names></name><name name-style="western"><surname>He</surname><given-names>L. Y.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>Z-ligustilide alleviates atherosclerosis by reconstructing gut microbiota and sustaining gut barrier integrity through activation of cannabinoid receptor 2</article-title>. <source>Phytomedicine</source><volume>135</volume>, <fpage>156117</fpage>. <pub-id pub-id-type="doi">10.1016/j.phymed.2024.156117</pub-id><pub-id pub-id-type="pmid">39426255</pub-id></mixed-citation></ref><ref id="B82"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Lian</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>B.</given-names></name><name name-style="western"><surname>Lan</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>X.</given-names></name></person-group> (<year>2014</year>). <article-title>GC-MS detection of essential oil of Chuanxiong Rhizoma extracted using different methods</article-title>. <source>Pharm. Clin. Chin. Materia Medica</source><volume>5</volume> (<issue>17-19</issue>).</mixed-citation></ref><ref id="B83"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>X.-t.</given-names></name><name name-style="western"><surname>Ren</surname><given-names>P.-w.</given-names></name><name name-style="western"><surname>Peng</surname><given-names>L.</given-names></name><name name-style="western"><surname>Kang</surname><given-names>D.-y.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>T.-l.</given-names></name><name name-style="western"><surname>Wen</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2016a</year>). <article-title>Effectiveness and safety of ShenXiong glucose injection for acute ischemic stroke: a systematic review and GRADE approach</article-title>. <source>Bmc Complem Altern. M.</source><volume>16</volume>, <fpage>68</fpage>. <pub-id pub-id-type="doi">10.1186/s12906-016-1038-8</pub-id><pub-id pub-id-type="pmcid">PMC4761180</pub-id><pub-id pub-id-type="pmid">26895969</pub-id></mixed-citation></ref><ref id="B84"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Luo</surname><given-names>Z. Q.</given-names></name><name name-style="western"><surname>Lv</surname><given-names>B. R.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>H. Y.</given-names></name><name name-style="western"><surname>Dong</surname><given-names>L.</given-names></name></person-group> (<year>2016b</year>). <article-title>Absorption and metabolism of Chuanxiong Rhizoma decoction with multi-component sequential metabolism method</article-title>. <source>Zhongguo Zhong Yao Za Zhi</source><volume>41</volume> (<issue>7</issue>), <fpage>1178</fpage>&#8211;<lpage>1182</lpage>. <pub-id pub-id-type="doi">10.4268/cjcmm20160703</pub-id><pub-id pub-id-type="pmid">28879727</pub-id></mixed-citation></ref><ref id="B85"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Qin</surname><given-names>X.</given-names></name><name name-style="western"><surname>Lei</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Chai</surname><given-names>H.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Z.</given-names></name></person-group> (<year>2021</year>). <article-title>Tetramethylpyrazine inhibits neutrophil extracellular traps formation and alleviates hepatic ischemia/reperfusion injury in rat liver transplantation</article-title>. <source>Expe Cell Res.</source><volume>406</volume> (<issue>1</issue>), <fpage>112719</fpage>. <pub-id pub-id-type="doi">10.1016/j.yexcr.2021.112719</pub-id><pub-id pub-id-type="pmid">34273405</pub-id></mixed-citation></ref><ref id="B86"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Long</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>S.</given-names></name><name name-style="western"><surname>Li</surname><given-names>D.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Deng</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>Preparation, characterization and safety evaluation of Ligusticum chuanxiong essential oils liposomes for treatment of cerebral ischemia-reperfusion injury</article-title>. <source>Food Chem. Toxicol.</source><volume>175</volume>, <fpage>113723</fpage>. <pub-id pub-id-type="doi">10.1016/j.fct.2023.113723</pub-id><pub-id pub-id-type="pmid">36935074</pub-id></mixed-citation></ref><ref id="B87"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lu</surname><given-names>C.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>W.</given-names></name><name name-style="western"><surname>Shao</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>F.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>A.</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>S.</given-names></name></person-group> (<year>2017a</year>). <article-title>Nrf2 activation is required for ligustrazine to inhibit hepatic steatosis in alcohol-preferring mice and hepatocytes</article-title>. <source>Toxicol. Sci.</source><volume>155</volume> (<issue>2</issue>), <fpage>432</fpage>&#8211;<lpage>443</lpage>. <pub-id pub-id-type="doi">10.1093/toxsci/kfw228</pub-id><pub-id pub-id-type="pmid">27837167</pub-id></mixed-citation></ref><ref id="B88"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lu</surname><given-names>F.</given-names></name><name name-style="western"><surname>Li</surname><given-names>X.</given-names></name><name name-style="western"><surname>Li</surname><given-names>W.</given-names></name><name name-style="western"><surname>Wei</surname><given-names>K.</given-names></name><name name-style="western"><surname>Yao</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Q.</given-names></name><etal/></person-group> (<year>2017b</year>). <article-title>Tetramethylpyrazine reverses intracerebroventricular streptozotocin-induced memory deficits by inhibiting GSK-3&#946;</article-title>. <source>Acta Bioch Bioph Sin.</source><volume>49</volume> (<issue>8</issue>), <fpage>722</fpage>&#8211;<lpage>728</lpage>. <pub-id pub-id-type="doi">10.1093/abbs/gmx059</pub-id><pub-id pub-id-type="pmid">28633346</pub-id></mixed-citation></ref><ref id="B89"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lu</surname><given-names>L.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>T.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Ke</surname><given-names>X.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>R.</given-names></name></person-group> (<year>2023</year>). <article-title>Research on the effectiveness and material basis of Ligusticum chuanxiong in alleviating acute liver injury</article-title>. <source>J. Ethnopharmacol.</source><volume>314</volume>, <fpage>116643</fpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2023.116643</pub-id><pub-id pub-id-type="pmid">37220808</pub-id></mixed-citation></ref><ref id="B90"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Luo</surname><given-names>M.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>P.-p.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>P.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>Y.-l.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>F.-g.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Sodium ferulate inhibits myocardial hypertrophy induced by abdominal coarctation in rats: involvement of cardiac PKC and MAPK signaling pathways</article-title>. <source>Biomed. Pharmacother.</source><volume>112</volume>, <fpage>108735</fpage>. <pub-id pub-id-type="doi">10.1016/j.biopha.2019.108735</pub-id><pub-id pub-id-type="pmid">30970525</pub-id></mixed-citation></ref><ref id="B91"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Luo</surname><given-names>S.</given-names></name><name name-style="western"><surname>Li</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhai</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Z.</given-names></name><etal/></person-group> (<year>2025</year>). <article-title>Diisooctyl phthalate (DIOP) exposure leads to cell apoptosis to HUVEC cells and toxicity to <italic toggle="yes">Caenorhabditis elegans</italic> through increasing the oxidative stress</article-title>. <source>Ecotoxicol. Environ. Saf.</source><volume>290</volume>, <fpage>117594</fpage>. <pub-id pub-id-type="doi">10.1016/j.ecoenv.2024.117594</pub-id><pub-id pub-id-type="pmid">39729937</pub-id></mixed-citation></ref><ref id="B92"><mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Ma</surname><given-names>D.</given-names></name></person-group> (<year>2009</year>). &#8220;<article-title>Comparative study between Ligusticum Chuanxiong and its close relative Ligusticum sinense Oliv. from three different origins</article-title>,&#8221; in <source>Master</source> (<publisher-loc>Chengdu</publisher-loc><publisher-name>Chengdu University of Traditional Chinese Medicine</publisher-name>).</mixed-citation></ref><ref id="B93"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ma</surname><given-names>K. T.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Y. J.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y. X.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>T.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>C.</given-names></name><name name-style="western"><surname>Peng</surname><given-names>F.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>A novel phthalein component ameliorates neuroinflammation and cognitive dysfunction by suppressing the CXCL12/CXCR4 axis in rats with vascular dementia</article-title>. <source>J. Ethnopharmacol.</source><volume>328</volume>, <fpage>118117</fpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2024.118117</pub-id><pub-id pub-id-type="pmid">38548120</pub-id></mixed-citation></ref><ref id="B94"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>ManLi</surname><given-names>Y.</given-names></name><name name-style="western"><surname>HaoDong</surname><given-names>Y.</given-names></name><name name-style="western"><surname>ZhiShu</surname><given-names>T.</given-names></name><name name-style="western"><surname>XiaoHui</surname><given-names>H.</given-names></name><name name-style="western"><surname>Rui</surname><given-names>Z.</given-names></name><name name-style="western"><surname>TaoTao</surname><given-names>X.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>Lignan and phthalide derivatives from the rhizome of ligusticum chuanxiong (rhizoma chuanxiong) and evaluation of their anti-xanthine oxidase activities</article-title>. <source>ACS omega</source><volume>8</volume> (<issue>42</issue>), <fpage>39855</fpage>&#8211;<lpage>39864</lpage>. <pub-id pub-id-type="doi">10.1021/acsomega.3c06172</pub-id><pub-id pub-id-type="pmid">37901529</pub-id><pub-id pub-id-type="pmcid">PMC10601418</pub-id></mixed-citation></ref><ref id="B95"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mao</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Tian</surname><given-names>L.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>N.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>G.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Ligustilide ameliorates hippocampal neuronal injury after cerebral ischemia reperfusion through activating PINK1/Parkin-dependent mitophagy</article-title>. <source>Phytomedicine</source><volume>101</volume>, <fpage>154111</fpage>. <pub-id pub-id-type="doi">10.1016/j.phymed.2022.154111</pub-id><pub-id pub-id-type="pmid">35512628</pub-id></mixed-citation></ref><ref id="B96"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mathew</surname><given-names>S.</given-names></name><name name-style="western"><surname>Abraham</surname><given-names>T. E.</given-names></name></person-group> (<year>2004</year>). <article-title>Ferulic acid: an antioxidant found naturally in plant cell walls and feruloyl esterases involved in its release and their applications</article-title>. <source>Crit. Rev. Biotechnol.</source><volume>24</volume> (<issue>2-3</issue>), <fpage>59</fpage>&#8211;<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1080/07388550490491467</pub-id><pub-id pub-id-type="pmid">15493526</pub-id></mixed-citation></ref><ref id="B97"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Michel</surname><given-names>H. E.</given-names></name><name name-style="western"><surname>Tadros</surname><given-names>M. G.</given-names></name><name name-style="western"><surname>Esmat</surname><given-names>A.</given-names></name><name name-style="western"><surname>Khalifa</surname><given-names>A. E.</given-names></name><name name-style="western"><surname>Abdel-Tawab</surname><given-names>A. M.</given-names></name></person-group> (<year>2017</year>). <article-title>Tetramethylpyrazine ameliorates rotenone-induced Parkinson&#8217;s disease in rats: involvement of its anti-inflammatory and anti-apoptotic actions</article-title>. <source>Mol. Neurobiol.</source><volume>54</volume> (<issue>7</issue>), <fpage>4866</fpage>&#8211;<lpage>4878</lpage>. <pub-id pub-id-type="doi">10.1007/s12035-016-0028-7</pub-id><pub-id pub-id-type="pmid">27514753</pub-id></mixed-citation></ref><ref id="B98"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Min</surname><given-names>S.</given-names></name><name name-style="western"><surname>Tao</surname><given-names>W.</given-names></name><name name-style="western"><surname>Ding</surname><given-names>D.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>S.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Tetramethylpyrazine ameliorates acute lung injury by regulating the Rac1/LIMK1 signaling pathway</article-title>. <source>Front. Pharmacol.</source><volume>13</volume>, <fpage>1005014</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2022.1005014</pub-id><pub-id pub-id-type="pmid">36686718</pub-id><pub-id pub-id-type="pmcid">PMC9859661</pub-id></mixed-citation></ref><ref id="B99"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ming</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhaoping</surname><given-names>W.</given-names></name><name name-style="western"><surname>Zhiqiang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Bo</surname><given-names>L.</given-names></name><name name-style="western"><surname>Hua</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Jing</surname><given-names>L.</given-names></name></person-group> (<year>2024</year>). <article-title>Network pharmacological study and experimental validationof Rhizoma Chuanxiong volatile oil in the treatment of angina pectoris</article-title>. <source>Chin. J. Laboratory Animals</source><volume>32</volume> (<issue>07</issue>), <fpage>867</fpage>&#8211;<lpage>878</lpage>.</mixed-citation></ref><ref id="B100"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mingyan</surname><given-names>L.</given-names></name><name name-style="western"><surname>Lirong</surname><given-names>L.</given-names></name><name name-style="western"><surname>Menghan</surname><given-names>F.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>M.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Yan</surname><given-names>X.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>Effect and mechanism of Chuanxiong Rhizoma on permeability of blood-brain barrier</article-title>. <source>Chinese herbal medicine.</source><volume>55</volume> (<issue>01</issue>), <fpage>138</fpage>&#8211;<lpage>147</lpage>.</mixed-citation></ref><ref id="B101"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Naito</surname><given-names>T.</given-names></name><name name-style="western"><surname>Ikeya</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Okada</surname><given-names>M.</given-names></name><name name-style="western"><surname>Mistuhashi</surname><given-names>H.</given-names></name><name name-style="western"><surname>Maruno</surname><given-names>M.</given-names></name></person-group> (<year>1996</year>). <article-title>Two phthalides from Ligusticum chuanxiong</article-title>. <source>Phytochemistry</source><volume>41</volume> (<issue>1</issue>), <fpage>233</fpage>&#8211;<lpage>236</lpage>. <pub-id pub-id-type="doi">10.1016/0031-9422(95)00524-2</pub-id></mixed-citation></ref><ref id="B102"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Or</surname><given-names>T. C. T.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>C. L. H.</given-names></name><name name-style="western"><surname>Law</surname><given-names>A. H. Y.</given-names></name><name name-style="western"><surname>Li</surname><given-names>J. C. B.</given-names></name><name name-style="western"><surname>Lau</surname><given-names>A. S. Y.</given-names></name></person-group> (<year>2011</year>). <article-title>Isolation and identification of anti-inflammatory constituents from Ligusticum chuanxiong and their underlying mechanisms of action on microglia</article-title>. <source>Neuropharmacology</source><volume>60</volume> (<issue>6</issue>), <fpage>823</fpage>&#8211;<lpage>831</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2010.12.002</pub-id><pub-id pub-id-type="pmid">21146552</pub-id></mixed-citation></ref><ref id="B103"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pu</surname><given-names>Z.-H.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Peng</surname><given-names>C.</given-names></name><name name-style="western"><surname>Luo</surname><given-names>M.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Q.-M.</given-names></name><name name-style="western"><surname>Xie</surname><given-names>X.-F.</given-names></name><etal/></person-group> (<year>2019a</year>). <article-title>Nucleoside alkaloids with anti-platelet aggregation activity from the rhizomes of Ligusticum striatum</article-title>. <source>Nat. Prod. Res.</source><volume>33</volume> (<issue>10</issue>), <fpage>1399</fpage>&#8211;<lpage>1405</lpage>. <pub-id pub-id-type="doi">10.1080/14786419.2017.1416382</pub-id><pub-id pub-id-type="pmid">29262724</pub-id></mixed-citation></ref><ref id="B104"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pu</surname><given-names>Z.-H.</given-names></name><name name-style="western"><surname>Peng</surname><given-names>C.</given-names></name><name name-style="western"><surname>Xie</surname><given-names>X.-F.</given-names></name><name name-style="western"><surname>Luo</surname><given-names>M.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Feng</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2019b</year>). <article-title>Alkaloids from the rhizomes of Ligusticum striatum exert antimigraine effects through regulating 5-HT1B receptor and c-Jun</article-title>. <source>J. Ethnopharmacol.</source><volume>237</volume>, <fpage>39</fpage>&#8211;<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2019.03.026</pub-id><pub-id pub-id-type="pmid">30880256</pub-id></mixed-citation></ref><ref id="B105"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Qi</surname><given-names>X. Y.</given-names></name><name name-style="western"><surname>Peng</surname><given-names>G. C.</given-names></name><name name-style="western"><surname>Han</surname><given-names>Q. T.</given-names></name><name name-style="western"><surname>Yan</surname><given-names>J.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>L. Z.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>T.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>Phthalides from the rhizome of Ligusticum chuanxiong Hort. attenuate diabetic nephropathy in mice</article-title>. <source>J. Ethnopharmacol.</source><volume>319</volume> (<issue>Pt 2</issue>), <fpage>117247</fpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2023.117247</pub-id><pub-id pub-id-type="pmid">37777028</pub-id></mixed-citation></ref><ref id="B106"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Qiu</surname><given-names>S. H.</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>Y. Q.</given-names></name><name name-style="western"><surname>Pan</surname><given-names>K. Y.</given-names></name><name name-style="western"><surname>Tang</surname><given-names>Y. C.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>J. M.</given-names></name></person-group> (<year>1979</year>). <article-title>Ligusticum chuanxiong <italic toggle="yes">acta phytotax</italic>
</article-title>. <source>Sin.</source><volume>17</volume>, <fpage>102</fpage>.</mixed-citation></ref><ref id="B107"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Qunfang</surname><given-names>R.</given-names></name></person-group> (<year>2024</year>). <article-title>Effects of Chuanxiong Cha Tiao San plus flavor combined with acupuncture on patients with chronic headache</article-title>. <source>Pract. Integr. Chin. West. Med. Clin.</source><volume>24</volume> (<issue>02</issue>), <fpage>98</fpage>&#8211;<lpage>100+116</lpage>. <pub-id pub-id-type="doi">10.13638/j.issn.1671-4040.2024.02.029</pub-id></mixed-citation></ref><ref id="B108"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rai</surname><given-names>U.</given-names></name><name name-style="western"><surname>Kosuru</surname><given-names>R.</given-names></name><name name-style="western"><surname>Prakash</surname><given-names>S.</given-names></name><name name-style="western"><surname>Tiwari</surname><given-names>V.</given-names></name><name name-style="western"><surname>Singh</surname><given-names>S.</given-names></name></person-group> (<year>2019</year>). <article-title>Tetramethylpyrazine alleviates diabetic nephropathy through the activation of Akt signalling pathway in rats</article-title>. <source>Eur. J. Pharmacol.</source><volume>865</volume>, <fpage>172763</fpage>. <pub-id pub-id-type="doi">10.1016/j.ejphar.2019.172763</pub-id><pub-id pub-id-type="pmid">31682792</pub-id></mixed-citation></ref><ref id="B109"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ran</surname><given-names>X.</given-names></name><name name-style="western"><surname>Qingfang</surname><given-names>W.</given-names></name></person-group> (<year>2024</year>). <article-title>Observation on the therapeutic effect of Da Chuanxiong Oral Liquid in the treatment of post-stroke sequelae</article-title>. <source>Syst. Med.</source><volume>9</volume> (<issue>21</issue>), <fpage>177</fpage>&#8211;<lpage>180</lpage>. <pub-id pub-id-type="doi">10.19368/j.cnki.2096-1782.2024.21.177</pub-id></mixed-citation></ref><ref id="B110"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ren</surname><given-names>D.</given-names></name><name name-style="western"><surname>Xie</surname><given-names>N.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>N.</given-names></name><name name-style="western"><surname>Qian</surname><given-names>S.</given-names></name><name name-style="western"><surname>Duan</surname><given-names>J.</given-names></name></person-group> (<year>2008</year>). <article-title>Studies on the chemical constituents of aerial parts of Ligusticum chuanxiong Hort</article-title>. <source>China J. Chin. Mat. Med.</source>, <fpage>2417</fpage>&#8211;<lpage>2418</lpage>.</mixed-citation></ref><ref id="B111"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ren</surname><given-names>D. C.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>N. Y.</given-names></name><name name-style="western"><surname>Qian</surname><given-names>S. H.</given-names></name><name name-style="western"><surname>Xie</surname><given-names>N.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>X. M.</given-names></name><name name-style="western"><surname>Duan</surname><given-names>J. A.</given-names></name></person-group> (<year>2007</year>). <article-title>Chemical study on aerial parts of Ligusticum chuanxiong</article-title>. <source>Zhongguo Zhong Yao Za Zhi</source><volume>32</volume> (<issue>14</issue>), <fpage>1418</fpage>&#8211;<lpage>1420</lpage>.<pub-id pub-id-type="pmid">17966355</pub-id></mixed-citation></ref><ref id="B112"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ren</surname><given-names>T.</given-names></name><name name-style="western"><surname>Xie</surname><given-names>D.</given-names></name><name name-style="western"><surname>Peng</surname><given-names>C.</given-names></name><name name-style="western"><surname>Gui</surname><given-names>L.</given-names></name><name name-style="western"><surname>Price</surname><given-names>M.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Molecular evolution and phylogenetic relationships of Ligusticum (Apiaceae) inferred from the whole plastome sequences</article-title>. <source>BMC Ecol. Evol.</source><volume>22</volume> (<issue>1</issue>), <fpage>55</fpage>. <pub-id pub-id-type="doi">10.1186/s12862-022-02010-z</pub-id><pub-id pub-id-type="pmid">35501703</pub-id><pub-id pub-id-type="pmcid">PMC9063207</pub-id></mixed-citation></ref><ref id="B113"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ren</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>P.</given-names></name><name name-style="western"><surname>Luo</surname><given-names>A.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kong</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>The effect of ligustrazine on L-type calcium current, calcium transient and contractility in rabbit ventricular myocytes</article-title>. <source>J. Ethnopharmacol.</source><volume>144</volume> (<issue>3</issue>), <fpage>555</fpage>&#8211;<lpage>561</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2012.09.037</pub-id><pub-id pub-id-type="pmid">23058991</pub-id></mixed-citation></ref><ref id="B114"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ruan</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>He</surname><given-names>X.</given-names></name></person-group> (<year>2003</year>). <article-title>Effects of different preparation methods on chemical constituents of volatile oil of Ligusticum chuanxiong Hort</article-title>. <source>China J. Chin. Mat. Med.</source>, <fpage>95</fpage>&#8211;<lpage>97</lpage>.</mixed-citation></ref><ref id="B115"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Scheltens</surname><given-names>P.</given-names></name><name name-style="western"><surname>De Strooper</surname><given-names>B.</given-names></name><name name-style="western"><surname>Kivipelto</surname><given-names>M.</given-names></name><name name-style="western"><surname>Holstege</surname><given-names>H.</given-names></name><name name-style="western"><surname>Chetelat</surname><given-names>G.</given-names></name><name name-style="western"><surname>Teunissen</surname><given-names>C. E.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Alzheimer's disease</article-title>. <source>Lancet</source><volume>397</volume> (<issue>10284</issue>), <fpage>1577</fpage>&#8211;<lpage>1590</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(20)32205-4</pub-id><pub-id pub-id-type="pmid">33667416</pub-id><pub-id pub-id-type="pmcid">PMC8354300</pub-id></mixed-citation></ref><ref id="B116"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shanshan</surname><given-names>L.</given-names></name><name name-style="western"><surname>Qin</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Pengfei</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Ming</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Shuyuan</surname><given-names>S.</given-names></name><name name-style="western"><surname>Xiaojin</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Effect and mechanism of phthalides from Ligusticum chuanxiong on oxygen-glucose deprivation/reperfusion induced MDCK-MDR1 cell injury</article-title>. <source>Chin. Herb. Med.</source><volume>52</volume> (<issue>10</issue>), <fpage>2958</fpage>&#8211;<lpage>2966</lpage>.</mixed-citation></ref><ref id="B117"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shao</surname><given-names>H.</given-names></name><name name-style="western"><surname>He</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Du</surname><given-names>S.</given-names></name><name name-style="western"><surname>Yi</surname><given-names>X.</given-names></name><name name-style="western"><surname>Cui</surname><given-names>X.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Efficacy of ligustrazine injection as adjunctive therapy in treating acute cerebral infarction: a systematic review and meta-analysis</article-title>. <source>Front. Pharmacol.</source><volume>12</volume>, <fpage>761722</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2021.761722</pub-id><pub-id pub-id-type="pmid">34880757</pub-id><pub-id pub-id-type="pmcid">PMC8646035</pub-id></mixed-citation></ref><ref id="B118"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shaojie</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Lijun</surname><given-names>A.</given-names></name><name name-style="western"><surname>Zhengguo</surname><given-names>L.</given-names></name><name name-style="western"><surname>Xuelian</surname><given-names>W.</given-names></name><name name-style="western"><surname>Honglin</surname><given-names>W.</given-names></name><name name-style="western"><surname>Lijuan</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Structural elucidation of an immunological arabinan from the rhizomes of Ligusticum chuanxiong, a traditional Chinese medicine</article-title>. <source>Int. J. Biol. Macromol.</source><volume>170</volume>, <fpage>42</fpage>&#8211;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2020.12.069</pub-id><pub-id pub-id-type="pmid">33316344</pub-id></mixed-citation></ref><ref id="B119"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sharawy</surname><given-names>M. H.</given-names></name><name name-style="western"><surname>El-Agamy</surname><given-names>D. S.</given-names></name><name name-style="western"><surname>Shalaby</surname><given-names>A. A.</given-names></name><name name-style="western"><surname>Ammar el</surname><given-names>S. M.</given-names></name></person-group> (<year>2013</year>). <article-title>Protective effects of methyl palmitate against silica-induced pulmonary fibrosis in rats</article-title>. <source>Int. Immunopharmacol.</source><volume>16</volume> (<issue>2</issue>), <fpage>191</fpage>&#8211;<lpage>198</lpage>. <pub-id pub-id-type="doi">10.1016/j.intimp.2013.04.007</pub-id><pub-id pub-id-type="pmid">23602676</pub-id></mixed-citation></ref><ref id="B120"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shi</surname><given-names>J.</given-names></name><name name-style="western"><surname>Li</surname><given-names>S.</given-names></name><name name-style="western"><surname>Yi</surname><given-names>L.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>M.</given-names></name><name name-style="western"><surname>Cai</surname><given-names>J.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>C.</given-names></name><etal/></person-group> (<year>2024a</year>). <article-title>Levistolide a attenuates acute kidney injury in mice by inhibiting the TLR-4/NF-&#954;B pathway</article-title>. <source>Drug Des. Devel Ther.</source><volume>18</volume>, <fpage>5583</fpage>&#8211;<lpage>5597</lpage>. <pub-id pub-id-type="doi">10.2147/dddt.S476548</pub-id><pub-id pub-id-type="pmcid">PMC11625643</pub-id><pub-id pub-id-type="pmid">39654604</pub-id></mixed-citation></ref><ref id="B121"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shi</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Li</surname><given-names>H.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>S.</given-names></name><name name-style="western"><surname>Shen</surname><given-names>G.</given-names></name></person-group> (<year>2024b</year>). <article-title>Effective constituents and protective effect of Mudan granules against Schwann cell injury</article-title>. <source>J. Ethnopharmacol.</source><volume>323</volume>, <fpage>117692</fpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2023.117692</pub-id><pub-id pub-id-type="pmid">38176668</pub-id></mixed-citation></ref><ref id="B122"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shuai</surname><given-names>S. Y.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>S. S.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>X. J.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>G. S.</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Yue</surname><given-names>P. F.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Essential oil of Ligusticum chuanxiong Hort. Regulated P-gp protein and tight junction protein to change pharmacokinetic parameters of temozolomide in blood, brain and tumor</article-title>. <source>J. Ethnopharmacol.</source><volume>298</volume>, <fpage>115646</fpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2022.115646</pub-id><pub-id pub-id-type="pmid">36031103</pub-id></mixed-citation></ref><ref id="B123"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shupei</surname><given-names>B.</given-names></name></person-group> (<year>2010</year>). <article-title>Clinical observation on 36 cases of chronic idiopathic pulmonary fibrosis treated with Chuanxiong auxiliary therapy</article-title>. <source>China Med. Front.</source><volume>5</volume> (<issue>04</issue>), <fpage>26+29</fpage>.</mixed-citation></ref><ref id="B124"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sikora</surname><given-names>J.</given-names></name><name name-style="western"><surname>Karczmarska-Wodzka</surname><given-names>A.</given-names></name><name name-style="western"><surname>Bugieda</surname><given-names>J.</given-names></name><name name-style="western"><surname>Sobczak</surname><given-names>P.</given-names></name></person-group> (<year>2022</year>). <article-title>The importance of platelets response during antiplatelet treatment after ischemic stroke-between benefit and risk: a systematic review</article-title>. <source>Int. J. Mol. Med.</source><volume>23</volume> (<issue>3</issue>), <fpage>1043</fpage>. <pub-id pub-id-type="doi">10.3390/ijms23031043</pub-id><pub-id pub-id-type="pmcid">PMC8835275</pub-id><pub-id pub-id-type="pmid">35162965</pub-id></mixed-citation></ref><ref id="B125"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Siqueira</surname><given-names>H. D. S.</given-names></name><name name-style="western"><surname>Neto</surname><given-names>B. S.</given-names></name><name name-style="western"><surname>Sousa</surname><given-names>D. P.</given-names></name><name name-style="western"><surname>Gomes</surname><given-names>B. S.</given-names></name><name name-style="western"><surname>da Silva</surname><given-names>F. V.</given-names></name><name name-style="western"><surname>Cunha</surname><given-names>F. V. M.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>&#945;-Phellandrene, a cyclic monoterpene, attenuates inflammatory response through neutrophil migration inhibition and mast cell degranulation</article-title>. <source>Life Sci.</source><volume>160</volume>, <fpage>27</fpage>&#8211;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1016/j.lfs.2016.07.008</pub-id><pub-id pub-id-type="pmid">27449945</pub-id></mixed-citation></ref><ref id="B126"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Song</surname><given-names>X.</given-names></name><name name-style="western"><surname>Xing</surname><given-names>W.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Ji</surname><given-names>J.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>Exploring the synergic mechanism of Ligusticum striatum DC. and borneol in attenuating BMECs injury and maintaining tight junctions against cerebral ischaemia based on the HIF-1&#945;/VEGF signalling pathway</article-title>. <source>J. Ethnopharmacol.</source><volume>301</volume>, <fpage>115764</fpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2022.115764</pub-id><pub-id pub-id-type="pmid">36183951</pub-id></mixed-citation></ref><ref id="B127"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Srimagal</surname><given-names>A.</given-names></name><name name-style="western"><surname>Mishra</surname><given-names>S.</given-names></name><name name-style="western"><surname>Pradhan</surname><given-names>R. C.</given-names></name></person-group> (<year>2017</year>). <article-title>Effects of ethyl oleate and microwave blanching on drying kinetics of bitter gourd</article-title>. <source>J. Food Sci. Technol.</source><volume>54</volume> (<issue>5</issue>), <fpage>1192</fpage>&#8211;<lpage>1198</lpage>. <pub-id pub-id-type="doi">10.1007/s13197-017-2518-7</pub-id><pub-id pub-id-type="pmid">28416869</pub-id><pub-id pub-id-type="pmcid">PMC5380615</pub-id></mixed-citation></ref><ref id="B128"><mixed-citation publication-type="webpage"><person-group person-group-type="author"><name name-style="western"><surname>Standardization</surname><given-names>I. O. f.</given-names></name></person-group> (<year>2024</year>). <article-title>Traditional Chinese medicine &#8212; ligusticum chuanxiong rhizome</article-title>. <comment>Available online at: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.iso.org/obp/ui/en/#iso:std:iso:8071:ed-1:v1:en" ext-link-type="uri">https://www.iso.org/obp/ui/en/#iso:std:iso:8071:ed-1:v1:en</ext-link>.</comment></mixed-citation></ref><ref id="B129"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>W.-T.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X.-C.</given-names></name><name name-style="western"><surname>Novakovic</surname><given-names>A.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name><name name-style="western"><surname>He</surname><given-names>G.-W.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Q.</given-names></name></person-group> (<year>2019</year>). <article-title>Protection of dilator function of coronary arteries from homocysteine by tetramethylpyrazine: role of ER stress in modulation of BKCa channels</article-title>. <source>Vasc. Pharmacol.</source><volume>113</volume>, <fpage>27</fpage>&#8211;<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1016/j.vph.2018.10.009</pub-id><pub-id pub-id-type="pmid">30389615</pub-id></mixed-citation></ref><ref id="B130"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Suru&#269;i&#263;</surname><given-names>R.</given-names></name><name name-style="western"><surname>Kundakovi&#263;</surname><given-names>T.</given-names></name><name name-style="western"><surname>Laku&#353;i&#263;</surname><given-names>B.</given-names></name><name name-style="western"><surname>Drakul</surname><given-names>D.</given-names></name><name name-style="western"><surname>Milovanovi&#263;</surname><given-names>S. R.</given-names></name><name name-style="western"><surname>Kova&#269;evi&#263;</surname><given-names>N.</given-names></name></person-group> (<year>2017</year>). <article-title>Variations in chemical composition, vasorelaxant and angiotensin I-converting enzyme inhibitory activities of essential oil from aerial parts of seseli pallasii besser (Apiaceae)</article-title>. <source>Chem. Biodivers.</source><volume>14</volume> (<issue>5</issue>). <pub-id pub-id-type="doi">10.1002/cbdv.201600407</pub-id><pub-id pub-id-type="pmid">27943628</pub-id></mixed-citation></ref><ref id="B131"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Szteyn</surname><given-names>K.</given-names></name><name name-style="western"><surname>Singh</surname><given-names>H.</given-names></name></person-group> (<year>2020</year>). <article-title>BK(Ca)Channels as targets for cardioprotection</article-title>. <source>Antioxidants</source><volume>9</volume> (<issue>8</issue>), <fpage>760</fpage>. <pub-id pub-id-type="doi">10.3390/antiox9080760</pub-id><pub-id pub-id-type="pmid">32824463</pub-id><pub-id pub-id-type="pmcid">PMC7463653</pub-id></mixed-citation></ref><ref id="B132"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Takashi</surname><given-names>N.</given-names></name><name name-style="western"><surname>Takao</surname><given-names>K.</given-names></name><name name-style="western"><surname>Kazuaki</surname><given-names>N.</given-names></name><name name-style="western"><surname>Yukinobu</surname><given-names>I.</given-names></name><name name-style="western"><surname>Minoru</surname><given-names>O.</given-names></name><name name-style="western"><surname>Hiroshi</surname><given-names>M.</given-names></name></person-group> (<year>1992</year>). <article-title>Two phthalides from Ligusticum chuangxiong</article-title>. <source>Phytochemistry</source><volume>31</volume> (<issue>2</issue>), <fpage>639</fpage>&#8211;<lpage>642</lpage>. <pub-id pub-id-type="doi">10.1016/0031-9422(92)90051-Q</pub-id></mixed-citation></ref><ref id="B133"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tan</surname><given-names>J.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Aobulikasimu</surname><given-names>N.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>C.</given-names></name><name name-style="western"><surname>Cao</surname><given-names>B.</given-names></name><name name-style="western"><surname>Lv</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>Senkyunolide B exhibits broad-spectrum antifungal activity against plant and human pathogenic fungi via inhibiting spore germination and destroying the mature biofilm</article-title>. <source>Pest Manag. Sci.</source><volume>79</volume> (<issue>12</issue>), <fpage>4952</fpage>&#8211;<lpage>4963</lpage>. <pub-id pub-id-type="doi">10.1002/ps.7696</pub-id><pub-id pub-id-type="pmid">37531560</pub-id></mixed-citation></ref><ref id="B134"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tang</surname><given-names>F.</given-names></name><name name-style="western"><surname>Yan</surname><given-names>Y. M.</given-names></name><name name-style="western"><surname>Yan</surname><given-names>H. L.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L. X.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>C. J.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H. L.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Chuanxiongdiolides R4 and R5, phthalide dimers with a complex polycyclic skeleton from the aerial parts of Ligusticum chuanxiong and their vasodilator activity</article-title>. <source>Bioorg Chem.</source><volume>107</volume>, <fpage>104523</fpage>. <pub-id pub-id-type="doi">10.1016/j.bioorg.2020.104523</pub-id><pub-id pub-id-type="pmid">33339668</pub-id></mixed-citation></ref><ref id="B135"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tang</surname><given-names>G. H.</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>G. H.</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>L. F.</given-names></name></person-group> (<year>2000</year>). <article-title>Pharmacokinetics of perlolyrine in rats by stable isotope dilution in conjunction with GC-MS</article-title>. <source>Acta Pharmacol. Sin.</source><volume>21</volume> (<issue>7</issue>), <fpage>660</fpage>&#8211;<lpage>662</lpage>.<pub-id pub-id-type="pmid">11360678</pub-id></mixed-citation></ref><ref id="B136"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>C.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>S.</given-names></name><name name-style="western"><surname>Luo</surname><given-names>S.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Profiling complex volatile components by HS-GC-MS and entropy minimization software: an example on Ligusticum chuanxiong Hort</article-title>. <source>J. Pharm. Biomed.</source><volume>218</volume>, <fpage>114854</fpage>. <pub-id pub-id-type="doi">10.1016/j.jpba.2022.114854</pub-id><pub-id pub-id-type="pmid">35660874</pub-id></mixed-citation></ref><ref id="B137"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>M.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>S.</given-names></name><name name-style="western"><surname>Hua</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Duan</surname><given-names>J. A.</given-names></name><name name-style="western"><surname>Su</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Identification and comparative quantification of bio-active phthalides in essential oils from si-Wu-tang, fo-shou-san, radix angelica and rhizoma chuanxiong</article-title>. <source>Molecules</source><volume>15</volume> (<issue>1</issue>), <fpage>341</fpage>&#8211;<lpage>351</lpage>. <pub-id pub-id-type="doi">10.3390/molecules15010341</pub-id><pub-id pub-id-type="pmid">20110895</pub-id><pub-id pub-id-type="pmcid">PMC6257054</pub-id></mixed-citation></ref><ref id="B138"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tianhao</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Ou</surname><given-names>D.</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>P.</given-names></name><name name-style="western"><surname>Jinfeng</surname><given-names>C.</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>P.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Study on the anti-migraineeffect of volatile oil of rhizoma chuanxiong based on 5-HT1B receptor</article-title>. <source>Chin. J. Traditional Chin. Med.</source><volume>40</volume> (<issue>03</issue>), <fpage>174</fpage>&#8211;<lpage>177+271</lpage>. <pub-id pub-id-type="doi">10.13193/j.issn.1673-7717.2022.03.040</pub-id></mixed-citation></ref><ref id="B139"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>T&#252;rkez</surname><given-names>H.</given-names></name><name name-style="western"><surname>Celik</surname><given-names>K.</given-names></name><name name-style="western"><surname>To&#287;ar</surname><given-names>B.</given-names></name></person-group> (<year>2014</year>). <article-title>Effects of copaene, a tricyclic sesquiterpene, on human lymphocytes cells <italic toggle="yes">in vitro</italic>
</article-title>. <source>Cytotechnology</source><volume>66</volume> (<issue>4</issue>), <fpage>597</fpage>&#8211;<lpage>603</lpage>. <pub-id pub-id-type="doi">10.1007/s10616-013-9611-1</pub-id><pub-id pub-id-type="pmid">24287609</pub-id><pub-id pub-id-type="pmcid">PMC4082788</pub-id></mixed-citation></ref><ref id="B140"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>G.</given-names></name><name name-style="western"><surname>Dai</surname><given-names>G.</given-names></name><name name-style="western"><surname>Song</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>M.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Hou</surname><given-names>X.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Lactone component from ligusticum chuanxiong alleviates myocardial ischemia injury through inhibiting autophagy</article-title>. <source>Front. Pharmacol.</source><volume>9</volume>, <fpage>301</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2018.00301</pub-id><pub-id pub-id-type="pmid">29651246</pub-id><pub-id pub-id-type="pmcid">PMC5884868</pub-id></mixed-citation></ref><ref id="B141"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Bao</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Yi</surname><given-names>H.</given-names></name><name name-style="western"><surname>Xia</surname><given-names>Q.</given-names></name></person-group> (<year>2019</year>). <article-title>The evaluation of embryotoxicity of Ligusticum chuanxiong on mice and embryonic stem cells</article-title>. <source>J. Ethnopharmacol.</source><volume>239</volume>, <fpage>111895</fpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2019.111895</pub-id><pub-id pub-id-type="pmid">31014960</pub-id></mixed-citation></ref><ref id="B142"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>K.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Shao</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Yin</surname><given-names>S.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>C.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2021a</year>). <article-title>Anticancer activities of TCM and their active components against tumor metastasis</article-title>. <source>Biomed. Pharmacother.</source><volume>133</volume>, <fpage>111044</fpage>. <pub-id pub-id-type="doi">10.1016/j.biopha.2020.111044</pub-id><pub-id pub-id-type="pmid">33378952</pub-id></mixed-citation></ref><ref id="B143"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>K.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Wen</surname><given-names>C.</given-names></name><name name-style="western"><surname>Du</surname><given-names>L.</given-names></name><name name-style="western"><surname>Li</surname><given-names>L.</given-names></name><name name-style="western"><surname>Cui</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>Protective effects of tetramethylpyrazine on myocardial ischemia/reperfusion injury involve NLRP3 inflammasome suppression by autophagy activation</article-title>. <source>Biochem. Pharmacol.</source><volume>229</volume>, <fpage>116541</fpage>. <pub-id pub-id-type="doi">10.1016/j.bcp.2024.116541</pub-id><pub-id pub-id-type="pmid">39284501</pub-id></mixed-citation></ref><ref id="B144"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>L.-Y.</given-names></name><name name-style="western"><surname>Tang</surname><given-names>Y.-P.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>M.</given-names></name><name name-style="western"><surname>Tao</surname><given-names>W.-W.</given-names></name><name name-style="western"><surname>Li</surname><given-names>W.-X.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Effects of ferulic acid on antioxidant activity in Angelicae Sinensis Radix, Chuanxiong Rhizoma, and their combination</article-title>. <source>Chin. J. Nat. Med.</source><volume>13</volume> (<issue>6</issue>), <fpage>401</fpage>&#8211;<lpage>408</lpage>. <pub-id pub-id-type="doi">10.1016/s1875-5364(15)30032-7</pub-id><pub-id pub-id-type="pmid">26073335</pub-id></mixed-citation></ref><ref id="B145"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hayashi</surname><given-names>H.</given-names></name><name name-style="western"><surname>Horinokita</surname><given-names>I.</given-names></name><name name-style="western"><surname>Asada</surname><given-names>M.</given-names></name><name name-style="western"><surname>Iwatani</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J.-x.</given-names></name><etal/></person-group> (<year>2021b</year>). <article-title>Neuroprotective effects of Senkyunolide I against glutamate-induced cells death by attenuating JNK/caspase-3 activation and apoptosis</article-title>. <source>Biomed. Pharmacother.</source><volume>140</volume>, <fpage>111696</fpage>. <pub-id pub-id-type="doi">10.1016/j.biopha.2021.111696</pub-id><pub-id pub-id-type="pmid">34044281</pub-id></mixed-citation></ref><ref id="B146"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>M.</given-names></name><name name-style="western"><surname>Yao</surname><given-names>M.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Takagi</surname><given-names>N.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>B.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Ligusticum chuanxiong exerts neuroprotection by promoting adult neurogenesis and inhibiting inflammation in the hippocampus of ME cerebral ischemia rats</article-title>. <source>J. Ethnopharmacol.</source><volume>249</volume>, <fpage>112385</fpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2019.112385</pub-id><pub-id pub-id-type="pmid">31730888</pub-id></mixed-citation></ref><ref id="B147"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>N.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Li</surname><given-names>X.</given-names></name><name name-style="western"><surname>Tong</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Kong</surname><given-names>H.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>G.</given-names></name></person-group> (<year>2010</year>). <article-title>Analysis of volatile oils of Ligusticum chuanxiong Hort. from different geographical origins by comprehensive two-dimensional gas chromatography/time-of-flight mass spectrometry</article-title>. <source>Se Pu</source><volume>28</volume> (<issue>4</issue>), <fpage>329</fpage>&#8211;<lpage>335</lpage>. <pub-id pub-id-type="doi">10.3724/sp.j.1123.2010.00329</pub-id><pub-id pub-id-type="pmid">20712112</pub-id></mixed-citation></ref><ref id="B148"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>X.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>P.</given-names></name><name name-style="western"><surname>Fushan</surname><given-names>A.</given-names></name><name name-style="western"><surname>Shunei</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Shanxia</surname><given-names>X.</given-names></name></person-group> (<year>1985</year>). <article-title>Adenine and adenosine, another group of active ingredients in chuanxiong rhizome</article-title>. <source>Chin. Tradit. Herb. Drugs</source><volume>16</volume>, <fpage>17</fpage>.</mixed-citation></ref><ref id="B149"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wei</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Du</surname><given-names>X.</given-names></name><name name-style="western"><surname>Luo</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Ligustrazine attenuates inflammation and the associated chemokines and receptors in ovalbumine-induced mouse asthma model</article-title>. <source>Environ. Toxicol. Phar</source><volume>46</volume>, <fpage>55</fpage>&#8211;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1016/j.etap.2016.07.005</pub-id><pub-id pub-id-type="pmid">27438894</pub-id></mixed-citation></ref><ref id="B150"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weng</surname><given-names>G.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>B.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>T.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>S.</given-names></name></person-group> (<year>2021</year>). <article-title>Tetramethylpyrazine improves cognitive function of alzheimer's disease mice by regulating SSTR4 ubiquitination</article-title>. <source>Drug Des. Devel Ther.</source><volume>15</volume>, <fpage>2385</fpage>&#8211;<lpage>2399</lpage>. <pub-id pub-id-type="doi">10.2147/DDDT.S290030</pub-id><pub-id pub-id-type="pmcid">PMC8179737</pub-id><pub-id pub-id-type="pmid">34103899</pub-id></mixed-citation></ref><ref id="B151"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Whelan</surname><given-names>J.</given-names></name></person-group> (<year>2008</year>). <article-title>The health implications of changing linoleic acid intakes</article-title>. <source>Prostagl. Leukot. Essent. Fat. Acids</source><volume>79</volume> (<issue>3-5</issue>), <fpage>165</fpage>&#8211;<lpage>167</lpage>. <pub-id pub-id-type="doi">10.1016/j.plefa.2008.09.013</pub-id><pub-id pub-id-type="pmid">18990554</pub-id></mixed-citation></ref><ref id="B152"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>J.-Z.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y.-J.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>G.-R.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>B.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>F.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>R.-P.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Mechanisms exploration of Angelicae Sinensis Radix and Ligusticum Chuanxiong Rhizoma herb-pair for liver fibrosis prevention based on network pharmacology and experimental pharmacologylogy</article-title>. <source>Chin. J. Nat. Med.</source><volume>19</volume> (<issue>4</issue>), <fpage>241</fpage>&#8211;<lpage>254</lpage>. <pub-id pub-id-type="doi">10.1016/s1875-5364(21)60026-2</pub-id><pub-id pub-id-type="pmid">33875165</pub-id></mixed-citation></ref><ref id="B153"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Mao</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Tian</surname><given-names>L.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>N.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>G.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Ligustilide attenuates ischemic stroke injury by promoting Drp1-mediated mitochondrial fission via activation of AMPK</article-title>. <source>Phytomedicine</source><volume>95</volume>, <fpage>153884</fpage>. <pub-id pub-id-type="doi">10.1016/j.phymed.2021.153884</pub-id><pub-id pub-id-type="pmid">34929562</pub-id></mixed-citation></ref><ref id="B154"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>X. W.</given-names></name></person-group> (<year>2008</year>). <article-title>GC-MS analysis of essential oil from rhizomes of Ligusticum chuanxiong cultivated in GAP base for Chinese medicinal materials of China</article-title>. <source>Zhongguo Zhong Yao Za Zhi</source><volume>33</volume> (<issue>3</issue>), <fpage>276</fpage>&#8211;<lpage>280</lpage>.<pub-id pub-id-type="pmid">18536465</pub-id></mixed-citation></ref><ref id="B155"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xia</surname><given-names>K.</given-names></name><name name-style="western"><surname>Jin</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Qiu</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Qiu</surname><given-names>T.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>Ligustilide alleviates oxidative stress during renal ischemia-reperfusion injury through maintaining Sirt3-dependent mitochondrial homeostasis</article-title>. <source>Phytomedicine</source><volume>134</volume>, <fpage>155975</fpage>. <pub-id pub-id-type="doi">10.1016/j.phymed.2024.155975</pub-id><pub-id pub-id-type="pmid">39216302</pub-id></mixed-citation></ref><ref id="B156"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xie</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>L.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>M.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Application of natural deep eutectic solvents to extract ferulic acid from Ligusticum chuanxiong Hort with microwave assistance</article-title>. <source>RSC Adv.</source><volume>9</volume> (<issue>39</issue>), <fpage>22677</fpage>&#8211;<lpage>22684</lpage>. <pub-id pub-id-type="doi">10.1039/c9ra02665g</pub-id><pub-id pub-id-type="pmid">35519449</pub-id><pub-id pub-id-type="pmcid">PMC9067139</pub-id></mixed-citation></ref><ref id="B157"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Jin</surname><given-names>A.</given-names></name><name name-style="western"><surname>Pan</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Meng</surname><given-names>X.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Trends and risk factors associated with stroke recurrence in China, 2007-2018</article-title>. <source>Jama Netw. Open</source><volume>5</volume> (<issue>6</issue>), <fpage>e2216341</fpage>. <pub-id pub-id-type="doi">10.1001/jamanetworkopen.2022.16341</pub-id><pub-id pub-id-type="pmid">35704318</pub-id><pub-id pub-id-type="pmcid">PMC9201671</pub-id></mixed-citation></ref><ref id="B158"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>T.</given-names></name><name name-style="western"><surname>Pan</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Dong</surname><given-names>M.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>C.</given-names></name><name name-style="western"><surname>Niu</surname><given-names>Y.</given-names></name></person-group> (<year>2015</year>). <article-title>Ferulic acid suppresses activation of hepatic stellate cells through ERK1/2 and Smad signaling pathways <italic toggle="yes">in vitro</italic>
</article-title>. <source>Biochem. Pharmacol.</source><volume>93</volume> (<issue>1</issue>), <fpage>49</fpage>&#8211;<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1016/j.bcp.2014.10.016</pub-id><pub-id pub-id-type="pmid">25449600</pub-id></mixed-citation></ref><ref id="B159"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xuhui</surname><given-names>L.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Yumei</surname><given-names>H.</given-names></name></person-group> (<year>2023</year>). <article-title>Exploring the inhibitory effect of Chuanxiong volatile oil on glioma angiogenesis based on EGFR/VEGF-A signaling pathway</article-title>. <source>Mod. J. Integr. Chin. West. Med.</source><volume>32</volume> (<issue>05</issue>), <fpage>633</fpage>&#8211;<lpage>636+679</lpage>.</mixed-citation></ref><ref id="B160"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yajing</surname><given-names>L.</given-names></name><name name-style="western"><surname>Zhi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Mingning</surname><given-names>D.</given-names></name><name name-style="western"><surname>Kexin</surname><given-names>J.</given-names></name><name name-style="western"><surname>Bing</surname><given-names>X.</given-names></name><name name-style="western"><surname>Fei</surname><given-names>Z.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>Chuanxiong Rhizoma extracts prevent cholestatic liver injury by targeting H3K9ac-mediated and cholangiocyte-derived secretory protein PAI-1 and FN</article-title>. <source>Chin. J. Nat. Med.</source><volume>21</volume> (<issue>9</issue>), <fpage>694</fpage>&#8211;<lpage>709</lpage>. <pub-id pub-id-type="doi">10.1016/S1875-5364(23)60416-9</pub-id><pub-id pub-id-type="pmid">37777319</pub-id></mixed-citation></ref><ref id="B161"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yan</surname><given-names>H.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Tang</surname><given-names>F.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>C.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>C.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>A comprehensive investigation on the chemical diversity and efficacy of different parts of Ligusticum chuanxiong</article-title>. <source>Food Funct.</source><volume>13</volume> (<issue>3</issue>), <fpage>1092</fpage>&#8211;<lpage>1107</lpage>. <pub-id pub-id-type="doi">10.1039/d1fo02811a</pub-id><pub-id pub-id-type="pmid">35083993</pub-id></mixed-citation></ref><ref id="B162"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yan</surname><given-names>X.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>J.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Z.</given-names></name><name name-style="western"><surname>David</surname><given-names>S. D.</given-names></name><name name-style="western"><surname>Liang</surname><given-names>D.</given-names></name><name name-style="western"><surname>Nie</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>The recent progress of tricyclic aromadendrene-type sesquiterpenoids: biological activities and biosynthesis</article-title>. <source>Biomolecules</source><volume>14</volume> (<issue>9</issue>), <fpage>1133</fpage>. <pub-id pub-id-type="doi">10.3390/biom14091133</pub-id><pub-id pub-id-type="pmid">39334899</pub-id><pub-id pub-id-type="pmcid">PMC11430642</pub-id></mixed-citation></ref><ref id="B163"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>C. K.</given-names></name><name name-style="western"><surname>Pan</surname><given-names>Q. Q.</given-names></name><name name-style="western"><surname>Ji</surname><given-names>K.</given-names></name><name name-style="western"><surname>Luo</surname><given-names>C. C.</given-names></name><name name-style="western"><surname>Tian</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>H. Y.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>Protective mechanism of tetramethylpyrazine on cardiovascular system</article-title>. <source>Zhongguo Zhong Yao Za Zhi</source><volume>48</volume> (<issue>6</issue>), <fpage>1446</fpage>&#8211;<lpage>1454</lpage>. <pub-id pub-id-type="doi">10.19540/j.cnki.cjcmm.20221012.402</pub-id><pub-id pub-id-type="pmid">37005832</pub-id></mixed-citation></ref><ref id="B164"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Qi</surname><given-names>G.</given-names></name></person-group> (<year>2018</year>). <article-title>Bornyl acetate suppresses ox-LDL-induced attachment of THP-1 monocytes to endothelial cells</article-title>. <source>Biomed. Pharmacother.</source><volume>103</volume>, <fpage>234</fpage>&#8211;<lpage>239</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopha.2018.03.152</pub-id><pub-id pub-id-type="pmid">29655164</pub-id></mixed-citation></ref><ref id="B165"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>D. D.</given-names></name><name name-style="western"><surname>Li</surname><given-names>D. G.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>B.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L. M.</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>C. L.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Tetramethylpyrazine exerts a protective effect against injury from acute myocardial ischemia by regulating the PI3K/Akt/GSK-3 signaling pathway</article-title>. <source>Cell Mol. Biol. Lett.</source><volume>24</volume>, <fpage>17</fpage>. <pub-id pub-id-type="doi">10.1186/s11658-019-0141-5</pub-id><pub-id pub-id-type="pmid">30858867</pub-id><pub-id pub-id-type="pmcid">PMC6390582</pub-id></mixed-citation></ref><ref id="B166"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>Y.-Y.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Z.-Y.</given-names></name><name name-style="western"><surname>Xia</surname><given-names>F.-B.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>J.-L.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Characterization of thrombin/factor Xa inhibitors in Rhizoma Chuanxiong through UPLC-MS-based multivariate statistical analysis</article-title>. <source>Chin. Med.</source><volume>15</volume> (<issue>1</issue>), <fpage>93</fpage>. <pub-id pub-id-type="doi">10.1186/s13020-020-00376-0</pub-id><pub-id pub-id-type="pmid">32874198</pub-id><pub-id pub-id-type="pmcid">PMC7457533</pub-id></mixed-citation></ref><ref id="B167"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yao</surname><given-names>X.</given-names></name><name name-style="western"><surname>Jiao</surname><given-names>S.</given-names></name><name name-style="western"><surname>Qin</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>W.</given-names></name><name name-style="western"><surname>Yi</surname><given-names>B.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>D.</given-names></name></person-group> (<year>2020</year>). <article-title>Vanillic acid alleviates acute myocardial hypoxia/reoxygenation injury by inhibiting oxidative stress</article-title>. <source>Oxid. Med. Cell Longev.</source><volume>2020</volume>, <fpage>8348035</fpage>. <pub-id pub-id-type="doi">10.1155/2020/8348035</pub-id><pub-id pub-id-type="pmid">32377308</pub-id><pub-id pub-id-type="pmcid">PMC7191373</pub-id></mixed-citation></ref><ref id="B168"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yeo</surname><given-names>D.</given-names></name><name name-style="western"><surname>Hwang</surname><given-names>S. J.</given-names></name><name name-style="western"><surname>Song</surname><given-names>Y. S.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>H. J.</given-names></name></person-group> (<year>2021</year>). <article-title>Humulene inhibits acute gastric mucosal injury by enhancing mucosal integrity</article-title>. <source>Antioxidants (Basel)</source><volume>10</volume> (<issue>5</issue>), <fpage>761</fpage>. <pub-id pub-id-type="doi">10.3390/antiox10050761</pub-id><pub-id pub-id-type="pmid">34064830</pub-id><pub-id pub-id-type="pmcid">PMC8150829</pub-id></mixed-citation></ref><ref id="B169"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yiyu</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Dechao</surname><given-names>M.</given-names></name><name name-style="western"><surname>Yongcheng</surname><given-names>H.</given-names></name><name name-style="western"><surname>Jie</surname><given-names>W.</given-names></name><name name-style="western"><surname>Jie</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Chaowen</surname><given-names>Z.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>Studies on the volatile oil fractions and <italic toggle="yes">in vitro</italic> anti-inflammatory activity of Rhizoma Ligustici Chuanxiong</article-title>. <source>Sichuan Agric. Sci. Technol.</source> (<issue>04</issue>), <fpage>116</fpage>&#8211;<lpage>120</lpage>.</mixed-citation></ref><ref id="B170"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yoon</surname><given-names>B. H.</given-names></name><name name-style="western"><surname>Jung</surname><given-names>J. W.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>J. J.</given-names></name><name name-style="western"><surname>Cho</surname><given-names>Y. W.</given-names></name><name name-style="western"><surname>Jang</surname><given-names>C. G.</given-names></name><name name-style="western"><surname>Jin</surname><given-names>C.</given-names></name><etal/></person-group> (<year>2007</year>). <article-title>Anxiolytic-like effects of sinapic acid in mice</article-title>. <source>Life Sci.</source><volume>81</volume> (<issue>3</issue>), <fpage>234</fpage>&#8211;<lpage>240</lpage>. <pub-id pub-id-type="doi">10.1016/j.lfs.2007.05.007</pub-id><pub-id pub-id-type="pmid">17570441</pub-id></mixed-citation></ref><ref id="B171"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yuan</surname><given-names>C.</given-names></name><name name-style="western"><surname>Sha</surname><given-names>X.</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>M.</given-names></name><name name-style="western"><surname>Zhong</surname><given-names>W.</given-names></name><name name-style="western"><surname>Wei</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Li</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Uncovering dynamic evolution in the plastid genome of seven Ligusticum species provides insights into species discrimination and phylogenetic implications</article-title>. <source>Sci. Rep.</source><volume>11</volume> (<issue>1</issue>), <fpage>988</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-020-80225-0</pub-id><pub-id pub-id-type="pmid">33441833</pub-id><pub-id pub-id-type="pmcid">PMC7806627</pub-id></mixed-citation></ref><ref id="B172"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yuan</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>X.</given-names></name></person-group> (<year>2000</year>). <article-title>Studies on volatile oil in Ligusticum chuanxiong by supercritical fluid extraction</article-title>. <source>Chin. Pharm. J.</source><volume>35</volume>, <fpage>84</fpage>&#8211;<lpage>87</lpage>.</mixed-citation></ref><ref id="B173"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yue</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Chunyan</surname><given-names>M.</given-names></name><name name-style="western"><surname>Zixin</surname><given-names>S.</given-names></name><name name-style="western"><surname>Yingxin</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Gaoqi</surname><given-names>L.</given-names></name></person-group> (<year>2024</year>). <article-title>Progress in the study of chemical composition and pharmacological effects of chuanxiong rhizome</article-title>. <source>Glob. Chin. Med.</source>, <fpage>1</fpage>&#8211;<lpage>9</lpage>.</mixed-citation></ref><ref id="B174"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yumei</surname><given-names>H.</given-names></name><name name-style="western"><surname>Ruibin</surname><given-names>L.</given-names></name><name name-style="western"><surname>Jie</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>Z.</given-names></name></person-group> (<year>2022</year>). <article-title>Impacts of volatile oil of ligusticum chuanxiong on glioma angiogenesis by regulating EGFR/VEGF-A pathway via LRlG2</article-title>. <source>Chin. Pharm.</source><volume>25</volume> (<issue>11</issue>), <fpage>1873</fpage>&#8211;<lpage>1877+1903</lpage>. <pub-id pub-id-type="doi">10.19962/j.cnki.issn1008-049X.2022.11.001</pub-id></mixed-citation></ref><ref id="B175"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yun</surname><given-names>H.</given-names></name><name name-style="western"><surname>Shuiqing</surname><given-names>G.</given-names></name><name name-style="western"><surname>Xianjian</surname><given-names>H.</given-names></name><name name-style="western"><surname>Dongliang</surname><given-names>Z.</given-names></name></person-group> (<year>2021</year>). <article-title>Effect of dl-3-n-butylphthalide on the lmprovement of neurological function in rats with traumatic brain lnjury</article-title>. <source>Chin. Pharm. Ind.</source><volume>30</volume> (<issue>08</issue>), <fpage>32</fpage>&#8211;<lpage>35</lpage>.</mixed-citation></ref><ref id="B176"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zeng</surname><given-names>P.</given-names></name><name name-style="western"><surname>Su</surname><given-names>H. F.</given-names></name><name name-style="western"><surname>Ye</surname><given-names>C. Y.</given-names></name><name name-style="western"><surname>Qiu</surname><given-names>S. W.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J. Z.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>A tau pathogenesis-based network pharmacology approach for exploring the protections of chuanxiong rhizoma in alzheimer's disease</article-title>. <source>Front. Pharmacol.</source><volume>13</volume>, <fpage>877806</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2022.877806</pub-id><pub-id pub-id-type="pmid">35529440</pub-id><pub-id pub-id-type="pmcid">PMC9068950</pub-id></mixed-citation></ref><ref id="B177"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhai</surname><given-names>J.</given-names></name><name name-style="western"><surname>Ren</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Han</surname><given-names>M.</given-names></name><name name-style="western"><surname>Han</surname><given-names>N.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Z.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Traditional Chinese patent medicine Zhixiong Capsule (ZXC) alleviated formed atherosclerotic plaque in rat thoracic artery and the mechanism investigation including blood-dissolved-component-based network pharmacology analysis and biochemical validation</article-title>. <source>J. Ethnopharmacol.</source><volume>254</volume>, <fpage>112523</fpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2019.112523</pub-id><pub-id pub-id-type="pmid">31884033</pub-id></mixed-citation></ref><ref id="B178"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>F.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Shen</surname><given-names>L.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>S.</given-names></name><name name-style="western"><surname>Li</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>GuanXinNing tablet attenuates alzheimer's disease via improving gut microbiota, host metabolites, and neuronal apoptosis in rabbits</article-title>. <source>Evid. Based Complement. Altern. Med.</source><volume>2021</volume>, <fpage>9253281</fpage>. <pub-id pub-id-type="doi">10.1155/2021/9253281</pub-id><pub-id pub-id-type="pmcid">PMC8568547</pub-id><pub-id pub-id-type="pmid">34745305</pub-id></mixed-citation></ref><ref id="B179"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Han</surname><given-names>T.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>C.-H.</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>Y.-P.</given-names></name><name name-style="western"><surname>Peng</surname><given-names>C.</given-names></name><name name-style="western"><surname>Ran</surname><given-names>X.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Analysis of the chemical composition, acute toxicity and skin sensitivity of essential oil from rhizomes of Ligusticum chuanxiong</article-title>. <source>J. Ethnopharmacol.</source><volume>144</volume> (<issue>3</issue>), <fpage>791</fpage>&#8211;<lpage>796</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2012.10.010</pub-id><pub-id pub-id-type="pmid">23085396</pub-id></mixed-citation></ref><ref id="B180"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Tang</surname><given-names>W.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>S.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Fan</surname><given-names>X.</given-names></name></person-group> (<year>2020a</year>). <article-title>Tetramethylpyrazine inhibits platelet adhesion and inflammatory response in vascular endothelial cells by inhibiting P38 MAPK and NF-kappa B signaling pathways</article-title>. <source>Inflammation</source><volume>43</volume> (<issue>1</issue>), <fpage>286</fpage>&#8211;<lpage>297</lpage>. <pub-id pub-id-type="doi">10.1007/s10753-019-01119-6</pub-id><pub-id pub-id-type="pmid">31720990</pub-id></mixed-citation></ref><ref id="B181"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Yan</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W.</given-names></name><name name-style="western"><surname>Li</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Du</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Enhancement of the functionality of attenuating acute lung injury by a microemulsion formulation with volatile oil of Angelicae Sinensis Radix and Ligusticum Chuanxiong Rhizoma encapsulated</article-title>. <source>Biomed. Pharmacother.</source><volume>156</volume>, <fpage>113888</fpage>. <pub-id pub-id-type="doi">10.1016/j.biopha.2022.113888</pub-id><pub-id pub-id-type="pmid">36272263</pub-id></mixed-citation></ref><ref id="B182"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Deng</surname><given-names>F.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>F.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>B.</given-names></name><etal/></person-group> (<year>2024a</year>). <article-title>Synergistic amelioration between Ligusticum striatum DC and borneol against cerebral ischemia by promoting astrocytes-mediated neurogenesis</article-title>. <source>J. Ethnopharmacol.</source><volume>327</volume>, <fpage>118062</fpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2024.118062</pub-id><pub-id pub-id-type="pmid">38492790</pub-id></mixed-citation></ref><ref id="B183"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Yan</surname><given-names>H. W.</given-names></name><name name-style="western"><surname>Feng</surname><given-names>Z. M.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y. N.</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>J. S.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>P. C.</given-names></name></person-group> (<year>2020b</year>). <article-title>Neophathalides A and B, two pairs of unusual phthalide analog enantiomers from Ligusticum chuanxiong</article-title>. <source>Org. Biomol. Chem.</source><volume>18</volume> (<issue>28</issue>), <fpage>5453</fpage>&#8211;<lpage>5457</lpage>. <pub-id pub-id-type="doi">10.1039/d0ob01014f</pub-id><pub-id pub-id-type="pmid">32638801</pub-id></mixed-citation></ref><ref id="B184"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Li</surname><given-names>D.</given-names></name><name name-style="western"><surname>Jia</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Mei</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2024b</year>). <article-title>Zhizi-Chuanxiong herb pair alleviates atherosclerosis progression in ApoE(-/-) mice by promoting the methylation of FGFR3 to inhibit MAPK/ERK-mediated apoptosis</article-title>. <source>J. Ethnopharmacol.</source><volume>319</volume> (<issue>Pt 1</issue>), <fpage>117188</fpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2023.117188</pub-id><pub-id pub-id-type="pmid">37716492</pub-id></mixed-citation></ref><ref id="B185"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>X.-j.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>C.-y.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>M.-m.</given-names></name><name name-style="western"><surname>Kou</surname><given-names>N.</given-names></name><name name-style="western"><surname>Qu</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Pretreatment with a combination of ligustrazine and berberine improves cardiac function in rats with coronary microembolization</article-title>. <source>Acta Pharmacol. Sin.</source><volume>37</volume> (<issue>4</issue>), <fpage>463</fpage>&#8211;<lpage>472</lpage>. <pub-id pub-id-type="doi">10.1038/aps.2015.147</pub-id><pub-id pub-id-type="pmid">26924290</pub-id><pub-id pub-id-type="pmcid">PMC4820796</pub-id></mixed-citation></ref><ref id="B186"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Qi</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Jia</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>L.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Q.</given-names></name><etal/></person-group> (<year>2024c</year>). <article-title>Effects and mechanisms of Zhizi Chuanxiong herb pair against atherosclerosis: an integration of network pharmacology, molecular docking, and experimental validation</article-title>. <source>Chin. Med.</source><volume>19</volume> (<issue>1</issue>), <fpage>8</fpage>. <pub-id pub-id-type="doi">10.1186/s13020-023-00874-x</pub-id><pub-id pub-id-type="pmid">38212797</pub-id><pub-id pub-id-type="pmcid">PMC10782628</pub-id></mixed-citation></ref><ref id="B187"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>D.-Y.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>D.-D.</given-names></name><name name-style="western"><surname>Ren</surname><given-names>L.</given-names></name><name name-style="western"><surname>Bi</surname><given-names>G.-R.</given-names></name></person-group> (<year>2020</year>). <article-title>Ligustilide protects PC12 cells from oxygen-glucose deprivation/reoxygenation-induced apoptosis via the LKB1-AMPK-mTOR signaling pathway</article-title>. <source>Neural Regen. Res.</source><volume>15</volume> (<issue>3</issue>), <fpage>473</fpage>&#8211;<lpage>481</lpage>. <pub-id pub-id-type="doi">10.4103/1673-5374.266059</pub-id><pub-id pub-id-type="pmid">31571659</pub-id><pub-id pub-id-type="pmcid">PMC6921349</pub-id></mixed-citation></ref><ref id="B188"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zheng</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Y.-y.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>P.-c.</given-names></name><name name-style="western"><surname>Tong</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Bao</surname><given-names>X.-y.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Q.-h.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Ligustrazine exerts cardioprotection in animal models of myocardial ischemia/reperfusion injury: preclinical evidence and possible mechanisms</article-title>. <source>Front. Pharmacol.</source><volume>9</volume>, <fpage>729</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2018.00729</pub-id><pub-id pub-id-type="pmid">30090062</pub-id><pub-id pub-id-type="pmcid">PMC6068386</pub-id></mixed-citation></ref><ref id="B189"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhong</surname><given-names>C.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Pu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Bao</surname><given-names>Y.</given-names></name></person-group> (<year>2021</year>). <article-title>Physicochemical properties of polysaccharides from Ligusticum chuanxiong and analysis of their anti-tumor potential through immunoregulation</article-title>. <source>Food Funct.</source><volume>12</volume> (<issue>4</issue>), <fpage>1719</fpage>&#8211;<lpage>1731</lpage>. <pub-id pub-id-type="doi">10.1039/d0fo02978e</pub-id><pub-id pub-id-type="pmid">33502414</pub-id></mixed-citation></ref><ref id="B190"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhong-Hui</surname><given-names>P.</given-names></name><name name-style="western"><surname>Peng</surname><given-names>C.</given-names></name><name name-style="western"><surname>Xie</surname><given-names>X. F.</given-names></name><name name-style="western"><surname>Min</surname><given-names>L.</given-names></name><name name-style="western"><surname>Huan</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Rui</surname><given-names>F.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Alkaloids from the rhizomes of Ligusticum striatum exert antimigraine effects through regulating 5-HT<sub>1B</sub> receptor and c-Jun</article-title>. <source>J. Ethnopharmacol.</source><volume>237</volume>, <fpage>39</fpage>&#8211;<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2019.03.026</pub-id><pub-id pub-id-type="pmid">30880256</pub-id></mixed-citation></ref><ref id="B191"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>G.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Q.</given-names></name></person-group> (<year>2024</year>). <article-title>Research progress on chemical constituents of ligusticum chuanxiong hort and their application in prevention and treatment of cardiovascular diseases</article-title>. <source>Tradit. Chin. Med.</source><volume>13</volume>, <fpage>2841</fpage>&#8211;<lpage>2849</lpage>. <pub-id pub-id-type="doi">10.12677/tcm.2024.1311419</pub-id></mixed-citation></ref><ref id="B192"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>L.</given-names></name><name name-style="western"><surname>Sheng</surname><given-names>H.</given-names></name></person-group> (<year>2013</year>). <article-title>GC-MS analysis of volatile components in Ligusticumv chuanxiong Hort</article-title>. <source>J. Shandong Univ. Trad. Chin. Med.</source><volume>37</volume>, <fpage>164</fpage>&#8211;<lpage>165</lpage>. <pub-id pub-id-type="doi">10.16294/j.cnki.1007-659x.2013.02.031</pub-id></mixed-citation></ref><ref id="B193"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>Y. L.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X. Y.</given-names></name><name name-style="western"><surname>Xie</surname><given-names>J.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J. F.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Senkyunolide I alleviates renal Ischemia-Reperfusion injury by inhibiting oxidative stress, endoplasmic reticulum stress and apoptosis</article-title>. <source>Int. Immunopharmacol.</source><volume>102</volume>, <fpage>108393</fpage>. <pub-id pub-id-type="doi">10.1016/j.intimp.2021.108393</pub-id><pub-id pub-id-type="pmid">34857480</pub-id></mixed-citation></ref><ref id="B194"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhuang</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Z.-H.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Y.-Y.</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Pan</surname><given-names>X.-D.</given-names></name></person-group> (<year>2020</year>). <article-title>Protective effect and possible mechanisms of ligustrazine isolated from Ligusticum wallichii on nephropathy in rats with diabetes: a preclinical systematic review and meta-analysis</article-title>. <source>J. Ethnopharmacol.</source><volume>252</volume>, <fpage>112568</fpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2020.112568</pub-id><pub-id pub-id-type="pmid">31978520</pub-id></mixed-citation></ref><ref id="B195"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zou</surname><given-names>J.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>G.-D.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>H.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Luo</surname><given-names>X.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>W.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Triligustilides A and B: two pairs of phthalide trimers from angelica sinensis with a complex polycyclic skeleton and their activities</article-title>. <source>Org. Lett.</source><volume>20</volume> (<issue>3</issue>), <fpage>884</fpage>&#8211;<lpage>887</lpage>. <pub-id pub-id-type="doi">10.1021/acs.orglett.8b00017</pub-id><pub-id pub-id-type="pmid">29360378</pub-id></mixed-citation></ref><ref id="B196"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zuo</surname><given-names>A.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>H.</given-names></name><name name-style="western"><surname>Li</surname><given-names>L.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Yi</surname><given-names>J.</given-names></name></person-group> (<year>2011</year>). <article-title>Identification of the absorbed components and metabolites in rat plasma after oral administration of Rhizoma Chuanxiong decoction by HPLC-ESI-MS/MS</article-title>. <source>J. Pharm. Biomed. Anal.</source><volume>56</volume> (<issue>5</issue>), <fpage>1046</fpage>&#8211;<lpage>1056</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpba.2011.08.010</pub-id><pub-id pub-id-type="pmid">21880453</pub-id></mixed-citation></ref><ref id="B197"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zuo</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Zuo</surname><given-names>P.-f.</given-names></name><name name-style="western"><surname>Sheng</surname><given-names>Z.-l.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Ding</surname><given-names>J.-d.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>G.-s.</given-names></name></person-group> (<year>2019</year>). <article-title>Tetramethylprazine attenuates myocardial ischemia/reperfusion injury through modulation of autophagy</article-title>. <source>Life Sci.</source><volume>239</volume>, <fpage>117016</fpage>. <pub-id pub-id-type="doi">10.1016/j.lfs.2019.117016</pub-id><pub-id pub-id-type="pmid">31678281</pub-id></mixed-citation></ref></ref-list><sec id="s13"><title>Glossary</title><def-list><def-item><term id="G1-fphar.2025.1523176">
A&#946;
</term><def><p>amyloid-&#946; protein</p></def></def-item><def-item><term id="G2-fphar.2025.1523176">
AD
</term><def><p>Alzheimer&#8217;s Disease</p></def></def-item><def-item><term id="G3-fphar.2025.1523176">
AKI
</term><def><p>acute kidney injury</p></def></def-item><def-item><term id="G4-fphar.2025.1523176">
ALI
</term><def><p>acute lung injury</p></def></def-item><def-item><term id="G5-fphar.2025.1523176">
ALS
</term><def><p>Amyotrophic lateral sclerosis</p></def></def-item><def-item><term id="G6-fphar.2025.1523176">
ARDS
</term><def><p>acute respiratory distress syndrome</p></def></def-item><def-item><term id="G7-fphar.2025.1523176">
AS
</term><def><p>atherosclerosis</p></def></def-item><def-item><term id="G8-fphar.2025.1523176">
ATP
</term><def><p>adenosine triphosphate</p></def></def-item><def-item><term id="G9-fphar.2025.1523176">
AMPK
</term><def><p>adenosine 5&#8216;-monophosphate (AMP)-activated protein kinase</p></def></def-item><def-item><term id="G10-fphar.2025.1523176">
AQP
</term><def><p>aquaporin 4</p></def></def-item><def-item><term id="G11-fphar.2025.1523176">
AK2
</term><def><p>Janus kinase 2</p></def></def-item><def-item><term id="G12-fphar.2025.1523176">
Bcl-2
</term><def><p>B-cell lymphoma-2</p></def></def-item><def-item><term id="G13-fphar.2025.1523176">
BKCa
</term><def><p>big potassium calcium-activated channels</p></def></def-item><def-item><term id="G14-fphar.2025.1523176">
Bax
</term><def><p>Bcl-2 associated X protein</p></def></def-item><def-item><term id="G15-fphar.2025.1523176">
CX
</term><def><p>dried rhizome of <italic toggle="yes">Ligusticum chuanxiong</italic>
</p></def></def-item><def-item><term id="G16-fphar.2025.1523176">
CCVD
</term><def><p>cardio-cerebral vascular diseases</p></def></def-item><def-item><term id="G17-fphar.2025.1523176">
CUL4B
</term><def><p>Cullin 4B</p></def></def-item><def-item><term id="G18-fphar.2025.1523176">
CCI
</term><def><p>chronic compression injury</p></def></def-item><def-item><term id="G19-fphar.2025.1523176">
c-JUN
</term><def><p>c-Jun N-terminal kinase</p></def></def-item><def-item><term id="G20-fphar.2025.1523176">
Cx43
</term><def><p>connexin43</p></def></def-item><def-item><term id="G21-fphar.2025.1523176">
CXCL12
</term><def><p>chemokine C-X-C motif ligand 12</p></def></def-item><def-item><term id="G22-fphar.2025.1523176">
CXCR4
</term><def><p>chemokine C-X-C motif receptor 4</p></def></def-item><def-item><term id="G23-fphar.2025.1523176">
Caspase-1
</term><def><p>cysteine-requiring aspartate protease-1</p></def></def-item><def-item><term id="G24-fphar.2025.1523176">
caspase-3
</term><def><p>cysteinyl aspartate specific proteinase 3</p></def></def-item><def-item><term id="G25-fphar.2025.1523176">
COX2
</term><def><p>cyclooxygenase-2</p></def></def-item><def-item><term id="G26-fphar.2025.1523176">
caspase-8
</term><def><p>cysteine-requiring aspartate protease-8</p></def></def-item><def-item><term id="G27-fphar.2025.1523176">
CCR1
</term><def><p>C-C Motif Chemokine Receptor 1</p></def></def-item><def-item><term id="G28-fphar.2025.1523176">
DN
</term><def><p>diabetic nephropathy</p></def></def-item><def-item><term id="G29-fphar.2025.1523176">
DNA
</term><def><p>deoxyriboNucleic Acid</p></def></def-item><def-item><term id="G30-fphar.2025.1523176">
EO
</term><def><p>essential oil</p></def></def-item><def-item><term id="G31-fphar.2025.1523176">
ERK
</term><def><p>extracellular signal-regulated kinase</p></def></def-item><def-item><term id="G32-fphar.2025.1523176">
FAK
</term><def><p>focal adhesion kinase</p></def></def-item><def-item><term id="G33-fphar.2025.1523176">
FGF
</term><def><p>fibroblast growth factor</p></def></def-item><def-item><term id="G34-fphar.2025.1523176">
FGFR3
</term><def><p>fibroblast growth factor receptor 3</p></def></def-item><def-item><term id="G35-fphar.2025.1523176">
GSK
</term><def><p>Glycogen Synthase Kinase</p></def></def-item><def-item><term id="G36-fphar.2025.1523176">
GTP
</term><def><p>guanosine triphosphate</p></def></def-item><def-item><term id="G37-fphar.2025.1523176">
GPX4
</term><def><p>glutathione peroxidase 4</p></def></def-item><def-item><term id="G38-fphar.2025.1523176">
GSDMD
</term><def><p>gasdermin D</p></def></def-item><def-item><term id="G39-fphar.2025.1523176">
HD
</term><def><p>Huntington&#8217;s disease</p></def></def-item><def-item><term id="G40-fphar.2025.1523176">
HO-1
</term><def><p>heme oxygenase-1</p></def></def-item><def-item><term id="G41-fphar.2025.1523176">
HSC
</term><def><p>hepatic stellate cell</p></def></def-item><def-item><term id="G42-fphar.2025.1523176">
H3K9ac
</term><def><p>histone 3 lysine 9 acetylation</p></def></def-item><def-item><term id="G43-fphar.2025.1523176">
hNOS
</term><def><p>human neuronal oxidative stress</p></def></def-item><def-item><term id="G44-fphar.2025.1523176">
IL
</term><def><p>Interleukin</p></def></def-item><def-item><term id="G45-fphar.2025.1523176">
I/R
</term><def><p>ischemia/reperfusion</p></def></def-item><def-item><term id="G46-fphar.2025.1523176">
iNOS
</term><def><p>inducible nitric oxide synthase</p></def></def-item><def-item><term id="G47-fphar.2025.1523176">
ISO
</term><def><p>International Organization for Standardization</p></def></def-item><def-item><term id="G48-fphar.2025.1523176">
KAT2A
</term><def><p>lysine acetyltransferase 2A</p></def></def-item><def-item><term id="G49-fphar.2025.1523176">
LCP
</term><def><p>ligusticum CX polysaccharides</p></def></def-item><def-item><term id="G50-fphar.2025.1523176">
LKB1
</term><def><p>liver kinase B1</p></def></def-item><def-item><term id="G51-fphar.2025.1523176">
LIMK1
</term><def><p>LIM Domain Kinase 1</p></def></def-item><def-item><term id="G52-fphar.2025.1523176">
LD50
</term><def><p>median lethal dose</p></def></def-item><def-item><term id="G53-fphar.2025.1523176">
MAPK
</term><def><p>mitogen-activated protein kinase</p></def></def-item><def-item><term id="G54-fphar.2025.1523176">
MCPIP1
</term><def><p>monocyte chemotactic protein-induced protein 1</p></def></def-item><def-item><term id="G55-fphar.2025.1523176">
ME
</term><def><p>microsphere-embolized</p></def></def-item><def-item><term id="G56-fphar.2025.1523176">
MMP
</term><def><p>matrix metalloprotein</p></def></def-item><def-item><term id="G57-fphar.2025.1523176">
mTOR
</term><def><p>mammalian target of rapamycin</p></def></def-item><def-item><term id="G58-fphar.2025.1523176">
NFTs
</term><def><p>neurofibrillary tangles</p></def></def-item><def-item><term id="G59-fphar.2025.1523176">
NMPA
</term><def><p>National Medical Products Administration</p></def></def-item><def-item><term id="G60-fphar.2025.1523176">
NO
</term><def><p>nitric oxide</p></def></def-item><def-item><term id="G61-fphar.2025.1523176">
Nrf2
</term><def><p>nuclear factor erythroid 2-related factor 2</p></def></def-item><def-item><term id="G62-fphar.2025.1523176">
NF&#954;B
</term><def><p>nuclear factor kappa-B</p></def></def-item><def-item><term id="G63-fphar.2025.1523176">
NADPH
</term><def><p>nicotinamide adenine dinucleotide phosphate</p></def></def-item><def-item><term id="G64-fphar.2025.1523176">
NOD2
</term><def><p>nucleotide-binding oligomerization domain 2</p></def></def-item><def-item><term id="G65-fphar.2025.1523176">
OGD/R
</term><def><p>oxygen-glucose deprivation/reperfusion</p></def></def-item><def-item><term id="G66-fphar.2025.1523176">
NLRP3
</term><def><p>Nod-like receptor family pyrin domain-containing 3</p></def></def-item><def-item><term id="G67-fphar.2025.1523176">
PD
</term><def><p>Parkinson&#8217;s disease</p></def></def-item><def-item><term id="G68-fphar.2025.1523176">
PKC
</term><def><p>protein kinase C</p></def></def-item><def-item><term id="G69-fphar.2025.1523176">
PI3K
</term><def><p>phosphoinositide 3-kinase</p></def></def-item><def-item><term id="G70-fphar.2025.1523176">
PPAR
</term><def><p>peroxisome proliferator-activated receptors</p></def></def-item><def-item><term id="G71-fphar.2025.1523176">
PINK1
</term><def><p>PTEN induced putative kinase 1</p></def></def-item><def-item><term id="G72-fphar.2025.1523176">
Prx1
</term><def><p>paired related homeobox 1</p></def></def-item><def-item><term id="G73-fphar.2025.1523176">
PGC-1&#945;
</term><def><p>peroxisome proliferator-activated receptor-&#947; coactivator-1&#945;</p></def></def-item><def-item><term id="G74-fphar.2025.1523176">
PKC-&#946;
</term><def><p>protein kinase C beta</p></def></def-item><def-item><term id="G75-fphar.2025.1523176">
PAI-1
</term><def><p>plasminogen activator inhibitor-1</p></def></def-item><def-item><term id="G76-fphar.2025.1523176">
QBT
</term><def><p>a novel phthalein metabolite</p></def></def-item><def-item><term id="G77-fphar.2025.1523176">
Rac1
</term><def><p>Rac Family Small GTPase 1</p></def></def-item><def-item><term id="G78-fphar.2025.1523176">
SMCs
</term><def><p>smooth muscle cells</p></def></def-item><def-item><term id="G79-fphar.2025.1523176">
SR
</term><def><p>scavenger receptor</p></def></def-item><def-item><term id="G80-fphar.2025.1523176">
SREBPs
</term><def><p>sterol regulatory element-binding proteins</p></def></def-item><def-item><term id="G81-fphar.2025.1523176">
STZ
</term><def><p>streptozotocin</p></def></def-item><def-item><term id="G82-fphar.2025.1523176">
SOD
</term><def><p>superoxide dismutase</p></def></def-item><def-item><term id="G83-fphar.2025.1523176">
siRNA
</term><def><p>small interfering RNA</p></def></def-item><def-item><term id="G84-fphar.2025.1523176">
STAT3
</term><def><p>signal transducer and activator of transcription 3</p></def></def-item><def-item><term id="G85-fphar.2025.1523176">
SSRT4
</term><def><p>somatostatin receptor 4</p></def></def-item><def-item><term id="G86-fphar.2025.1523176">
SIRT-1
</term><def><p>silent information regulator 1</p></def></def-item><def-item><term id="G87-fphar.2025.1523176">
SCAP
</term><def><p>sterol regulatory element-binding proteins leavage activating protein</p></def></def-item><def-item><term id="G88-fphar.2025.1523176">
TBN
</term><def><p>tetramethylpyrazine nitrone</p></def></def-item><def-item><term id="G89-fphar.2025.1523176">
TCM
</term><def><p>traditional Chinese medicine</p></def></def-item><def-item><term id="G90-fphar.2025.1523176">
TMP
</term><def><p>tetramethylpyrazine</p></def></def-item><def-item><term id="G91-fphar.2025.1523176">
TNF
</term><def><p>tumor necrosis factor</p></def></def-item><def-item><term id="G92-fphar.2025.1523176">
TRAF6
</term><def><p>tumor necrosis factor receptor-associated factor 6</p></def></def-item><def-item><term id="G93-fphar.2025.1523176">
TLR4
</term><def><p>Toll-like receptor 4</p></def></def-item><def-item><term id="G94-fphar.2025.1523176">
TDP-43
</term><def><p>TAR DNA-binding protein of 43&#160;kDa;</p></def></def-item><def-item><term id="G95-fphar.2025.1523176">
WCVP
</term><def><p>World Checklist of Vascular Plants</p></def></def-item><def-item><term id="G96-fphar.2025.1523176">
xCT
</term><def><p>cystine-glutamate antiporter</p></def></def-item><def-item><term id="G97-fphar.2025.1523176">
ZO-1
</term><def><p>Zonula occludens-1</p></def></def-item><def-item><term id="G98-fphar.2025.1523176">
3-NP
</term><def><p>3-Nitropropionic acid</p></def></def-item><def-item><term id="G99-fphar.2025.1523176">
5-HIAA
</term><def><p>5-hydroxyindole acetic acid</p></def></def-item><def-item><term id="G100-fphar.2025.1523176">
5-HT
</term><def><p>5-hydroxytryptamine</p></def></def-item><def-item><term id="G101-fphar.2025.1523176">
5-HT1B
</term><def><p>5-Hydroxytryptamine Receptor 1B</p></def></def-item></def-list></sec></back></article></pmc-articleset>